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CHAPTER 
1 
GENERAL INTRODUCTION 

CHAPTER 1.1 
CHROMOSOMAL ABERRATIONS IN HUMAN CANCER 
In his classical work entitled Zur Frage der Entstehung maligner Tumoren Boveri (1914) 
made several statements connecting genetics with cancer that can best be formulated as follows: 
(1) a malignant cell descends from a normal cell by losing its normal characteristics; (2) persistent 
changes in chromatin force the cell into further divisions without requirement for other stimuli; (3) 
typically, every tumor cell arises from a single cell that undergoes one or more permanent 
changes (which occur by chance), thereafter giving rise to billions of similarly altered cells; (4) 
the abnormal chromatin (chromosome) combination of the tumor also induces a characteristic 
metabolism: there are chromosomes which suppress and those which stimulate cell divisions and if 
either one is affected, a tumor cell arises; (5) cancer may be hereditary, but malignancy arises 
only if both (parental) chromosomes are affected; (6) there may be several different chromosomal 
aberrations, which are correlated with a defined tumor entity, but there may also be a single 
abnormal chromosome combination for a given cell population which makes the cell malignant; 
(7) cancer, thus, is a genetic disease at the cellular level. Although most of Boveri's statements 
eventually turned out to be true, it was not until 1960 that the first consistent chromosomal 
abnormality was found in human tumor cells (i.e., the Philadelphia chromosome in chronic 
myelogenous leukemia) (Nowell and Hungerford, 1960). With the subsequent introduction and 
continuous improvement of various chromosome banding techniques, that allowed the precise 
delineation of each individual chromosome or chromosomal (sub-)region (Caspersson, 1970; 
Seabright, 1970; Sumner et al., 1971; Patii et al., 1971; Hagemeijer et al., 1979; Yunis, 1981), a 
large-scale search for specific karyotypic abnormalities could be initiated. Since then, a vast 
amount of detailed information on the incidence and nature of chromosomal anomalies in human 
cancer has been accumulated (see Mitelman, 1991) and it is now well established that the 
occurrence of clonal, acquired chromosomal aberrations is a characteristic feature of neoplastic 
cells in general (Heim and Mitelman, 1987; Sandberg, 1990). 
Another conclusion emerging from these cytogenetic studies was that some chromosomal 
changes seem to be restricted to a particular neoplasm whilst others are more widely observed. In 
principle, any chromosomal aberration in a given tumor cell can be referred to one of the 
following three categories (see Heim and Mitelman, 1987; Mitelman and Heim, 1991): (1) 
Primary aberrations; these are frequently found as the sole karyotypic abnormality and are often 
associated with a particular tumor type. Primary abnormalities occur early in the oncogenetic 
process and are thought to be essential for the establishment of the neoplasm. (2) Secondary 
chromosomal aberrations; these are rarely or never found as solitary change but, instead, occur in 
addition to the primary abnormalities. Though less specific than the primary ones, secondary 
abnormalities show clear non-random features (Heim and Mitelman, 1986). They often become 
apparent in later stages of the disease and, hence, may play a role in tumor progression, probably 
by giving the tumor cells a selective growth advantage (see also Sandberg, 1991). (3) Cytogenetic 
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noise, these seemingly unspecific chromosomal aberrations most likely result from genetic 
instability Although many of these latter anomalies may be neutral or, alternatively, deleterious to 
the tumor cell, they may be detectable (temporarily) as non-clonal aberrations Sometimes it is 
difficult to make a clear-cut discrimination between genuine secondary changes and cytogenetic 
noise 
The various chromosomal anomalies that are encounterd in tumor cells may present 
themselves as numerical changes (due to gain or loss of chromosomes or segments thereof), 
structural changes (due to interchromosomal translocations or insertions, or intrachromosomal 
inversions or insertions) or amplifications (usually visible as extrachromosomal double minutes 
[dmin's], intrachromosomal homogeneously staining regions [hsr's] or abnormally banding regions 
[abr's]) Several studies have indicated that the genomic sites involved in such tumor-associated 
chromosomal rearrangements may correspond to the location of (one of the) two major currently 
known classes of genes which are thought to be most relevant for cancer development, ι e , the 
dominantly-acting oncogenes or the recessive tumor suppressor genes The oncogenes code for 
factors that, via signal transduction pathways, control cellular proliferation and differentiation 
processes (Gordon, 1985) In several leukemias for example, the action of cellular proto-
oncogenes was found to be converted into that of active oncogenes via transposition to new 
genetic locations (for reviews see Holliday, 1989, and Cleary, 1991) In some instances, this may 
result in a mere overexpression of an otherwise normal gene product In other cases tumor 
specific chimaeric genes are formed that encode fusion mRNAs and, finally, fusion proteins 
unique to the tumor cell involved (Heisterkamp et al , 1983, Shtivelman et al , 1985, Kamps et 
al , 1990, Nourse et al , 1990 , Von Lindern et al , 1990) Other oncogenes become activated 
through (point-) mutations (Tabin et al , 1982, Reddy et al , 1982, Klein and Klein, 1986) On the 
other hand, tumor suppressor genes (or anti-oncogenes Green and Wyke, 1985) control cellular 
proliferation processes in a negative manner Mutational inactivation and/or deletion of a tumor 
suppressor gene ( e g , the retinoblastoma or RBI gene Friend et al , 1986) has been found to 
facilitate neoplastic growth To date, most molecular mechanisms underlying carcinogenesis have 
been elucidated through the study of hematological tumors (leukemias and lymphomas) which 
collectively represent less than 10% of all the cancers in man (see Trent and Meltzer, 1993) 
Although human solid tumors play a more predominant role in human morbidity and 
mortality than do hematological neoplasms, much less is known about the cytogenetic 
abnormalities that characterize them Several problems, mostly technical in nature, have for a long 
time hampered the acquisition of cytogenetic data on solid tumors (see Atkin, 1989, Teyssier, 
1989) (1) Solid tumors yield low numbers of viable cells after biopsy, often have obvious or 
cryptic infections, have low mitotic activities in tissue culture and, in addition, may be infiltrated 
by inflammatory cells and/or fibroblasts that overgrow the tumor cells in culture (2) 
Investigations are usually carried out on advanced tumors They may contain abnormalities that 
are acquired during later stages of tumor development, thereby leading to complex karyotypes (3) 
The quality of the metaphases (as compared to blood or bone marrow preparations) is relatively 
poor Consequently, structural rearrangements may remain undefined or primary abnormalities 
may be difficult to distinguish (4) Finally, cytogenetic studies on long-term tumor cell lines can 
be misleading since secondary cytogenetic abnormalities may be acquired during propagation in 
tissue culture Technical improvements in solid tumor cytogenetics (e g , introduction of short-
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term cultures initiated from mechanically and/or enzymaticaJly disaggregated tumor cells, 
supplementation of culture media with growth factors and/or other growth promoting agents: 
Limon et al., 1986; Thompson et al., 1991; Mandahl et al., 1992) contributed significantly to our 
present knowledge on consistent abnormalities in both malignant and benign tumors, a partial list 
of which is presented in Table 1 (from Trent and Meltzer, 1993). In some cases, the detection of 
a highly specific primary chromosomal change may already be indicative not only for the presence 
of a given rumor (sub-)type (i.e., tumor diagnosis), but also for the prognosis of that same tumor. 
The impact of solid tumor cytogenetics in clinical oncology, however, is still relatively low. 
Therefore, the further identification and detailed characterization of the entire spectrum of 
chromosome aberrations that do occur in these tumors is of major importance. At present, this 
research is still in its infancy for most tumors (Mandahl, 1994), but ongoing cytogenetic studies 
are rapidly gaining speed owing to among others progress that is being made in related 
(molecular) disciplines. 
Indeed, during the last five years, newly developed molecular-genetic techniques have made 
a considerable contribution to solid tumor cytogenetics. In particular, the possibility to use 
polymorphic DNA markers to discriminate between both chromosome homologues (Botstein et al., 
1980) has added a new dimension to the analysis of various solid tumors (Seemayer and Cavenee, 
1989; Hunter, 1991). By comparing tumor DNA with constitutive DNA from the same patient 
chromosomal deletions, imbalances and/or rearrangements can be detected. Sets of informative 
polymorphic (e.g., di- or tri-nucleotide repeat) probes allow for the screening of all human 
chromosomes in order to generate a so-called 'allelotype', the molecular-genetic counterpart of the 
'karyotype'. In this way, non-random allele losses, presumably involving tumor suppressor loci, 
have been detected in various (familial) solid cancers. In some cases, this approach has even led to 
the identification of the relevant rumor suppressor genes (e.g., RBI, WT1, TP53 in 
retinoblastoma: Friend et al., 1986; Wilms tumor: Call et al., 1990, and Gessier et al., 1990; and 
the Li-Fraumeni syndrome, respectively: Malkin et al., 1990; see also Knudson, 1993). Although 
these latter syndromes represent only a relatively small fraction of all cases, knowledge about the 
underlying mechanisms may contribute considerably to our understanding of the more common 
non-familial forms of cancer (Knudson, 1993). 
Quantitation of the total nuclear DNA content, or DNA-ploidy analysis, can be achieved by 
flow- or image cytometry. This technique is particularly suited for studying relationships between 
DNA-ploidy and clinico-pathological parameters such as tumor aggressiveness (see Cornelisse and 
Tanke, 1991). The type of information obtained, however, provides little detail: minimal 
aneuploidies involving one or two chromosomes can not be measured and specific data on 
over/underrepresented chromosomes can not be acquired. Still, DNA-ploidy changes, including 
the heterogeneity of intratumor ploidy, have been succesfully demonstrated in nearly all tumor 
types tested via this relatively fast and generally applicable technique (Cornelisse et al., 1991). 
DNA information on the single cell or even single chromosomal level can best be obtained 
via in situ hybridization techniques (see Chapter 2). This molecular-cytogenetic technique allows 
for the screening of specific DNA targets, ranging from as little as a few kilobase pairs (kbp) to 
whole chromosomes. In this way, normal chromosomes and/or chromosomal rearrangements may 
be traced down not only in individual tumor metaphase spreads but also in interphase nuclei that, 
otherwise, are not accessible for conventional cytogenetic methods. 
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TABLE 1: Examples of recurring chromosomal abnormalities in solid tumors 
Disease 
Malignant epithelial neoplasms 
Bladder carcinoma 
Breast tumor 
Colon cancer 
Kidney cancer 
Ovarian cancer 
Prostate cancer 
Small-cell lung cancer 
Wilms' tumor 
Germ cell neoplasms 
Testicular teratoma/seminoma 
Malignant mesenchymal neoplasms 
Alveolar rhabdomyosarcomas 
Myxoid liposarcoma 
Chondrosarcoma 
Ewing's sarcoma 
Synovial sarcoma 
Malignant neurogenic neoplasms 
Gliomas 
Neuroblastoma 
Retinoblastoma 
Melanocytic neoplasms 
Malignant melanoma 
Benign mesenchymal neoplasms 
lipoma 
leiomyoma 
Benign neurogenic neoplasms 
Meningioma 
Chromosomal alteration 
Structural alterations 1, 3, and 11 
i(5p)/5q-, +7, -9/9q-
Structural alterations 1, 7 
t/del(16q) 
Structural alterations 1, 17, 18 
del(5q), del(6q) 
t(5;14)(ql3;q22) 
Structural alterations 1, 7, 11 
t/del(6q), t(6;14)(q21;q24) 
del(7)(q22), del(10)(q24) 
del(3)(pl4p23) 
t/del(ll)(pl3) 
i(12p) 
t(2;13)(q37;ql4) 
t(12;16)(ql3;pll) 
t(9;22)(q31;q25) 
t(ll;22)(q24;ql2) 
t(X;18)(pll;qll) 
dmin's, -1-7, +10 
dmin's, hsr's 
del(l)(p31-32) 
i(6p) 
t/del(6q), t(l;19)(ql2;pl3), t/del 9p 
t(12;?)(ql3-14;?) 
t(12;14)(ql4-15;q23-24), del(7q) 
-22/22q-
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CHAPTER 1.2 
SCOPE OF THE THESIS 
The studies described in this thesis are aimed at the introduction, application and further 
development of fluorescence in situ hybridization (FISH) techniques for the analysis of (complex) 
karyotypes encountered in human solid tumors. Through FISH, a rapid detection and identification 
of tumor-associated chromosomal abnormalities may be accomplished in different solid tumor 
types, irrespective of their origin and accessibility by means of conventional cytogenetic 
techniques. As such, FISH may result in the delineation of consistent chromosomal 
rearrangements in (interphase) tumor cells and, subsequently, enable the detailed characterization 
of genomic regions involved in tumor initiation and/or progression. Finally, such information may 
lead to the identification of gene alterations responsible for malignant growth. On the other hand, 
FISH may enable discrimination between tumor (sub)types without prior detailed knowledge about 
the molecular mechanisms underlying their pathogenesis. It can be envisaged that these 
developments will have a considerable impact on tumor diagnosis and prognosis. A compilation of 
developments, applications, prospects and concomitant restrictions of the FISH technology, as well 
as its possible relevance for tumor cytogenetics, is presented in Chapter 2. The employment of a 
scala of FISH techniques and its feasibility in the study of human germ cell tumors is described in 
detail in Chapter 3. In Chapter 4, initial studies aimed at the characterization of specific 
chromosomal abnormalities in some soft tissue- and renal tumors are described. A general 
discussion and a survey of future perspectives are provided in Chapter 5. A summary of the work 
is presented in Chapter 6. 
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CHAPTER 
FLUORESCENCE IN SITU 
HYBRIDIZATION TECHNIQUES 

CHAPTER 2.1 
INTRODUCTION 
Radioactive in situ hybridization 
The sensitive detection and localization of specific nucleic acid sequences in 
morphologically preserved biological structures, such as chromosomes, cells and tissues, can be 
achieved via a technique that has been denoted as in situ hybridization (ISH). This technique, 
which was independently developed by three different groups (Pardue and Gall, 1969; John et al., 
1969; Buongiorno-Nardelli and Arnaldi, 1969), is based on the observation that under appropriate 
conditions single-stranded complementary nucleic acid (either DNA or RNA) sequences can 
encouter each other in register and form duplex molecules (Marmur et al., 1963). This process of 
duplex (e.g., DNA-DNA or DNA-RNA) formation is known as hybridization. Proceeding from 
this principle, the above mentioned research groups used radioactively labeled nucleic acid 
sequences as probes for hybridization to immobilized complementary targets. Subsequent detection 
and visualization of the resulting hybrids was accomplished by means of autoradiography 
(noticeable as grains under a light microscope). 
The concurrent development and introduction of molecular recombinant DNA technologies 
and the continuous improvement of probe labeling methods led to considerable improvements in 
the sensitivity of the ISH technique (Gerhard et al., 1981; Harper and Saunders, 1981). Despite its 
suitability for physical gene mapping (see Henderson, 1982; Harper and Marsell, 1986) and other 
applications, such as the detection of viral and other pathogenic sequences (Braphic and Haase, 
1978; Haase, 1986; Lo, 1986) and monitoring the expression (mRNAs) of cellular genes (Cox et 
al., 1984), the use of radioactive ISH procedures for routine purposes remained limited however. 
This was due to several inherent disadvantages: (1) the long exposure times for autoradiography to 
achieve the sensitivity required; (2) the poor topological resolution as a consequence of radial 
emittance of radioactive signals; (3) the need for statistical establishment of complex multiple 
sequence localizations; and (4) radiation hazards and other costs associated with handling materials 
and waste. 
Nonradioactive in situ hybridization 
A new era of non-isotopic ISH was ushered in during the late seventies and early eighties 
by the introduction of nonradioactive labels (Manning et al., 1975; Rudkin and Stellar, 1977; 
Bauman et al., 1980; Langer et al., 1981; Brigati et al., 1982) and the employment of high-
affinity reagents that allow immunocytochemical detection and amplification of the nonradioactive 
signal strength (Schmitz and Kampa, 1979; Bauman et al., 1981; Van Prooijen-Knegt et al., 1982; 
Pinkel et al., 1986b). Further refinement of probe labeling techniques allowed the enzymatic and 
chemical introduction of fluorochromized (Dirks et al., 1990, 1991; Wiegant et al., 1991) or 
hapten-like labeled nucleotides (Brigati et al., 1982; Manuelidis et al., 1982; Landegent et al., 
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1984; Tchen et al., 1984; Viscidi et al., 1986; Hopman et al., 1986b; Kessler, 1990). 
Consequently, relatively large amounts of labeled probes could be produced in a rather simple 
manner (Hopman et al., 1988a; Raap et al., 1990). In addition, indirect nonradioactive ISH 
methods, that make use of haptenized instead of fluorochromized probes, enabled the visualization 
of hybridization results with three different types of reporter molecules, depending on the choice 
of evaluation at the microscopic level. For fluorescence microscopy fiuorochromes like FITC 
(yellow), TRITC (red) and AMCA (blue) (Nederlof et al., 1989a, 1990), for light or reflection-
contrast microscopy cytochemically detectable enzymes (producing colored precipitates) such as 
peroxidase and alkaline phosphatase (Landegent et al., 1985), and for electron microscopy 
electron-dense particles like colloidal gold (Hutchinson et al., 1982, Binder et al., 1986, Trask et 
al., 1989) have been used, respectively. Together, these technical innovations have turned this 
technique into a simpler and more accessible one as compared to radioactive ISH. As a result, the 
application of nonradioactive ISH has expanded enormously in various fields of biological 
research. 
The wide use of fluorescence in situ hybridization (FISH), by which fluorescent signals 
visualize the site of probe hybridization, results from many factors (see review Trask, 1991). 
Firstly, FISH has advantages over hybridization with isotopically labeled probes with respect to 
spatial resolution, speed (usually results within 24 hrs), probe stability (storage for a period longer 
than 6 months), and statistical evaluation of the results (no longer required). Secondly, the 
sensitivity of FISH approaches that of isotopically labeled probes (2-5 kbp: Lawrence et al., 1988; 
Pinkel et al., 1988; Viegas-Péquignot et al., 1989; Viegas-Péquignot et al., 1991, who reported 
the localization of a 900-bp-long DNA probe). Thirdly, a variety of probe-labeling and 
immunocytochemical detection schemes are available for simultaneous detection, in different 
colors, of up to twelve sequences in the same metaphase, prophase or interphase nucleus (Hopman 
et al., 1986a, 1988b; Nederlof et al., 1989a, 1990, 1992b; Ried et al., 1992a, 1992b; Dauwerse 
et al., 1992). Fourthly, DNA sequences can not only be localized in targets ranging from 
metaphase spreads to so-called DNA halo and stretched duplex DNA preparations with a spatial 
resolution of less than 10 kb (Wiegant et al., 1992; Parra and Windle, 1993), but also in 
interphase nuclei in suspension whereby their three-dimensional structure is preserved (Trask et 
al., 1985; Pinkel et al., 1986a; Trask et al., 1988). Moreover, probe-labeling and fluorescent dye-
labeled affinity reagents are commercially available, making the FISH procedure more 
standardized and, thus, its results reproducible and reliable. Furthermore, the optic quality of 
fluorescence microscopes has improved steadily over the last decade, and the prospective 
implementation of highly advanced opto-electronic instrumentation for digital image microscopy 
(Arndt-Jovin et al., 1985; Hiraoka et al., 1987; Aikens et al., 1989) will even further optimize the 
sensitivity of FISH and the interpretation of (multiple color) in situ hybridization results in the 
near future (Viegas-Péquignot et al., 1989; Nederlof et al., 1992a, 1992c; Ried et al., 1992a; 
Putman et al., 1993). Finally, with the introduction of the in situ suppression hybridization 
strategy - which allows hybridization of only unique sequences within complex genomic DNAs 
by specifically blocking the interspersed reiterated sequences via a preannealing step with 
unlabeled competitor DNA (Landegent et al., 1987; Cremer et al., 1988a; Lichter et al., 1988a) -
the entire genome of a particular species, entire chromosomes, chromosomal subregions, or single 
loci can specifically be highlighted. The lengths of probe sequences may range from 10 to 50 
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oligonucleotides as in synthetic oligonucleotides (Dirks et al., 1990, 1991), to more than ten 
million as in somatic cell hybrids (Kievits et al., 1990b). As a consequence, it is expected that 
FISH will continue to play an increasingly important role in (biological) research disciplines, 
particularly in gene mapping, gene dosimetric and expression studies, studies on three-dimensional 
nuclear organization, flow cytometric quantification of probe fluorescence and, last but not least, 
cytogenetics, including the post- and prenatal diagnosis of inherited and/or acquired disorders and 
the analysis of malignant diseases (see review Trask, 1991). 
Application of FISH in tumor cytogenetics 
The significance of ISH techniques in tumor cytogenetics was already recognized in the 
early and mid eighties, when several research groups initiated the localization of cellular 
oncogenes relative to chromosomal translocation breakpoints in haematological malignancies 
(Bartram et al., 1983; Emanuel et al., 1984; Emanuel, 1985). With the application of 
chromosome-specific repetitive sequences such as alpha satellite and satellite III DNA (Cooke and 
Hindley, 1979; Lau, 1985; Devilee et al., 1986; Willard and Waye, 1987; see review Vogt, 1990) 
as probes in FISH studies (Cremer et al., 1988b; Devilee et al., 1988; Hopman et al., 1988b; 
Nederlof et al., 1989b), a new application arose: DNA probes were used as representatives of 
whole chromosomes to establish their copy number in interphase cells, an approach known now as 
interphase cytogenetics (Cremer et al., 1986; Hopman et al., 1988b). Although the kind of 
information obtained from these studies was restricted to the absence or presence of 
pericentromeric and/or other heterochromatic regions on specified chromosomes only, it became 
evident that in particular the field of solid tumor cytogenetics would benefit from this FISH 
approach. Analyses were no longer hampered by the low quality of chromosome spreads and high 
complexity of numerous chromosomal abnormalities which in many cases made conventional 
chromosome banding studies virtually impossible. Moreover, these chromosome-specific repeat 
probes appeared to be perfectly useful not only for monitoring chromosomes in non-dividing 
(interphase) cells in fresh tissue samples (Cremer et al., 1986, 1988b; Devilee et al., 1988; 
Hopman et al., 1988b, 1989; Giwercman et al., 1990; Van Dekken et al., 1990a, 1990b) but also 
in archival frozen or paraffin-embedded specimens (Emmerich et al., 1989; Walt et al., 1989; 
Arnoldus et al., 1991; Hopman et al., 1991; Van de Kaa et al., 1991). In addition, unlike other 
techniques for quantification of the total nuclear DNA content (e.g., flow- or image cytometry), 
FISH allowed analyses at the level of the individual cell. As such, it became not only suitable for 
revealing minimal aneuploidies involving one or two chromosomes, but also for detecting 
heterogeneity of intratumor ploidy. In other words, fluorescence (and other nonradioactive) ISH 
methods enabled partial karyotyping where classical cytogenetics and cytometric techniques 
appeared inadequate or even impossible. 
While bi- (Hopman et al., 1986a), tri- (Nederlof et al., 1989a) and multicolor (Nederlof et 
al., 1990) FISH procedures opened up the possibility to simultaneously detect several target sites 
representing different chromosomes in especially non-dividing cells, the development of 
chromosome-specific recombinant libraries (Latt et al., 1989; Van Dilla and Deaven, 1990; 
Collins et al., 1991) offered further perspectives. Such chromosome libraries are composites of 
small genomic fragments cloned into phage or plasmid vectors and represent the total genomic 
DNA content of one distinct chromosome. As such, DNAs extracted from these libraries allow the 
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delineation of whole chromosomes by FISH, a technique denoted as 'chromosome painting' 
(Pinkel et al., 1988). Since the application of a given chromosome library enables the detection of 
any sequence derived from that particular chromosome (Lichter et al., 1988a; Pinkel et al., 1988), 
it potentially simplifies the identification of structural aberrations in metaphase spreads and 
facilitates the detection of numerical aberrations in interphase nuclei (Cremer et al., 1988a; 
Lichter et al., 1988b; Pinkel et al., 1988). Similarly, genomic DNAs extracted from human-rodent 
somatic cell hybrids, containing one particular human chromosome (Kievits et al., 1990a) or a 
chromosomal subregion (Zhang et al., 1989; see Chapter 2.3: Sinke et al., 1992; see Chapter 3.2: 
Geurts van Kessel et al., 1991) as its sole human component, can be used as a 'paint' to highlight 
and identify single chromosomes or segments thereof (see Chapters 3.3-3.S, 3.7: Suijkerbuijk et 
al., 1991, 1992a, 1993a, 1994a). In analogy to multicolor FISH analyses with centromeric repeat 
probes, chromosome paints carrying three distinct labels mixed in multiple ratios (see Nederlof et 
al., 1992b) were used to visualize half of the chromosomal complement in twelve different colors 
(Dauwerse et al., 1992). Although at present this latter strategy is only amenable to the analyses 
of dividing cells, its versatility may well enable detection and characterization of minimal and/or 
complex chromosomal rearrangements in the near future. On the basis of the same principle, 
digital fluorescence microscopy based on ratio-imaging with four spectrally separable 
fluorochromes would, theoretically, allow the discrimination of all human chromosomes in 
different colors in a single FISH experiment (see Popp et al., 1993) and, as such, create a full 
molecular karyotype (Dauwerse et al., 1992). A further refinement of this approach may be 
achieved through the combination of chromosome painting and standard Giemsa banding 
techniques, which has already been shown to improve the characterization of complex tumor 
karyotypes (Smit et al., 1990, 1991; Klever et al., 1991). FISH with chromosome-specific 
libraries and DNAs from other origins has also been proven useful in confirming the origin of 
rearranged chromosomes, and in identifying the constitution of so-called marker chromosomes 
(Hamers et al., 1991; Smit et al., 1991; Kibbelaar et al., 1992; Speleman et al., 1992; see 
Chapter 3.3-3.5: Suijkerbuijk et al., 1991, 1992a, 1993a; see Chapters 4.2-4.3: Pedeutour et al., 
1993, 1994). Furthermore, FISH has enabled the correction of initial karyotype interpretations 
which were based on conventional cytogenetic analyses only (Smit et al., 1991; Olde Weghuis et 
al., 1994). 
If the analysis is focused on particular chromosomal subregions, however, chromosome 
painting appears inappropriate because in general it does not provide regional (sub-)localization 
information. In such situations, the application of much smaller DNA probes such as cosmids 
(Arnoldus et al., 1990; Tkachuk et al., 1990; Dauwerse et al., 1990; Ried et al., 1992c; De 
Leeuw et al., 1993b), YACs (Rowley et al., 1991; Knight et al., 1992; De Leeuw et al., 1993a; 
see Chapter 4.6: Suijkerbuijk et al., 1993b; De Leeuw et al., 1994), microlibraries (Schoenmakers 
et al., 1993) and PCR-generated probes may be useful. In this manner, dividing and non-dividing 
tumor cells can easily be recognized and classified, but this procedure is limited to those 
rearrangements for which defined probes are available. Despite worldwide efforts in the context of 
the 'Human Genome Project' (see HGM 11 report, 1991) to develop high resolution physical 
maps of all individual chromosomes, current maps of small chromosomal segments usually consist 
of little more than isolated and/or scattered landmarks (Hozier and Davis, 1992). Region-specific 
probes are not yet available for several of the chromosomal rearrangements that have been 
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identified in tumors. In addition, detailed cytogenetic data on specific rearrangements involved in 
solid tumor initiation and/or progression are still rather scarce (see Chapter 1). 
Novel FISH approaches 
Very recently, research has been aimed at the analysis of chromosomal fragments or total 
DNA isolated from primary tumors and tumor-derived cell lines. These DNAs themselves are 
used as probes for FISH in order to detect and define specific chromosomal aberrations. This 
approach will render molecular tumor cytogenetics independent from the availability of specific 
recombinant DNA probes and prior detailed knowledge about the respective genome 
rearrangements will no longer be required. One of these strategies is based on the combined 
application of flow cytometry (Gray et al., 1979; Young et al., 1981), DNA amplification by 
interspersed repeat polymerase chain reaction (PCR) (Saiki et al,., 198S, 1988; Cotter et al., 
1989; Nelson et al., 1989; Ledbetter et al., 1990) and FISH (Lichter et al., 1990). In short, low 
copy numbers (250-500) of metaphase chromosomes of interest are isolated by dual laser beam 
flow sorting. The resulting DNA is amplified by Alu element- or degenerated oligonucleotide 
primer (DOP)-mediated PCR and, finally, used as probe mixture for FISH ('reverse painting') 
onto normal human metaphase chromosomes (Telenius et al., 1992a; see Chapter 2.2: Suijkerbuijk 
et al., 1992b). Provided that sufficient dividing cells are available for flow sorting, this strategy 
may directly lead to the recognition and elucidation of the constitution of the isolated (aberrant) 
chromosomes (Carter et al., 1992; Telenius et al. 1992b; see Chapter 2.2: Suijkerbuijk et al., 
1992b; Boschman et al., 1993). Moreover, chromosome paints specific for normal and aberrant 
chromosomes can be generated in a relatively short time period (see Chapter 2.2: Suijkerbuijk et 
al., 1992b; Yerle et al., 1993; Hoebee et al., 1994). 
Another strategy makes use of microdissection of particular chromosomal segments, DOP-
PCR amplification and, finally, FISH to determine the origin of these chromosomal segments 
(Meltzer et al., 1992). In this way, several unidentifiable marker chromosomes and unbalanced 
translocations could be identified unequivocally (Meltzer et al., 1992). The resolving power of this 
sophisticated technique, which has been denoted as Micro-FISH, resides in the potential to 
elucidate the constitution of virtually all cytologically visible chromosomal rearrangements which 
remain unidentifiable by standard chromosome banding analyses. 
The third strategy, called comparative genomic in situ hybridization or CGH (Kallioniemi et 
al., 1992; Du Manoir et al., 1993), utilizes total rumor DNA instead of DNA derived from 
specified chromosomes or chromosomal segments. This newly developed technique is based on the 
simultaneous in situ suppression hybridization (see above) of differentially labeled test (i.e., 
tumor) and reference (i.e., normal) DNAs to normal human chromosome spreads and the 
detection of their hybridization patterns with two different fluorochromes (i.e., red and yellow, 
respectively). Since (1) the reference DNA serves as a control for local variations in the efficiency 
to hybridize to target sequences, and (2) the relative amounts of test and reference DNA bound at 
a given chromosomal locus are dependent on the relative abundance of these sequences in the two 
samples, intensity differences in the fluorescent hybridization patterns of test DNA and normal 
DNA can be interpreted as DNA sequence copy number differences between the two genomes. 
The possibility of comparing the copy numbers of chromosome sequences between two genomes 
by means of a digital image analysis system should eventually result in the construction of 'copy 
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number karyotypes'. In the case of tumors, comparison of genomes derived from malignant and 
normal cells may lead to the identification of regions of DNA gain (amplification) or loss 
(deletion). In this way, the CGH technique provides a means to detect and map regions containing 
genes that are important in cancer initiation and/or progression (Kallioniemi et al., 1992; Jóos et 
al., 1993; Mohamed et al., 1993; Chapter 3.7: Suijkerbuijk et al., 1994b; Chapter 4.4: 
Suijkerbuijk et al., 1994a; S eruca and Suijkerbuijk, unpublished observations). Unfortunately, this 
technique does neither provide any direct information on the chromosomal constitution of the test 
genome, nor reveal balanced chromosomal rearrangements resulting from inversions or 
translocations. Moreover, screening of genetic imbalances may be hampered by the presence of 
contaminating normal cells and intratumor heterogeneity. On the other hand, this technique allows 
- in a single hybridization step - a comprehensive survey of whole genomes derived not only from 
fresh tissue, but also from archival (including formalin-fixed, paraffin-embedded) materials 
(Speicher et al., 1993; see also Chapter 3.7: Suijkerbuijk et al., 1994b) that were not accessible to 
cytogenetic analyses previously. 
Taken together, with the expanding arsenal of different techniques and the increasing 
number of DNA probes available, FISH (and ISH in general) has become an increasingly 
important tool in molecular cytogenetics, supplementing classical cytogenetics and molecular 
genetics. Although some of these techniques (like CGH) are stilt in their infancy and some of the 
methods (i.e., microdissection, flow sorting) as well as the necessary instrumentation are as yet 
only available in specialized laboratories (see Chapters 2.2 and 2.3), it is anticipated that the 
various ISH techniques described will eventually become implemented in routine karyotyping of 
human malignancies. The different studies presented in this thesis (see below) will further 
illustrate this point. 
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ABSTRACT 
A novel approach to the identification of human chromosomes has been developed. Chromosomal 
in situ hybridization (or 'chromosome painting') has been performed using Alu element-mediated 
PCR products from small quantities (250-500) of flow-sorted normal and abnormal chromosomes. 
Chromosome paints for various normal chromosomes, including # 5, 6, 7, 14, 18, 19, 21, and 
22, were generated and shown to be effective in the identification of the appropriate 
chromosomes. In addition, certain abnormal chromosomes, including a mental retardation-
associated deletion chromosome 11 (q22-q23), the products of the constitutional translocation 
t(ll;22), and the CML-associated t(9;22), were used to generate region-specific paints. In each 
case, the appropriate regions of the chromosomes were highlighted and this strategy is, therefore, 
well suited to the identification of previously unidentified marker chromosomes. A further direct 
consequence of this work is that chromosome paints specific for the common aberrant 
chromosomes, such as the Philadelphia chromosome, can be generated and made widely available. 
These may find particular use in the analysis of complex or masked chromosomal translocations. 
Figures 1-9 are represented on Color Plate I 
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INTRODUCTION 
Nonradioactive in situ hybridization techniques, allowing the detection of specific nucleic 
acid sequences in microscopic preparations, are being increasingly applied in cytogenetics. The 
availability of chromosome-specific repetitive DNA probes (usually centromeric) has opened up 
the possibility of the detection of almost any particular chromosome in metaphase spreads and 
interphase nuclei (Alitalo et al., 1989; Arnoldus et al., 1989; Bums et al., 1985; Callen et al., 
1990; Cremer et al., 1986; Crolla and Llerena, 1988; Devilee et al., 1988; Hopman et al., 1988b; 
Julien et al., 1986; Lau, 1985; Piper et al., 1990; Smit et al., 1990; Speleman et al., 1991; 
Wessman et al., 1989). Following in situ suppression hybridization strategies (Cremer et al., 
1988a; Landegent et al., 1987; Pinkel et al., 1988), complex probe sets such as chromosome-
specific libraries and genomic DNA from mono-chromosomal human-rodent somatic cell hybrids 
can be used to 'paint' and thus identify complete chromosomes (Cremer et al.,1988a, 1990; 
Kievits et al., 1990b; Pinkel et al., 1988; Suijkerbuijk et al., 1991). Similarly, specific cloned 
DNA fragments in cosmids, yeast artificial chromosomes, or microlibraries can be used to 
investigate the fate of specific regions in cells bearing chromosomal aberrations (Arnoldus et al., 
1990; Cotter et al., 1991b; Dauwerse et al., 1990; Kievits et al., 1990a; Lengauer et al., 1991; 
Lüdecke et al., 1989, 1990; Rowley et al., 1990; Tkachuk et al., 1990). 
Currently, the derivation of chromosome paints requires a pure source of the relevant 
chromosomal DNA and thus has been limited to cell hybrids or chromosome-specific DNA 
libraries. Potentially, flow-sorted chromosomes could provide an ideal basis for the construction 
of such paints, provided that the disadvantage of limited amounts of starting material can be 
overcome. Alu element-mediated PCR has been used successfully to derive DNA probes from 
small numbers of flow-sorted chromosomes (Cotter et al., 1991a). We report the extension of this 
approach to the construction of effective paints from sorted chromosomes. The great flexibility of 
this approach is demonstrated by the derivation of paints for particular chromosomes, yielding 
region-specific paints. Combined with flow-sorting, this approach may also have important 
implications for the analysis of the marker chromosomes which are such a consistent feature of 
solid tumors. 
MATERIALS AND METHODS 
Chromosome preparation and flow-sorting 
Normal and abnormal chromosomes were flow-sorted from a series of lymphoblastoid cell 
lines. These included the cell line GM6229, derived from an individual with a balanced 
constitutional t(ll;22)(q23;qll) translocation (Human Genetic Mutant Cell Repository, Camden 
NJ); the cell line SD-1, derived from a leukemia patient carrying the Philadelphia translocation 
t(9;22) (Dhut et al., 1991); and the cell line FC11, derived from a patient with a constitutional 
deletion of chromosome ll(q22-23) (Cotter et al., unpublished results). Cultures were treated 
overnight with colcemid (0.05 jig/ml) and chromosomes were prepared by the digitonin-polyamine 
method (Young et al., 1981) for flow analysis. A final centrifugation (1000 rpm, 1 min) was used 
to remove nuclei. The chromosome suspension was stained with the fluorescent dyes Hoechst 
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33258 at 2.8 μg/ml and chromomycin A3 at 75 μg/ml, and after equilibaration at 4°C for 2 hrs 
the chromosomes were analyzed on a dual-beam FACS Star Plus sorter. The primary laser was 
tuned to 366 nm to excite Hoechst 33258 and the secondary laser to 457 nm to excite 
chromomycin A3. Chromosomes were passed through the sorter at approximately 200/s and the 
resulting Divariate distributions collected. Chromosomes were sorted in sheath fluid (0.1 M NaCl, 
10 mM Tris-HCl, 1 шМ EDTA) from appropriate windows directly into tubes containing PCR 
buffer as described previously (Cotter et al., 1989). 
PCR amplification 
Alu element-mediated PCR amplification was carried out following standard procedures with 
1.5 ßg АІи-ЖЗЗ primer (5'-CTGGGATTACAGGCGTGAGC-3': Sinke et al., 1992) and 
approximately 250-500 flow-sorted chromosomes. For comparison, 500 ng total human DNA or 
genomic DNAs from the monochromosomal somatic hybrid cell lines 86Rdyl8, WEGROTH-B3, 
and WEGROTH-D2, containing human chromosome 7, 14, and 22, respectively, were also 
subjected to Л/и-ВКЗЗ PCR amplification. Furthermore, PCR was performed using 1.4 μg Alu-
517 primer (Ledbetter et al., 1990; Nelson et al., 1989) and total human DNA. In all cases, the 
reaction mixture was heated at 96°C for 10 min, after which 2.5 U Taq DNA polymerase (Cetus) 
was added to start cycling for 1 min at 92°C, 1 min at 55°C, and 4 min at 70°C on a DNA 
thermal cycler (Perkin-Elmer, Cetus) for 40 cycles. Next, the PCR products were purified by 
chloroform extraction and spun through a Sephadex G-50 (Pharmacia) column. The eluted fraction 
was purified using phenol/chloroform, subsequently precipitated with ethanol, and dissolved in TE 
(10 mM Tris, 1 mM EDTA, pH 7.0). 
DNA labeling and chromosomal in situ suppression hybridization 
Purified DNA products from ВКЗЗ-mediated PCR of flow-sorted chromosomes, somatic 
cell hybrids, and total human DNA were labeled with biotin-11-dUTP (Sigma) by nick translation 
using a nick-translation kit (Gibco-BRL, Life Technologies). For comparison, DNAs from the 
chromosome 6-, 7-, 14-, 18-, 19-, 21-, and 22-specific (Bluescribe) libraries (Collins et al., 
1991), obtained through the courtesy of Dr. J.W. Gray, were also biotinylated. Labeled DNA was 
separated from unincorporated nucleotides on a Sephadex G-50 spin column and used as a probe 
for chromosomal in situ suppression hybridization. 
An amount of 1 μg probe DNA was ethanol-precipitated in the presence of 50 /tg herring 
sperm DNA, 50-100 yg Cof.l DNA (Gibco-BRL, Life Technologies), and eventually 50 μ% 
unlabeled total human DNA as a competitor. Both herring sperm DNA and total human DNA 
were sonicated to a medium fragment length of approximately 300-500 bp. The DNA probes were 
dissolved in a hybridization mixture, containing 50% (v/v) deionized formamide, 10% (w/v) 
dextrane sulphate, 1% (v/v) Tween-20, 2 χ SSC (final pH 7.0), to yield a probe DNA 
concentration of 10-100 ng per μΐ, depending on the original DNA source. 
Prior to hybridization, preannealing of the probe DNA (except for the ВКЗЗ-mediated PCR 
product of total human DNA) was necessary to suppress cross-hybridization to nontarget 
chromosomes resulting from reiterated DNA sequences (Cremer et al., 1988a; Landegent et al., 
1987; Pinkel et al., 1988). Therefore, the hybridization mixture was denatured at 80°C for 10 
min, chilled down quickly on ice, and incubated at 37°C for 1-2 hrs. 
31 
Chromosomal preparations were pretreated before hybridization. First, they were rinsed in 
70% acetic acid for 1 min, washed with PBS, and dehydrated in an ethanol series. Then, they 
were digested using RNase A (100 /ig/ml 2 χ SSC, pH 7.0) at 37°C for 1 hr, washed with 2 χ 
SSC, and dehydrated. Subsequently, the chromosomal preparations were denatured at 70°C for 2-
3 min, immediately followed by three washings with ice-cold 2 χ SSC (2 min each), and again 
dehydrated. After air-drying, the slides were prewarmed at 37°C until hybridization. Ten 
microliters of the preannealed hybridization mixture was added to the slide and enclosed under a 
18xl8-mm coverslip. Hybridization was performed in a moist chamber at 37°C for 1-3 days. 
Immunocytochemical detection of the hybridizing probe DNAs was carried out exactly as 
described before (Suijkerbuijk et al., 1991). Briefly, chromosomes or chromosomal regions 
hybridizing to labeled probe DNA were visualized using alternating incubations of fluoresceinated 
avidin and biotinylated goat anti-avidin antibodies (both from Vector Laboratories) until two layers 
of fluoresceinated avidin were present (Pinkel et al., 1986b). Finally, chromosomal preparations 
were mounted in an antifade solution, supplemented with di-azobicyclo-(2, 2, 2)-octane (1.4%, 
w/v; Merck) as antifade agent and propidium iodide (PI, 1 μΐ/ml; Sigma) and, eventually, 
diamidino phenylindole (DAPI, 1 μΐ/ml; Sigma) as DNA counterstain(s). 
Microscopy 
Slides were examined under a Zeiss Axiophot epifluorescence microscope, equipped for the 
visualization of fluorescein isothiocyanate (FITC), DAPI, and PI fluorescence. Digital images 
were captured using a Bio-Rad MRC 600 confocal laser-scanning microscope workstation. 
Photographs were taken from the computer screen using Kodak EPP 100 Plus color slide film. 
RESULTS 
BK33 and 517 Alu primer-mediated PCR of total human DNA 
Alu element-mediated PCR amplification of total human DNA was carried out to determine 
the utility of the Alu primer BK33 for PCR and chromosome painting purposes. A comparison 
was made with the more widely used Alu primer 517. Gel electrophoresis revealed that, with both 
primers, PCR products ranging in size from approximately 300 bp up to 4 kb were generated. For 
the 517-mediated PCR products, discrete bands (probably due to preferential amplification) could 
be distinguished. In contrast, an evidently thicker DNA smear of ВКЗЗ-mediated PCR products 
was present, indicating a significantly higher amount and a more even distribution of PCR 
products obtained with this primer than with Alu-517 (not shown). In situ hybridization using 517-
mediated PCR products from total human DNA as a mixture targeted to normal human metaphase 
spreads revealed a chromosomal R-banding-like hybridization pattern (Baldini and Ward, 1991). 
In those regions known to contain large blocks of highly repetitive alpha and/or other satellite 
sequences, i.e., the pericentromeric and heterochromatic regions, no signals could be detected. 
When ВКЗЗ-mediated PCR products were used as a probe, only a poor banding pattern due to a 
more or less overall staining of the chromosomes was seen, except again for those regions 
containing highly repetitive sequences (not shown). These findings indicated that the Alu primer 
BK33 generated 'mter-AIu sequences of greater complexity and was therefore chosen to generate 
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probe mixtures from flow-sorted chromosomes. 
Flow-sorted normal chromosomes 
Chromosomal in situ suppression hybridization using ВКЗЗ-mediated PCR products of small 
numbers (250-500) of flow-sorted normal chromosomes as probes was performed to achieve an 
efficient identification of these chromosomes in a straightforward manner. To determine aspecific 
hybridization to non-target chromosomes, hybridization results were compared (where possible) 
with those obtained from similarly amplified DNAs from human-rodent somatic cell hybrids, 
containing the same chromosome as its sole human component. In addition, hybridization results 
of DNAs from the respective chromosome-specific libraries except If 5, which had been achieved 
under the same competition and hybridization conditions, were included. 
Figure 1 shows hybridization of about 500 ng of PCR products of a flow-sorted 
chromosome 5 fraction to a normal human metaphase spread. Prior to hybridization, preannealing 
was allowed at 37°C for 90 min using 100-fold amount of С,/. 1 DNA to increase specific 
hybridization. As a result, two chromosomes are clearly visualized that do not stain 
homogeneously because of С</.1 preannealing. Instead, a faint R-banding-like hybridization 
pattern is recognized, which allows the identification of these chromosomes as being two copies of 
# 5 . 
Figure 2 shows hybridization of 100 ng of PCR products of a flow-sorted chromosome 6 
fraction, obtained under conditions similar to those as described above. Again, two chromosomes 
can be distinguished and recognized as being two copies of ¡P 6 due to the banding pattern. 
Although the positive bands are very bright, the negative bands show some faint painting as well, 
indicating that DNA sequences originating from these regions were also present in the probe 
mixture but at much lower concentrations. Hybridization of 100 ng of DNA originating from the 
chromosome 6-specific library pBS-6 resulted in a relatively homogeneous staining of both copies 
of # 6 only (Fig. 3), but still some differential staining of several regions on chromosome 6 can 
be discerned. This is even more pronounced after the application of lower probe concentrations of 
pBS-6 for in situ hybridization (not shown). 
Using 400 ng of PCR products obtained from flow-sorted chromosome 14 after Q/.l 
preannealing, once again a banded hybridization pattern is observed on both copies of # 14 only 
(Fig. 4). Specificity of chromosome 14-derived probe mixtures could also be demonstrated using 
either 100 ng of PCR products of the somatic cell hybrid WEGROTH-B3, containing only human 
chromosome 14 (Fig. 5), or DNA from the chromosome 14-specific library pBS-14 (Fig. 6) as a 
probe. In this latter case, again, both copies of # 14 are somewhat more uniformly stained. 
In this way, PCR products from several other flow-sorted chromosomes (# 7, 18, 19, 21, 
and 22) were succesfully used for fluorescent in situ hybridization. Their utility for 'chromosome 
painting' is essentially the same as that achieved with corresponding chromosome-specific library 
DNAs (pBS-7, -18, -19, -21, and -22) and/or PCR products of monochromosomal human-rodent 
hybrids (86Rdyl8 and WEGROTH-D2, containing only human chromosome 7 and 22, 
respectively) (not shown). 
Flow-sorted marker chromosomes 
We have extended our studies further to determine whether marker chromosomes can be 
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flow-sorted and, subsequently, identified as such using the combined Alu-PCR chromosome in situ 
identification strategy as described above. For this purpose, a few well defined aberrant 
chromosomes, displaying relatively small chromosomal anomalies as compared to the length of the 
respective normal chromosomes, were selected. Figure 7 shows the hybridization results obtained 
with 300 ng of PCR products from a flow-sorted del(l I)(q22-q23) chromosome, the deletion of 
which comprises approximately 5-8% of the normal chromosomal length. Here, two copies of 
chromosome 11 are readily recognized due to their hybridization banding pattern. Moreover, a 
rather small unstained region (arrows) can be distinguished on the distal part of the long arm of 
both chromosomes 11, despite the fact that it appears to be present in a relatively faintly staining 
chromosomal segment. The total absence of hybridization signals in this region demonstrates the 
lack of DNA sequences from Ilq22-q23 in the applied probe mixture and, independently, 
confirms the presence of the deletion. 
Similarly, the application of 300 ng of PCR products from flow-sorted 
der(22)t(ll;22)(q23.2;qll.2) chromosomes as probe for in situ hybridization leads to the 
identification of both chromosomal constituents concerned (Fig. 8). Strong hybridization signals 
can be discerned on four chromosomes that, after careful examination, are interpreted as 
representing two copies of both the terminal parts of the long arm of chromosome 11 (arrows) and 
the proximal parts of the long arm of chromosome 22 (arrowheads). Although some dim 
background staining is seen on other chromosomes as well, chromosomal identification has never 
been difficult to perform because of the high signal/background ratio. 
Hybridization of 600 ng of PCR products from the chronic myeloid leukemia (CML)-
specific Philadelphia translocation der(9)t(9;22)(q34.1;qll.2) reveals a slightly more complicated 
painting pattern on normal human metaphase chromosomes, involving three types of chromosomes 
(Fig. 9). As expected, the distal part of the long arm of both chromosomes 22 (arrowheads) and 
the entire length, except for the terminal part of the long arm, of both chromosomes 9 (arrows) 
are highlighted. In addition, an F-group-derived metacentric chromosome pair, presumably # 19, 
is entirely painted (asterisks), although its signal intensity is considerably less than those on 
chromosomes 9 and 22. Preceding preannealing of the same PCR products with a significantly 
higher amount of Cj. 1 DNA will result in an almost complete absence of this hybridization signal 
on chromosome 19 and, therefore, in an umambiguous characterization of the chromosomal 
constituents of the marker chromosome examined (not shown). These latter results indicate that a 
further specific characterization of chromosomal constituents can be achieved by means of the 
chromosome in situ identification using appropriate competitor DNAs. 
DISCUSSION 
Here, we report a novel strategy for rapidly identifying human chromosomes by means of 
nonradioactive in situ hybridization, designated fluorescent in situ identification. This strategy, 
which is based on the application of Alu element (BK33)-mediated PCR amplification products 
obtained from low numbers (250-500) of flow-sorted chromosomes as probes for in situ 
hybridization (chromosome painting), allows the straightforward visualization of the chromosomal 
constituents of individual chromosomes or chromosomal markers, the identity of which needs to 
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be verified. As a demonstration, chromosomal probe mixtures generated from flow-sorted normal 
human chromosomes 5, 6, 7, 14, 18, 19, 21, and 22 were tested and it appeared that, after 
chromosome painting, the corresponding chromosomes could be identified with satisfactory 
accuracy and reliability. As for chromosomes 7, 14, and 22, our results could be compared 
directly with those found for chromosome-specific libraries and genomic DNA from 
monochromosomal somatic cell hybrids, respectively. Similar results were obtained, indicating 
that sorted chromosomes are, after Alu element-mediated PCR, very well suited to use as probes 
for fluorescent in situ identification purposes. A chromosome 5-specific paint, until recently, not 
available through the use of libraries or hybrids (Collins et al., 1991), was easily obtained using 
the present technique. 
Moreover, in this initial study, our fluorescent in situ identification method has successfully 
been applied to the characterization of the chromosomal constituents of three different types of 
well-defined aberrant chromosomes, namely del(ll)(q22-q23), der(22)t(ll;22)(q23.3;qll.2), and 
the CML-specific der(9)t(9;22)(q34.1;qll.2). Flow cytometric analysis performed during the 
sorting of the del(ll) indicated that the deletion represented approximately 5-8% of the size of a 
normal chromosome 11. Since the amount of DNA in chromosome 11 has been estimated to be 
approximately 144 Mb (Morton, 1991) it is concluded that the deletion visualized was around 7-12 
Mb. The lower limit of aberration detectable by this approach is dependent on the resolution 
obtainable on the flow sorter (previously estimated at 1/2000th of the male genome). It can thus 
be estimated that deletions of approximately 1.6 Mb can be detected by this approach. From these 
results we conclude that this method also appears to be excellently suited for the direct 
characterization of marker chomosomes present in various genetic or neoplastic disorders (such as 
hemopoietic and solid tumors, chorionic villi, or amniotic fluid cells), which cannot easily be 
identified using previously available cytogenetic and/or molecular techniques. A direct 
consequence of this work is that chromosome paints specific for the common aberrant 
chromosomes, such as the Philadelphia chromosome, can be generated and made widely available. 
These may find particular use in the analysis of complex or masked chromosomal translocations. 
Compared to whole chromosome paints obtained with DNAs from chromosome-specific 
libraries or monochromosomal hybrids, the paints generated from flow-sorted chromosomes 
display a slight R-banding-like hybridization pattern on the respective chromosomes. This R-
banding effect may be due to the fact that DNA originating from the Giemsa-negative 
chromosomal bands (the R-bands) is preferentially amplified, since it is known that /i/u-sequences 
are more abundant in Giemsa-negative bands than in Giemsa-positive bands (Baldini and Ward, 
1991; Korenberg and Rykowski, 1988). These results, however, do not necessarily hamper the 
identification of the original chromosomes used as probes, but rather faclilitate the recognition of 
the hybridizing sequences without the requirement of additional conventional chromosomal 
banding or cohybridization of chromosome-specific DNA probes. Still, the possibility exists that 
chromosomal segments, the identification of which is essential to achieve a correct description of 
the marker chromosome(s) concerned, are missed as a consequence of Alu element-mediated PCR. 
This has evidently been demonstrated for those regions (e.g., centromeres, heterochromatic 
blocks) known to contain large arrays of highly repetitive DNA sequences such as alpha and/or 
other satellite DNA sequences (Moyzis et al., 1989; Vogt, 1990). The fluorescent in situ 
identification technique may be improved via the use of additional primers - e.g., LINE and SINE 
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sequences, alone or in combination, or universal primers - for PCR amplification of flow-sorted 
chromosomes or, alternatively, by combining different PCR products to finally obtain an uniform 
whole chromosome paint. 
Cross-hybridization may, in some cases, be another complicating factor. One out of eight 
chromosomes (# 22, not shown) and one out of three tested flow-sorted aberrant chromosomes 
[der(9)t(9;22)(q34.1;qll.2)] yielded hybridization signals on nontarget chromosomes. For 
chromosome 22, this cross-hybridization appears to be the consequence of common DNA 
sequences shared by various acrocentric human chromosomes (Alexandrov et al., 1988; Choo et 
al., 1989; Jeirgensen et al., 1988; McDermid et al., 1986; Waye and Willard, 1989), and is in 
agreement with results described elsewhere for # 22-paints (Collins et al., 1991; Cremer et al., 
1988a; Lichter et al., 1990). Cross-hybridization on chromosome 19, as found in the second case, 
cannot simply be explained this way. This unexpected result might theoretically be caused by 
inefficient chromosome flow-sorting. However, the DNA contents of # 19 and 
der(9)t(9;22)(q34.2;11.2) chromosomes differ so much that this would be unlikely. Cross-
hybridization may also be a phenomenon inherent in Alu PCR amplification of certain flow-sorted 
chromosomes. Complete exclusion of this cross-hybridization on chromosome 19, which might 
have occurred because # 19 is known to be rich in Alu sequences (Baldini and Ward, 1991; 
Korenberg and Rykowski, 1988), could in our case be achieved by addition of appropriate 
competitor DNA (i.e., Q/. 1 DNA or Alu PCR products from flow-sorted chromosome 19). 
The application of flow-sorted chromosomes for painting purposes has several advantages 
over the use of chromosome-specific libraries. For instance, because only small numbers (ranging 
from 250 to 500) of a particular chromosome are required, the sorting time is very short, i.e., 3-4 
minutes. Such a short sorting time considerably reduces the chance of chromosomal breaks and 
subsequent contamination, compared to the concomitant risks of a 1- to 2-weeks period of sorting 
required for the construction of a chromosome-specific DNA library. Furthermore, as all cloning 
procedures are obviated, it will be relatively simple to 'fine tune' these paints by adding unlabeled 
competitor sequences from flow-sorted fractions and thus create region- or band-specific paints. 
Since flow-sorted fractions are currently available for virtually all human chromosomes (B.D. 
Young, unpublished results), our fluorescent in situ identification technique can be applied to the 
whole human genome as a fast and reliable alternative to chromosome-specific libraries and/or 
monochromosomal somatic cell hybrids. 
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ABSTRACT 
We have employed an irradiation and fusion procedure to generate somatic cell hybrids 
containing various fragments of the short arm of human chromosome 12 using a 12p-only hybrid 
(M28) as starting material. For the initial identification of hybrids retaining human DNA, 
nonradioactive in situ hybridization was performed. Seventeen cell lines appeared to contain 
detectable amounts of human material. Detailed characterization of these hybrids by Southern blot 
analysis and chromosomal in situ suppression hybridization (chromosome painting), using hybrid 
DNAs as probes after Alu element-mediated PCR, resulted in a hybrid panel encompassing the 
entire chromosome 12p arm. This panel will provide a valuable resource for the rapid isolation of 
region-specific DNA markers. In addition, this panel may be useful for the characterization of 
chromosome 12 aberrations in, e.g., human germ cell tumors. 
Figures 11-14 are represented on Color plate I. 
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INTRODUCTION 
Somatic cell hybrids containing well-defined human chromosomal fragments on a rodent 
background can be used for high-resolution physical gene mapping. In addition, they may provide 
a valuable resource for the isolation of DNA fragments that map to a specific chromosomal 
region. More than a decade ago, Goss and Harris (197S) introduced a method for the generation 
and transfer of chromosomal fragments. This method, based on irradiation and gene transfer via 
cell fusion, was used for mapping loci on the human X chromosome. However, the hybrids they 
obtained from fusion of lethally irradiated human lymphocytes with recipient hamster cells often 
contained fragments from multiple human chromosomes. Cox et al. (1989) circumvented this 
problem by using a human-rodent hybrid containing a single human chromosome 4 as irradiated 
donor. They found a high frequency of retention of nonselected human chromosome 4-derived 
fragments in the resulting hybrids. This technique was also used by Benham et al. (1989), 
Goodfellow et al. (1990), and Zoghbi et al. (1991) to isolate fragments of the human 
chromosomes X, 10, and 6, respectively. In this study, we have used a similar approach to 
generate somatic cell hybrids containing fragments of human chromosome 12p. This newly 
developed hybrid panel may be used as a resource for the development of new probes from 
particular regions of 12p. Furthermore, we intend to use this panel for the investigation of 
chromosome 12 aberrations in human neoplastic disorders such as testicular germ cell tumors 
(TGCTs). 
In 1982, Atkin and Baker reported the occurrence of an isochromosome of the short arm of 
chromosome 12 [designated i(12p)] in TGCTs. Until now i(12p) appears to be one of the few 
known consistent chromosomal abnormalities in human solid tumors (for review see: De Jong et 
al.,1990). The i(12p) marker has been observed in more than 80% of adult TGCTs, but also in 
dysgerminomas and some extragonadal GCTs. Since i(12p) formation does not lead to gross loss 
of heterozygosity of the long arm of chromosome 12, we argued previously that formation of this 
marker must be a secondary event following a polyploidization step (Geurts van Kessel et al. 
1989). In both i(12p)-negative and -positive TGCTs other chromosome 12 aberrations are 
frequently found (Gibas et al.,1986; Castedo et al.,1988; Suijkerbuijk et al.,1991). Together with 
the observation that the occurrence of additional copies of 12p appears to be associated with a 
significant greater likelyhood of treatment failure of patients with GCTs (Bosl et al., 1989), a 
prominent role for certain chromosome 12 sequences in the development of malignant GCTs is 
implicated. To investigate whether indeed particular chromosome 12p regions are specifically 
involved in GCT development, new probes must be developed. As a first step towards this goal 
we here report the generation of a panel of radiation-reduced 12p hybrids. As starting material we 
used a mouse-human hybrid cell line (M28), which contains a human i(12p) chromosome as its 
only human constituent. The i(12p) chromosome in this cell line is derived from a patient with 
Pallister-Killian syndrome in which this marker was present as a constitutional aberration (Zhang 
et al., 1989). 
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MATERIALS AND METHODS 
Cell lines and cidture 
M28 is a mouse-human hybrid cell line containing a Pallister-Killian-derived 
isochromosome 12p as its only human component (Zhang et al.,1989). Wg3-h is a hamster cell 
line deficient in hypoxanthine phosphoribosyl transferase (HPRT) activity. M28 and Wg3-h cells 
were cultured in FIO or Dulbecco's modified Eagles medium (DMEM), supplemented with 
antibiotics, glutamin and 10% fetal calf serum (FCS). 
X-ray irradiation and cell fusion 
M28 cells, 8x10s, were harvested, washed with S ml FIO medium, and resuspended in S ml 
FIO medium. The cell suspension was then exposed to a lethal dose of 40,000 rads of X-ray 
irradiation. The irradiated cells were fused at a ratio of 5:1 with Wg3-h cells by means of 
polyethylene glycol 1500 (Boehringer, Mannheim) or Sendai virus (1000 HAU) procedures. The 
cell suspension resulting from each fusion was seeded into 60-mm petri dishes with 4 ml FIO 
medium + 15% FCS each and incubated at 37°C. After 1 day, the medium was replaced by 
selective medium. Due to the fact that the i(12p) marker, present in the original M28 cell line, 
contains several copies of a dominant neomycin resistance gene, selection with both HAT (100 
μΜ hypoxanthine, 1 μΜ aminopterin, 12 μΜ thymidine) and G418 (400 μg/ml, Life 
Technologies) was carried out. Controls included Wg3-h and irradiated M28 cells in FIO + HAT 
and/or G418. No colonies were observed in either case. The medium in all dishes was refreshed 
about every 3 days. Hybrid colonies were visible 2-4 weeks following fusion and care was taken 
that they were isolated separately (2-3 colonies/dish). 
Characterization of radiation reduced hybrids 
To select those hybrid clones that have retained fragments of 12p, we first performed 
nonradioactive in situ hybridization experiments using biotinylated total human DNA as a probe 
(Pinkel et al., 1986b). Clones showing clear positive signals were selected for further analysis and 
designated as WgM hybrids. 
Further characterization of the 12p component of the WgM hybrids was accomplished by 
Southern blot analysis following standard protocols. Hybrid and control DNAs, 10-15 μg, were 
digested to completion using EcoRI, electrophoresed in 0.7% agarose gels, and transferred to 
nylon membranes. Blots were hybridized with chromosome 12p-specific DNA markers labeled by 
random priming (Feinberg and Vogelstein, 1984). 
In situ hybridization with Alu-PCR products 
In addition, we performed chromosomal in situ suppression hybridization (chromosome 
painting: Cremer et al. 1988b; Lichter et al. 1988a; Pinkel et al. 1988), using Л/u-element 
mediated PCR products of the WgM hybrids as a probe (Lengauer et al., 1990, Lichter et al., 
1990), in conjunction with fluorescent R-banding (Cherif et al., 1990) on metaphase spreads 
obtained from normal human blood lymphocytes. 
The Alu-PCR was carried out following standard procedures with 1.5 μg Л/и-ВКЗЗ primer 
(5'-CTGGGATTACAGGCGTGAGC-3') and 500 ng (hybrid)DNA digested with Xhol at 37°C for 
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1 hr. The reaction mixture was heated at 96°C for 10 min and 2.5 U Taq DNA polymerase 
(Cetus) was added to start cycling for 1 min at 92°C, 1 min at 55°C, and 4 min at 70°C on a 
DNA thermal cycler (Perkin Elmer; Cetus) for 30 cycles. Prior to labeling, the PCR products 
were purified by phenol/chloroform extraction and eluted through a Sephadex G-SO (Pharmacia) 
column. The eluted fraction was then precipitated with ethanol and dissolved in TE (10 mM Tris, 
1 mM EDTA, pH 7.0). 
For in situ hybridization, 1 /ig of purified PCR product was labeled with biotin-11-dUTP 
(Sigma) using a nick-translation kit (Life Technologies). The labeled DNA was purified through a 
Sephadex G-50 column and precipitated in the presence of sonicated sperm herring DNA (SO ¿ig) 
and С,/. 1 DNA (25 μg, Life Technologies). Subsequently, this DNA mixture was dissolved in a 
hybridization solution (50% [v/v] deionized formamide, 10% [w/v] dextrane sulphate, 2 χ SSC, 
1% [v/v] Tween-20, pH 7.0) to a final concentration of 25 ng probe DNA per μ\. Prior to 
hybridization, the probe was denatured at 80°C for 10 min, chilled on ice and incubated at 37°C 
for 1-2 hrs allowing preannealing. 
Chromosomal preparations were made from human blood lymphocytes (BrdU-incorporated), 
derived from healthy donors. These preparations were pretreated with RNase A (100 ¿tg/ml in 2 χ 
SSC at 37°C for 1 hr) before denaturation in 70% formamide, 2 χ SSC, pH 7.0 at 70°C for 2-3 
min. Then, 10 μ\ of the preannealed probe was added to each slide under a 18xl8-cm coverslip. 
Hybridization was performed in a moist chamber at 37 °C for 1-3 days. After 
immunocytochemical detection of the hybridized probes and simultaneous R-banding of the 
chromosomes, the slides were mounted in antifade medium containing propidium iodide (0.5 
μg/ml, Sigma) as DNA counterstain and di-azobicyclo-(2, 2, 2)-octane (1.4% [w/v], Merck) as 
antifade agens. 
Slides were viewed under a Zeiss Axiophot epifluorescence microscope, equipped for the 
visualization of fluorescein isothiocyanate (FITC) and propidium iodide fluorescence. Digital 
images were captured with a Bio-Rad MRC 500 confocal laser-scanning microscopy workstation. 
Photographs were taken from the computer screen using Kodak EPP 100 color slide film. 
RESULTS 
Generation of human-hamster hybrids containing fragments of human chromosome 12p 
Fusions were carried out between the hamster cell line Wg3-h and the mouse-human cell 
line M28, which contains the Pallister-Killian-derived isochromosome 12p as its only human 
component, using both PEG 1500 or Sendai virus. Prior to the fusion with the Wg3-h cells, M28 
cells were irradiated with a lethal dose of 40,000 rads. Initially, hybrid cells were selected in 
HAT medium, which selects for the rescue and retention of the murine HPRT gene from the 
irradiated M28 cell line. After HAT selection 50 colonies were isolated. Due to the presence of 
multiple copies of the neomycin resistance gene in the i(12p) chromosome of M28 cells, selection 
following fusion with the Wg3-h cells could also be carried out using G418. By application of 
G418 selection, another 10 colonies were isolated. 
40 
: s ; 5 S I ? S ? - Б 
^Щ 
4-
Figure 10 Southern blot analysis of the radiation-reduced (WgM) hybrids. DNAs of WgM 
hybrids, M28 (mouse-human hybrid cell line containing i(12p)) and A3TE7b (hamster-human 
hybrid cell line containing a complete human chromosome 12) were digested using EcoSl. The 
resulting blots were hybridized with pPRP-1, pal2H8, p640, pl2-16, pha2ml, and pV3 (panels A 
to F, respectively). The arrow indicates the human-specific signal. 
Selection of hybrids containing human chromosomal fragments 
The 60 isolated second-generation hybrids were tested for the retention of human 
chromosomal fragments by nonradioactive in situ hybridization with biotinylated total human 
DNA as a probe. Seventeen Hybrids, designated as WgM hybrids, gave a clear positive 
hybridization signal (not shown) and were selected for further characterization. Two types of 
signal could be distinguished in the positive hybridizing WgM hybrids: (a) loose, apparently 
centromere-containing, fragments varying in size from very small to fragments as large as half an 
i(12p) chromosome; (b) incorporated fragments, visible as one or more bands in the hamster 
chromosomes, or as telomeric-associated pieces. In most of the hybrids, the human-specific 
signals were visible in the majority (but not all) of the metaphases. In some instances a 
combination of loose and incorporated signals was observed. 
Characterization of the human chromosome 12p content of the WgM hybrids 
1. Southern blot analysis: 
The WgM hybrids were tested for the presence or absence of 12p sequences using 
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Southern blot analyses with chromosome 12p-specific probes. These probes and their 
chromosomal localizations are listed in Table 2. It is apparent (see also HGM10, 1989) that the 
currently available 12p probes are not very evenly distributed along 12p. In all hybridizations a 
parental control (M28) was included and also a total chromosome 12 containing hybrid (A3TE7b, 
Looijengaet al.,1990). 
Examples of the Southern blot analyses are shown in Fig. 10, whereas a summary of these 
results is given in Table 2. The chromosome 12-specific pericentromeric alphoid repeats (D12Z3; 
probe: pal2H8) are retained in 10 of the 17 hybrids tested. Six of the 17 hybrids give a clear 
positive hybridization signal with FGF.6 (probe: pV3), which seems to be the most distal marker 
of the ones we tested. Two hybrids (WgM7A and WgMl.lneo) appear to contain the major part 
of a 12p arm derived from the original isochromosome, since they hybridize to all but one of the 
probes tested, pV3 and ScIAP8, respectively. Two hybrids do not hybridize with any of the 
probes used (WgM22A and 28A). Based on these analyses, 10 hybrids seem to contain more than 
one human 12p fragment as, delineated from the known probe order (Table 2), they show gaps in 
these Southern blot analyses (WgM8B, 10A, 22C, 23A, 23B, Lineo, lO.lneo, ІЗ.Іпео, 23.1neo 
and 28.1neo). 
2. Chromosome painting: 
Further characterization of the human chromosome 12p content of the WgM hybrids was 
accomplished by using suppression in situ hybridization (chromosome painting) techniques in 
conjunction with fluorescent chromosomal R-banding. Since the human component in radiation-
reduced somatic cell hybrids may be relatively small, Alu element-mediated PCR was carried out 
prior to the in situ hybridization to specifically amplify the human component in these hybrids. 
The primer we chose (BK33) is located at the 5' end of the Alu consensus sequence. By doing 
this, we were able to precisely localize the human fragments present in the WgM hybrids on 
chromosome 12. Examples of such nonradioactive in situ hybridization experiments with /4/u-PCR 
products as a probe hybridized to normal human lymphocyte metaphase spreads are given in Figs. 
11-14. These chromosome painting results confirm the presence of chromosome 12p fragments in 
the WgM hybrids. Furthermore, some of the hybrids appear to contain fragments of chromosome 
12p that had not been detected before via Southern blot analysis: WgM6B, for instance, gave a 
signal only with the pal2H8 and pl2-16 probes. However, besides this 12pll region, 
chromosome painting clearly shows the presence of part of the 12p 13 region in this hybrid cell 
line (Fig. 11). Similar results were obtained with WgM7C and WgM22B. 
By combining the results from both Southern blot analysis and in situ hybridization 
a consensus physical map as depicted in Fig. 15 is proposed. 
DISCUSSION 
We employed a radiation-induced method to generate human-rodent somatic cell hybrids 
containing various fragments of the short arm of chromosome 12. This strategy was very similar 
to the one used by Cox et al. (1989), who isolated fragments of the distal short arm of human 
chromosome 4, containing the region for the Huntington's disease gene. In their procedure they 
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Figure 15 Schematic representation of the human chromosome 12p contents of the WgM hybrids 
resulting from combining both Southern blot analyses and chromosome painting data. 
did not specifically select for the retention of human material. Similar techniques were also used 
by Benham et al. (1989) and Goodfellow et al. (1990) to isolate fragments of human chromosomes 
X and 10, respectively. They showed that a higher irradiation dose leads to a higher frequency of 
retention of human sequences in the hybrids (Benham, 50,000 rads: 100%; Goodfellow, 50,000 
rads: 75%), which may be explained by the notion that more extensive chromosome fragmentation 
facilitates the association with rodent chromosomal material. To identify those hybrids that had 
retained human chromosomal fragments, we used nonradioactive in situ hybridization with total 
human DNA as a probe. In 17 of 60 hybrids (designated as WgM hybrids) tested the presence of 
human material could be demonstrated. This retention frequency of 28% at an irradiation dose of 
experiments, 40,000 rads is lower than those reported by other groups. This may be due to the 
relatively small size of the i(12p) chromosome as compared to, e.g., chromosomes 10 and X and 
the possibility that minor fragments may have been missed in the original screening. 
Characterization of the human 12p content of the WgM hybrids was performed by Southern 
blot analysis. It is difficult to correlate the chromosome 12p content of the WgM hybrids, as 
assessed by the Southern blot analyses and by the fluorescence in situ hybridization experiments 
using total human DNA as a probe. For example, not all hybrids with loose-positive reacting 
fragments hybridize with the porl2H8 probe. These fragments probably contain a rodent 
centromeric region. The applied dose of 40,000 rads of irradiation appears to induce chromosomal 
breaks with high frequency as may be concluded from the observation that only two hybrids 
(WgM7A and WgMl.lneo) seem to contain an almost entire 12p arm. The chromosome 12-
specific pericentromeric alphoid repeats are retained in 10 of the 17 hybrids (59%). This selective 
retention of alphoid repeats in somatic cell hybrids resulting from chromosome fragmentation 
experiments has been reported previously (Pritchard et al., 1987, 1989; Goodfellow et al., 1990), 
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and is thought to reflect the inherent stability of centromeres in these hybrids. Furthermore, 9 of 
the 17 hybrids appear to contain more than one 12p fragment. The precise regional localization of 
several of the 12p-specific probes that we used is as yet unknown. Based on our Southern blot 
analyses we put them in a hypothetical order as shown in Table 2. As there are relatively few 
12p-specific probes available, the precise characterization of the human component in the WgM 
hybrids via Southern blot analysis is not possible. 
Chromosome painting, with Alu element-mediated PCR (BK33) products of the WgM 
hybrids as a probe, reveals the precise constitution of the human component in these hybrids. 
Besides the localization of the 12p fragments present, it also reveals the gaps in the hybrids as 
determined before by Southern blot analysis (e.g., WgM8B: Table 2, Fig. 12). Furthermore, 
some of the hybrids (e.g., WgM6B: table 2, Fig. 11) appear to contain regions of chromosome 
12p that remained undetected via the Southern blot analysis. Also WgM22A and WgM28A, which 
do not hybridize to any of the 12p-specific probes tested, give a clear positive signal on the distal 
part of the 12pl3 region (not shown). However, WgM7A, which hybridizes to all probes tested 
from 12pl2, shows a gap in this region using chromosome painting. Similarly, WgM13.1neo and 
WgM28.1neo both hybridize with the pl2-16 probe. Chromosome painting, however, does not 
reveal the putative presence of this particular region in these hybrids. By using BK33, which is a 
primer complementary to one of the less conserved regions at the 5' end of the Alu repeat, as a 
primer for our PCR reactions, we previously found a rather even staining of the human 
chromosomes with some minor R-banding. This R-banding effect is much more pronounced when 
the Alu-511 primer is used (Lichter et al., 1990). Still, however, we cannot exclude some 
preferential amplification of certain 12p regions. This might explain some of the discordancies 
found by comparing the results from Southern blot analyses and chromosome painting 
experiments. Thus, a combined use of both Southern blot analysis and chromosome painting 
seems to be a prerequisite for a reliable characterization of radiation-reduced hybrids. 
As a result of this dual characterization, a panel of radiation-reduced hybrids has been 
assembled, encompassing the whole human chromosome 12p arm. This panel will help us to 
identify regions of chromosome 12p which are specifically involved in the chromosome 12 
aberrations observed in, e.g., human germ cell tumors. Once established, new relevant probes 
may be isolated by using Alu element-mediated PCR techniques and/or by cloning the hybrids into 
cosmids or yeast artificial chromosomes. To a limited extend, the hybrids may also be used for 
the ordering or linking of probes as is apparent for, e.g., pvWFl 100 and pß3r (see Table 2). For 
this purpose further extension and subcloning of the panel of cell lines may be required. 
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CHAPTER 
ANALYSIS OF CHROMOSOME 12 
ABERRATIONS IN HUMAN 
GERM CELL TUMORS 

CHAPTER 3.1 
INTRODUCTION 
Germ cell tumors 
Human genii cell tumors (GCTs) constitute a heterogeneous group of neoplasms that are 
thought to originate from primordial germ cells. They occur in the testis, the ovary and, 
sometimes, in extragonadal sites (Mostofi and Price, 1973; Scully, 1979; Gonzales-Crussi, 1982). 
Two main entities can be distinguished based on both clinical and morphological criteria: 
(1) Tumors that are composed of neoplastic germ cells, called seminomas in the testis, 
dysgerminomas in the ovary and sometimes germinomas in extragonadal sites. Germinomas are 
usually seen in the midline of the body (pineal region, hypothalamic region, anterior and posterior 
mediastinum, retroperitoneum and sacral area), but may also be encountered elsewhere (e.g., 
orbit, neck, stomach, placenta) (Oosterhuis et al., 1990). Testicular seminomas and ovarian 
dysgerminomas are indistinguishable with respect to their (ultrastructural) morphology, histology 
and immunohistochemistry (Jacobsen and N0rgaard-Pedersen, 1984; Oosterhuis et al., 1990; 
Gondos, 1993). Therefore, it has been reasoned that these tumors must originate from the same 
precursors and, even more importantly, that they are composed of the same cell types (see review 
Damjanov, 1991). This may also be true for most extragonadal germ cell tumors, which are 
morphologically identical with their gonadal counterparts. 
(2) Non-seminomatous GCTs (NSGCTs) consisting of embryonic and/or extra-embryonic tissues 
(Martineau, 1969; Oosterhuis et al., 1990). NSGCTs may exhibit histologic features of embryonal 
carcinomas, (im)mature teratomas, yolk sac tumors and/or choriocarcinomas. These tumors are 
thought to originate from pluripotent cells which, in turn, derive from germ cells (Damjanov, 
1991). 
Tumors with a seminoma/dysgerminoma and a non-seminoma component are classified as 
combined tumors (Brittish classification; Pugh, 1976). NSGCTs are usually more aggressive than 
seminomas (in men) and dysgerminomas (in females), although the degree of malignancy of GCTs 
may also depend on the age and sex of the patient, the anatomical site of the tumor, its 
histological composition and cytogenetic constitution (Castedo, 1988; Oosterhuis et al., 1990). 
Testicular germ cell tumors 
Testicular germ cell tumors (TGCTs) themselves, again, comprise a diverse group of 
malignancies with widely differing histopathological appearances (Ulbright and Roth, 1987; 
Mostofi et al., 1987) and age distribution of the patients (Morris et al., 1986). They can be 
divided into three major epidemiologically distinct subgroups: infantile tumors, tumors of 
adolescents and young adults, and tumors of elderly men. 
Infantile TGCTs occur in prepubertal boys and usually manifest themselves as malignant 
tumors. Most of these tumors exhibit either pure yolk sac (i.e., orchidoblastomas) or, less 
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commonly, pure teratoma characteristics (Gonzalez-Crussi, 1986; Harms and Jänig, 1986; 
Sesterhenn et al., 1986). Their pathology and clinical presentation are identical to those found in 
adults (Brodsky, 1991). However, infantile TGCTs lack carcinoma-in-situ (CIS) lesions (Guinand 
and Hedinger, 1981; Koide et al., 1987), which are considered to be the precursors of testicular 
tumors of adults (Jacobsen and Nergaard-Pedersen, 1984; Skakkebsk et al., 1987). Infantile 
TGCTs are mostly diploid or, less frequently, near-tetraploid (Oosterhuis et al., 1987, 1990). 
TGCTs of adults predominantly occur in patients from 20 to 55 years of age, depending on 
the histological (sub)type (Pugh, 1976). They represent the third most common group of 
malignancies in the third and fourth decade, being preceded only by leukemias/lymphomas and 
central nervous system gliomas (Brodsky, 1991). In men aged from 15 to 34 they are the most 
common malignancy (Silverberg, 1982). TGCTs of adults can be divided into seminomas (about 
50%) and NSGCTs (about 40%), while in the remaining tumors seminoma and nonseminoma 
components are combined (De Jong et al., 1990). Both seminomas and NSGCTs are thought to 
originate from dysplastic CIS cells (see below), which in fact are pre-malignant counterparts of 
primordial germ cells or gonocytes (i.e., gonocytomas: Skakkebxk et al., 1987). Seminomas are 
usually hypertriploid whereas NSGCTs are most often hypotriploid. The components of combined 
tumors share the ploidy levels of their pure counterparts (see Oosterhuis et al., 1990). In addition, 
the vast majority of both seminomas and NSGCTs exhibit a characteristic and tumor-specific 
chromosomal abnormality, i.e., an isochromosome of the short arm of chromosome 12 or i(12p) 
(Atkin and Baker, 1982, 1983; see De Jong et al., 1990 for review), which is not found in 
TGCTs of children or elderly men. 
TGCTs of elderly men represent only 2-3% of all testicular tumors and occur exclusively in 
men over the age of 50 years (Brodsky, 1991). They have a histology of so-called spermatocyte 
seminomas and are almost always benign, although some may have a malignant potential (Floyd et 
al., 1988; True et al., 1988). Spermatocytic seminomas are not related to classical seminomas, 
and appear to be quite distinct from all other GCTs. These tumors are not composed of neoplastic 
gonocytes, but of more mature germ cell precursors equivalent to spermatogenic cells like 
spermatogonia and spermatids (Jacobsen and Norgaard, 1984; Skakkebxk et al., 1987). 
Moreover, spermatocytic seminomas are neither associated with adjacent intratubular seminomas 
(Skakkebxk et al., 1987) nor found in conjunction with any other type of germ cell tumors 
(Brodsky, 1991). In fact, this subgroup of TGCTs represents the only true spermatogenic tumors 
and is, thus, an unique entity. TGCTs of elderly man usually display a diploid karyotype (Müller 
et al., 1987). 
Histogenesis of testicular germ cell tumors 
Although it is generally agreed that both seminomas and NSGCTs are neoplasms derived 
from primordial germ cells, there has been some controversy about the histogenetic relationship 
between the two subtypes. According to the histologic classifications originally developed by 
Friedman and Moore (1946) and further refined by Dixon and Moore (1952), seminomas that 
recapitulate some aspects of spermatogenesis are distinct from NSGCTs, which represent 
descendants of pluripotent embryonic cells derived from germ cells through parthenogenetic 
activation. As a consequence, seminomas and NSGCTs must have developed from germ cells 
along two unrelated pathways. Later, the stage of intratubular noninvasive CIS - found in the 
62 
Spermatogonia 
Ca in Situ Ca in Situ Ca in Situ Ca in Situ Ca in situ 
Seminoma Embryonal Yolk-sac Choriocarcinoma Teratoma 
Carcinoma Tumour 
b) -Yolk-sac Tumour 
Ca in Situ »Seminoma »Embryonal^-—»Choriocarcinoma 
Carcinoma ^ v . 
»Teratoma 
Figure 16 Models of origin of germ cell tumors of the testis (from Castedo, 1988). 
testicular parenchyma surrounding the invasive tumor - was recognized as the precursor lesion of 
both seminomas and NSGCTs (Skakkebaek and Berthelsen, 1978; Skakkeba* et al., 1987). It was 
still unclear, however, whether seminomas and NSGCTs develop directly through a multifocal 
process or, alternatively, develop clonally from a single cell undergoing malignant transformation. 
The first concept (Pierce and Abell, 1972; Skakkebxk and Berthelsen, 1981; Mostofi et al., 1987) 
assumes the derivation of seminomas and NSGCTs (i.e., embryonal carcinoma, yolk sac tumor, 
choriocarcinoma, teratoma) from dysplastic intratubular germ cells through CIS via two distinct 
pathways (see Fig. 16a). The other concept (Ewing, 1911; Friedman, 1951; Nochomowitz and 
Rosai, 1978; Raghavan et al., 1982; Oliver, 1987; Oosterhuis et al., 1989a) suggests one single 
neoplastic pathway for TGCTs, with seminomas representing an intermediate stage after CIS 
through which all TGCTs (except spermatocyte seminomas and, possibly, infantile TGCTs) 
progress (see Fig. 16b). As a consequence, seminomas and NSGCTs may be very closely related. 
The putative histogenetic relationship between seminomas and NSGCTs has been studied 
intensively. Combined germ cell tumors containing both seminoma and NSGCT components 
support a close relatedness between the two (Damjanov, 1991). Moreover, DNA flow cytometric 
and cytogenetic studies on seminomas, NSGCTs and combined tumors also appear to be consistent 
with a concept that links seminomas and NSGCTs through a common histogenetic pathway 
(Berger et al., 1987; Haddad et al., 1988; Oosterhuis et al., 1989a; De Jong et al., 1990). Reports 
of tumors with features that are intermediate between seminoma and embryonal carcinoma (EC) -
which are malignant nonseminomatous equivalents of pluripotent embryonic cells - (Walt et al., 
1986), and the existence of cell lines that have hybrid seminoma-ЕС characteristics (Damjanov et 
al., 1993) further argue for a possible link between the two subtypes with seminoma as an 
intermediate stage in the transition from CIS to EC. However, at this moment it is not clear 
whether all ECs develop through an obligatory seminoma stage or whether direct transitions from 
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CIS to invasive EC and other NSGCTs may occur as well (Damjanov, 1993). 
Cytogenetics of testicular germ cell tumors 
Cytogenetic and ploidy studies on TGCTs revealed the presence of an aneuploid 
chromosomal complement ranging from hyperdiploid to hypertriploid (Atkin and Baker, 1983; 
Delozier-Blanchet et al., 1987). As mentioned above, seminomas are usually hypertriploid with 
modal chromosome numbers which are significantly higher than those of teratomas (hypotriploid) 
(reviewed in De Jong et al., 1990; Sandberg et al., 1990). Combined tumors exhibit intermediate 
chromosome numbers (Martineau, 1969; Oosterhuis et al., 1989a). Moreover, recent DNA flow 
cytometric studies on these tumors showed a significantly higher DNA index (as a measure of the 
chromosomal complement) for the seminoma component as compared with the nonseminomatous 
part of the combined tumors. A limited number of CIS has also been examined and, surprisingly, 
peritetraploidy has been observed in patients who have not yet developed invasive cancer (Müller 
and Skakkebsek, 1981; Müller et al., 1987). In addition, near-tetraploidy was reported in CIS 
from patients with symptoms of abnormal sexual differentiation and, therefore, a high risk for 
developing a germ cell tumor (Vorechovsky and Mazanec, 1991). In contrast, CIS cells located 
next to the corresponding invasive tumors were found to have a peritriploid chromosomal 
constitution (Vos et al., 1990). Accordingly, Oosterhuis and coworkers (1989a; see also De Jong 
et al., 1990) suggested that polyploidization of a dysplastic germ cell precursor, resulting in 
noninvasive tetraploid CIS, may be a primary step in the oncogenesis of TGCT. Accordingly, 
progression of noninvasive CIS into invasive seminoma and, similarly, seminoma into NSGCT 
may result from a net loss of chromosomes. 
Indeed, cytogenetic analyses of both seminomas and NSGCTs revealed a nonrandom loss 
and retention of certain chromosomes (Castedo et al., 1989a; De Jong et al., 1990): normal copies 
of chromosomes 11, 13 and 18 are underrepresented, while chromosomes 7, 8, 12 and X are 
overrepresented in both tumor subtypes. These striking similarities in the average copy numbers 
of chromosomes (and even chromosomal arms: De Jong et al., 1990) in seminomas and NSGCTs 
was one of the most convincing arguments in favor of their common origin and close relationship. 
It has been suggested that chromosomes that are consistently underrepresented (e.g., 11, 13, and 
18) may contain genes that are important for normal germ cell differentiation and have tumor-
suppressing properties. On the other hand, chromosomes that are overrepresented (e.g, 7, 8, 12, 
and X) may harbor genes that confer a more malignant phenotype to the cells (Castedo et al., 
1989a, 1989c, 1991; De Jong et al., 1990). Therefore, chromosomes found to be significantly 
underrepresented in NSGCTs as compared with seminomas (e.g., 15 and 21: Castedo et al., 
1989a, 1989c) may very well contain genetic information that, when lost, triggers the transition of 
a seminoma stage cell into a NSGCT. 
Apart from numerical chromosomal alterations, TGCTs of adults may contain a variety of 
structural chromosomal anomalies (Delozier-Blanchet et al., 1987; Castedo et al., 1989a, 1989c; 
Sandberg, 1990; Ilson et al., 1991). The most prominent and common structural abnormality is an 
isochromosome of the short arm of chromosome 12, i(12p) (Atkin and Baker, 1982, 1983; 
Delozier-Blanchet et al., 1985) (Fig. 17). This abnormality constitutes a highly specific and 
consistent chromosomal marker for TGCTs of adults (Atkin and Baker 1982, 1983, 1985; Gibas 
et al. 1986; Oosterhuis et al. 1986; Delozier-Blanchet et al. 1985, 1987; Castedo et al. 1989a, 
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Figure 17 Partial karyotype of a germ cell tumor depicting two copies of a normal chromosome 
12 and one i(12p). 
1989c; for reviews see De Jong et al. 1990; Ilson et al., 1991) and is found in more than 80% of 
such TCGTs (Castedo et al. 1988; Bosl et al. 1989), regardless of their histology. In contrast, 
only one out of three karyotyped CIS located next to invasive testicular cancer contained an i(12p) 
(Vos et al., 1990). Little is known about the exact nature and significance of i(12p) in tumor 
development, but its frequent occurrence in seminomas and NSGCTs indicates that it plays an 
important role in the oncogenesis of TGCTs (De Jong et al., 1990). There is consensus that its 
presence correlates with the malignant character of the tumor (Delozier-BIanchet et al., 1987; 
Castedo et al., 1989b, Bosl et al., 1989). Moreover, it has been suggested that the occurrence of 
additional copies of i(12p) may be correlated with treatment failure (Bosl et al., 1989). 
Other less consistent structural chromosomal abnormalities are also observed in TGCTs. 
Extensive evaluation of these chromosomal rearrangements, however, indicates a clear clustering 
of breakpoints. Delozier-BIanchet and coworkers (1987) showed that the most affected 
chromosomal regions in 23 tumors studied were: 12p, 17q, lp and lq, 9q, 22q, 6q, and 7p, 
respectively. More specifically, Samaniego et al. (1990) found, after extensively reviewing the 
literature, that rearrangements in seminomas seem to cluster predominantly in the regions lp l l , 
12pll, 12q24 and in chromosome 17, leading to the formation of i(17q), while in NSGCTs 
rearrangements tend to cluster around Ip32-»p36, lqll-»q21, 12pll, 12ql3-»q22, 7pll-»p22, and 
17q25. So, common breakpoint regions in chromosomes 1 and 12, leading to i(12p), may occur in 
both seminomas and NSGCTs. For chromosome 1, deletions of the ρ arm appear to be most 
predominant (Wang et al., 1980; Atkin and Baker, 1985; Parrington et al., 1985; Parrington and 
West, 1985, 1986; Gibas et al., 1986; Delozier-BIanchet et al., 1987). Thus, it is tempting to 
speculate that, besides i(12p) formation, loss of lp material may be another important factor in the 
oncogenesis of TGCTs. Chromosome 1 rearrangements, however, are very common in various 
other solid and hematological tumors (Mitelman, 1985). Moreover, Castedo and coworkers 
(1989a) could not find any support for a possible relationship between structural abnormalities of 
chromosome 1 and enhanced metastatic potential, as suggested by Delozier-BIanchet et al. (1987) 
in their series of TGCTs. 
Besides i(12p), Samaniego and coworkers (1990) found a second nonrandom aberration 
affecting chromosome 12 which was identified as del(12)(ql3-»q22) in 7 out of 16 NSGCTs 
studied (44%). Further molecular mapping of these deletions, via the analysis of eight 
polymorphic 12q loci in paired normal/tumor DNA samples of 45 TGCT patients, revealed two 
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regions in which loss of heterozygosity is frequent (LOH: incidence higher than 40%), one at 
12ql3 and the other at 12q22 (Murty et al., 1992). Therefore, the authors postulated that these 
12q deletions may represent loss of gene(s) that play a key role in the malignant transformation of 
germ cells. On the other hand, Heimdall and coworkers (personal communication) and Looijenga 
et al. (1994) failed to confirm these high incidences of LOH in their collections of TGCTs 
(<25%) indicating that, as yet, the significance of loss of genetic material on 12q during TGCT 
development remains a matter of debate and, as such, requires further investigation. 
The role ofi(12p) in TGCT development 
The frequent occurrence of aneuploidization and i(12p) formation in seminomas and 
NSGCTs (more than 80%) indicates that these anomalies must play a prominent role in the 
oncogenesis of TGCTs of adults. Aneuploidization, due to polyploidization or cell fusion, has 
been recognized as an early event preceding i(12p) formation, since it may already be found in 
premalignant, noninvasive CIS (Vos et al., 1990). Moreover, RFLP analyses have provided 
evidence that aneuploidization precedes the formation of the i(12p) marker chromosome during 
development of TGCTs (Geurts van Kessel et al., 1989, 1991). The consistent presence of i(12p) 
in GCTs (in one case as only structural chromosomal abnormality: Gibas et al., 1986), the finding 
of a significantly higher copy number of this marker chromosome in more aggressive NSGCTs as 
compared with seminomas, and its absence in CIS cells suggest that the occurrence of i(12p) 
correlates with the acquisition of malignancy in TGCTs (Delozier-Blanchet et al., 1987; Castedo 
et al., 1989b, Dmitrovsky et al., 1991). 
The presence of i(12p) is not only restricted to TGCTs of adults, but can be found in other 
germ cell tumors as well. Isochromosome 12p has been observed in two dysgerminomas of the 
ovary (Atkin and Baker, 1987; Jenkyn and McCartney, 1987), three ovarian NSGCTs (Speleman 
et al., 1990, 1992; Hoffner et al. 1992), one Mullerian mixed tumor (Atkin and Baker, 1987), a 
dysgenetic gonadal germ cell tumor (Hamers et al., 1991), and some extragonadal GCTs (Dal Cin 
et al., 1989; Chaganti et al., 1989; Samaniego et al., 1990; Rodriguez et al., 1992; De Brain et 
al., 1994). Up to now, the occurrence of this chromosomal anomaly in solid neoplasms other than 
germ cell tumors has been limited to only four isolated cases (Van der Riet-Fox et al., 1979; 
Oosterhuis et al., 1989b; Rodriguez et al., 1990; Sreekantaiah et al., 1992), thus demonstrating its 
specificity for germ cell tumors. The occurrence of i(12p) in germ cell tumors from different 
anatomical sites points to a common pathogenetic pathway. 
In about 20% of all TGCTs no i(12p) is found (De Jong et al., 1990). If i(12p) plays a 
critical role in the oncogenetic process, i(12p)-negative TGCTs may represent a different group of 
germ cell tumors, where malignancy may be related to other factors (Castedo et al., 1989a). 
Alternatively, in both i(12p)-positive and -negative TGCTs common mechanisms leading to 
malignancy may be at work (Castedo et al., 1988b). Indeed, cytogenetic analysis of a group of 13 
i(12p)-negative TGCTs revealed other structural abnormalities of chromosome 12 in about 75% of 
the cases (De Jong et al., 1990). These abnormalities might, in combination with structural and/or 
numerical aberrations of other chromosomes, have the same ultimate effect as the i(12p) 
chromosome (Castedo et al., 1988b, 1989a). 
Several questions about the origin and nature of i(12p) still remain. Up to now, most 
information has come from intensive and laborious cytogenetic analyses of primary tumors. Such 
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analyses, however, are hampered by the difficulty of obtaining satisfactory numbers of high-
quality metaphase spreads which reliably represent the tumorigenic cell population(s). Another 
problem is the diversity of chromosomal abnormalities which may obscure the most relevant 
chromosomal changes. In view of the common occurrence of i(12p) in primary and metastatic 
germ cell tumors, it is clear that a more rapid and reliable approach to detect this anomaly is 
needed. To circumvent some of the problems mentioned, the application of FISH strategies, 
allowing the detection and localization of specific 'target' sequences in microscopic preparations 
by means of fluorescent reporter molecules (see Chapter 2), may serve as a molecular means to 
provide such detailed karyotypic information. 
In the following sections (3.2-3.7) the introduction and application of FISH techniques in 
the study of GCTs, in particular the testicular tumors, is described. Chapter 3.2 deals with the 
sequential order of aneuploidization and i(12p) formation in the process of tumorigenesis and, in 
addition, describes initial attempts to develop a FISH probe (a 'chromosome paint') that 
specifically detects i(12p). Chapter 3.3 describes the introduction of chromosome painting as a 
technique to verify the identity of i(12p) in TGCTs. Chapter 3.4 describes the application of 
double color FISH to evaluate and demonstrate the presence of not only i(12p) but also other 
chromosome 12 abnormalities in GCTs. In Chapter 3.S similar FISH strategies were used to study 
the presence of chromosome 12, especially 12p-derived sequences, in i(12p)-negative TGCTs and 
to clarify oncogenetic similarities between i(12p)-positive and -negative TGCTs. Chapter 3.6 deals 
with the parental origin and molecular nature of i(12p) and, in addition, provides some clues about 
the mechanism(s) that may lead to i(12p) formation. In Chapter 3.7 the identification and 
characterization of a specific subchromosomal region on 12p, possibly involved in the progression 
of TGCTs, is described using a combination of cytogenetic, FISH and molecular strategies. 
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CHAPTER 3.2 
MOLECULAR ANALYSIS OF ISOCHROMOSOME 12p IN TESTICULAR 
GERM CELL TUMORS 
Ad Geurts van Kessel, Ron F. Suijkerbuijk, Bauke de Jong, J. Wolter Oosterhuis 
From the Department of Human Genetics, University Hospital Nijmegen, The Netherlands 
(A.G.V.K., R.F.S.), and the Departments of Medical Genetics and Pathology, University of 
Groningen, The Netherlands (B.d.J., J.W.O.) 
Published in Recent Results in Cancer Research 123:113-118, 1991. 
ABSTRACT 
We have demonstrated, by using RFLP analysis, that formation of the i(12p) chromosome 
in TGCTs does not lead to loss of heterozygosity of various loci on the q arm of chromosome 12. 
This result suggests that aneuploidization precedes the formation of the i(12p) marker chromosome 
during the malignant transformation leading to the formation of germ cell tumors. In situ 
hybridization ("chromosome painting") is a valuable new approach for the detection of the i(12p) 
chromosome in germ cell tumors. 
Figure 19 is represented on Color Plate I. 
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INTRODUCTION 
Testicular germ cell tumors (TGCTs) of adults are marked by a common structural 
chromosomal abnormality: i(12p) (Atkin and Baker, 1988). This chromosome anomaly is 
characteristic for all histologic varieties of TGCTs and is observed in more than 80% of all 
cases. This frequent occurrence suggests that the altered chromosome 12 could play an important 
role in the pathogenesis of germ cell tumors. However, at the present time little is known about 
the role of this chromosome in tumorigenesis. In addition, TGCTs are usually highly aneuploid. 
Thus, besides i(12p) formation, aneuploidization could play an important role in the oncogenesis 
of TGCTs. We supply evidence suggesting that i(12p) formation is not the first step in the 
development of TGCTs and that its generation does not lead to gross loss of material of the long 
arm of chromosome 12. We also show that in situ hybridization ("chromosome painting") 
represents a valuable new approach for the detection of the i(12p) chromosome in germ cell tumor 
material. 
MATERIALS AND METHODS 
High molecular weight DNAs were extracted from primary tumor samples, normal tissues, 
and cultured cell lines as reported previously (Geurts van Kessel et al., 1985). DNAs were 
cleaved to completion with restriction enzymes according to the specification of the suppliers, 
subjected to electroporesis through 0.7% agarose gels, and transferred to Nytran filters (New 
England Nuclear). Probe labeling was carried out using random priming (Feinberg and 
Vogelstein, 1983). After hybridization, filters were washed to 0.3 χ sodium saline citrate (SSC) at 
65°C. Fuji X-ray films were exposed at -80°C for 1-3 days using intensifying screens. 
Nonradioactive in situ hybridizations were carried out essentially as described by Pinkel et 
al. (1986). Total human or hybrid cell DNA was labeled with biotin-11-dioxyuridinetriphosphate 
(dUTP) or biotin-16-dUTP by nick translation. Hybridizations were carried out in a moist 
chamber at 37 °C for 24 hr. Detection of the biotinylated probes was achieved using fluorescein 
isothyocyanate (FITC)-conjugated avidin followed by an amplification step using biotin-conjugated 
goat anti-avidin antibodies and again FITC-conjugated avidin (Vector Laboratories). After 
washing, the slides were mounted in antifade medium (DABCO, Sigma) containing 4,6-diamino-2-
phenylindole (DAPI, Sigma) for counterstaining of the chromosomes. 
RESULTS AND DISCUSSION 
In general, the formation of an isochromosome in diploid cells leads to loss of the 
chromosomal arm not included in the anomaly. As a consequence, this leads to a loss of 
heterozygosity of genes located on the deleted chromosomal arm. In the case of the i(12p) 
chromosome, this results in the loss of heterozygosity of genes on the q arm of chromosome 12. 
Subsequent aneuploidization may generate mutiple identical copies of the unaffected chromosome 
12 in the tumor cells. Alternatively, if aneuploidization occurs prior to generation of the i(12p) 
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Figure 18 Restriction fragment length polymorphism analysis of normal (left pannel) and TGCT-
derived (right раппеГ) DNAs cleaved with Р иІІ and hybridized with an IGF-1 probe. The 5.1-
and 4.7-kb hybridizing fragments represent different polymorphic alleles. The 8.4- and 2.5-kb 
bands represent constitutively hybridizing fragments. Patients В and С are heterozygous in both 
normal (left) and tumor-derived (right) samples. 
marker, this sequence of events will not necessarily result in the loss of heterozygosity of genes 
located on 12q. 
To test the order of these events, we assayed TGCT cells for the presence or absence of 
chromosome 12q heterozygosity using restriction fragment length polymorphism (RFLP) analysis. 
For this analysis we used various primary tumor samples and i(12p)-positive cell lines (Andrews 
et al., 1986; Geurts van Kessel et al., 1989). In Fig. 18, examples of the RFLP analyses are 
presented. Screening of normal DNAs obtained from several TGCT patients for the presence of 
heterozygous alleles of the polymorphic insulin-like growth factor-1 (IGF-l) locus on chromosome 
12q after Pvull digestion (Höppener et al., 1985) revealed that patients A, D, E, and F were 
negative and that patients В and С were positive and, therefore, informative for our present study 
(5.1- and 4.7-kb bands). Subsequent analysis of the tumor DNAs from seminoma and embryonal 
carcinoma clearly revealed the retention of this heterozygosity (Fig. 18, lanes В, C). Previously, 
we had already demonstrated that TGCT-derived NT2/D1 cells are heterozygous for the 
polymorphic 12q markers D12S4 using ra^l-cleaved DNA and D12S6 and D12S8 using Mspi-
cleaved DNAs (Geurts van Kessel et al., 1989). In the same study, very similar results were 
obtained with another TGCT line, Scha-1. Moreover, via somatic cell hybrid analysis, we were 
able to demonstrate in the tumor cells the presence of at least two intact (maternal and paternal 
derived) allelic copies of chromosome 12 (Geurts van Kessel et al., 1989). 
Taken together, we conclude that loss of gene heterozygosity on the q arm of chromosome 
12 is not a general characteristic of i(12p)-positive TGCTs. Therefore, teleologically, we argue 
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that aneuplodization seems to be at least one step ahead of the formation of the i(12p) anomaly 
during the evolution of these tumors This conclusion is in agreement with the previous suggestion 
of Oosterhuis et al (1988) that polyploidization is an early step in the pathogenesis of germ cell 
tumors of the testis Our results are also in accordance with the suggestion made by Delozier-
Blanchet et al (1987) that multiple copies of the i(12p) marker usually characterize tumors with 
aggressive growth and therefore in advanced clinical stages at the tissue of diagnosis The exact 
nature of the i(12p) anomaly has, so far, not been determined Using somatic cell hybrid analysis 
we have previously demonstrated that the i(12p) marker is indeed derived from the short arm of 
chromosome 12 (Geurts van Kessel et al , 1989) Recently, a new approach has been developed 
that will enable us (a) to determine the exact nature of the TGCT-specific marker and (b) to 
determine in detail its occurrence during the etiology of germ cell tumors This new approach is 
based on already existing nonradioactive in situ hybridization procedures which allow visualization 
of a whole chromosome or a specific fragment thereof For these "chromosome painting" 
procedures, various probes can be used such as chromosome-specific cosmid or phage libraries, or 
somatic cell hybrids that have retained only one particular human chromosome (Pinkel et al , 
1988, Cremer et al , 1988) A cell hybrid that has retained the Pallister-Killian syndrome-
associated i(12p) chromosome has been isolated (Zhang et al , 1989) Molecular analysis has 
shown that this hybrid indeed contains only 12p material When we hybridized metaphase 
chromosomes from this cell line with total human DNA as a probe, only a single human 
chromosome with i(12p) morphology could be observed (Fig 19), often present in multiple copies 
per cell When, in turn, DNA extracted from this hybrid was used as a probe on normal human 
metaphase chromosomes, hybridization with 12p was observed exclusively, again confirming that 
only 12p material is present Obviously, application of this new probe, in conjunction with 
"chromosome painting", will enable us to determine the exact nature of the i(12p) chromosome in 
TGCTs Moreover, since these procedures can in principle also be applied to interphase nuclei, in 
both fresh and archival material, we may now have the tools to study the occurrence of this 
specific marker during the etiology of TGCT 
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ABSTRACT 
The recently developed competitive in situ hybridization (CISH) strategy was applied to the 
analysis of chromosome 12 aberrations in testicular germ cell tumors (TGCTs). DNAs from two 
rodent-human somatic cell hybrids, containing either a normal chromosome 12 or the ρ arm of 
chromosome 12 as their unique human material, were used as probes. Our results demonstrate a 
genuine iso-12p character of the standard marker chromosome in TGCTs. Moreover, variant 
markers were identified representing translocation products that also involve chromosome 12. 
Figures 20-23 are represented on Color Plate I. 
73 
INTRODUCTION 
Testicular germ cell tumors (TGCT) are characterized by a highly specific marker 
chromosome which, according to its morphological appearance, has been described as an iso-12p 
chromosome (Atkin and Baker 1983). The same marker chromosome has been detected in 
dysgerminomas (ovarian germ cell tumors [Atkin and Baker 1987; Jenkyn and McCartney 1987]), 
and in some extragonadal germ cell tumors (Chaganti et al. 1989; Dal Cin et al. 1989; De Bruin 
et al., 1994). The frequent and consistent occurrence of the iso-12p chromosome may be 
indicative for an important role in the development of these various germ cell tumors. Iso-12p 
negative TGCTs have also been described, but in these cases other chromosome 12 aberrations are 
often found (Gibas et al. 1986; Castedo et al. 1988). Since the iso-12p marker chromosome has so 
far been defined by morphological criteria only, the nature of this anomaly still needs verification. 
Here, we describe the application of competitive in situ hybridization (CISH) techniques 
(Kievits et al. 1990) to the identification of chromosome 12 aberrations in primary tumors and 
TGCT-derived cell lines. The probes used have recently become available and consist of DNAs 
from two rodent-human somatic cell hybrids, one containing an entire chromosome 12 
(constructed as described by Warburton et al. [1990]) and another one containing a Pallister-
Killian-derived isochromosome 12p (Zhang et al. 1989) as the only human material present. Our 
results indicate that a genuine iso-12p chromosome as well as variant markers with involvement of 
chromosome 12p are present in the tumor and tumor-derived cell lines. 
MATERIALS AND METHODS 
Cells and preparation of metaphase spreads 
The Chinese hamster-human somatic hybrid cell line PK-89-12, containing a normal human 
chromosome 12, was constructed as described by Warburton et al. (1990). The mouse-human 
somatic hybrid cell line M28, containing the short arm of chromosome 12 (as an isochromosome 
12p derived from a patient with Pallister-Killian syndrome) as the only human chromosome, was 
developed by Zhang et al. (1989). The primary tumors used in this study included a primary 
testicular non-seminomatous germ cell tumor and a residual mature teratoma following 
chemotherapy. The N Tera-2 clone DI (NT2/D1) and Scha-1 cell lines were used as typical 
representatives of two distinct human TGCTs (embryonal carcinomas [Thompson et al. 1984; 
Andrews et al. 1987]). 
Cells were cultured in FIO or RPMI-1640 medium, supplemented with antibiotics, 
glutamine and 10-15% FCS. Metaphase spreads from NT2/D1 cells, Scha-1 cells, primary tumors 
and human blood lymphocytes (derived from healthy donors) were prepared following standard 
protocols (Vos et al. 1990). Chromosome preparations were stored in 70% ethanol at 4 °C until 
use. G-banding was carried out according to standard procedures. 
Probes and biotin labeling 
DNA from rodent-human hybrid cell lines PK-89-12 and M28 was isolated and purified as 
described previously (Geurts van Kessel et al. 1989). The DNAs were sonicated to a fragment 
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length of about 300-500 bp. Subsequently, they were used as probes. Biotinylation of these probes 
was performed by standard nick translation using Bio-11-dUTP (Sigma) or Bio-16-dUTP 
(Boehringer). After purification, DNA was dissolved at a concentration of 10 ng (PK-89-12) or 
100 ng (M28) per μΐ hybridization mixture containing 50% (v/v) deionized formamide, 2 χ 
SSC(pH 5.0), 10% (w/v) dextrane sulphate, 1 % (v/v) Tween-20, sonicated herring sperm DNA (5 
μg/μl) as carrier DNA and an excess sonicated total human DNA (see below) as competitor DNA. 
Prehybridization and hybridization 
Competitive in situ hybridization (CISH) experiments were carried out following protocols 
developed by Kievits et al. (1990) with some slight modifications. Prehybridization (partial 
reannealing) of PK-89-12 or M28 was carried out in the presence of an excess total human DNA 
(500 ng/μΐ or 1 μglμ\ hybridization mixture, giving competitonprobe ratios of 50:1 or 10:1) at 
37°C for 2 hrs or 24 hrs, respectively. Prior to hybridization, the chromosome slides were 
washed in PBS, dehydrated, airdried, and finally prewarmed at 70°C. Denaturation of the slides 
was achieved by immersing them in 70% (v/v) formamide, 2 χ SSC (final pH 7.0) at 70°C for 3-
5 min. The slides were taken out and, subsequently, the partially reannealed probe mixture was 
added to the slides (10 μΐ per 18xl8-mm coverslip). Hybridizations were performed in a moist 
chamber at 37 °C for three days. 
Immunoeytochemical detection 
After hybridization, the slides were washed three times in 50% (v/v) formamide, 2 χ SSC 
(final pH 7.0) and 2 χ SSC (pH 7.0) at 42°C for 5 min, and once in 4 χ SSC, 0.05% (v/v) 
Tween-20 (final pH 7.0) at room temperature (RT) for 3 min. Then the slides were incubated with 
5% nonfat dry milk (Protifar, Nutricia) in 4 χ SSC, 0.05% Tween-20 at RT for 5 min, as 
described by Kievits et al. (1990). Fluorescent staining of the hybridized probe was accomplished 
by alternate incubations with fluorescein-avidin DCS and biotinylated goat anti-avidin antibody 
(Vector Laboratories), until two layers of avidin were applied, essentially as described by Pinkel 
et al. (1986). Finally, the slides were mounted in antifade-medium, supplemented with 1,4-
diazobicyclo-(2,2,2)-octane (DABCO, Sigma) and 4,6-diamino-2-phenyIindole (DAP1, Sigma) or 
propidium iodide (PI, Kodak) for counterstaining. 
RESULTS AND DISCUSSION 
In the cell hybrids PK-89-12 and M28, whose DNA was used as a probe, the human 
chromosome (chromosome 12 in PK-89-12 and isochromosome 12p in M28) carried histidinol or 
neomycin resistance genes, respectively, so that it could be selected for during culture (Zhang et 
al. 1989; Warburton et al. 1990). The presence of the respective chromosomes in the hybrid cell 
lines was visualized by fluorescence in situ hybridization with total human DNA as a probe on 
hybrid metaphase spreads as described by Pinkel et al. (1986). In these lines one copy (PK-89-12) 
or two to three copies (M28) of the human chromosome were found to be present per cell (Geurts 
van Kessel et al. 1991). In addition, the origin of the human chromosomes in the hybrid cell lines 
was confirmed by competitive in situ hybridization (CISH, see Kievits et al. 1990) using hybrid 
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cell DNA as a probe on normal human blood lymphocyte chromosomes (unpublished results). 
When PK-89-12 DNA was hybridized onto metaphase spreads of the first tumor, a primary 
testicular non-seminomatous germ cell tumor, the probe revealed the presence of three copies of 
chromosome 12 and four copies of a marker chromosome, resembling an iso-12p chromosome 
both in size and morphology (Fig. 20). The resulting fluorescent staining of both types of 
chromosomes appeared to be somewhat less intense near the centromeres. This may be explained 
by the presence in these regions of highly repeated sequences, which are competed for during 
prehybridization steps (Kievits et al. 1990). Under the stringent conditions used here, a high 
signal:noise ratio was achieved, which underlines the specific character of this probe. 
In metaphase spreads of the second tumor, a residual mature teratoma following 
chemotherapy, again three copies of chromosome 12 and one marker chromosome, 
morphologically resembling an iso-12p, could be detected (Fig. 21). In addition, a second marker 
chromosome - a translocation product between a positively staining part of chromosome 12 
(probably, but not unambiguously 12p) and another negatively staining and as yet unknown 
chromosome - was observed. 
These results are in agreement with the occurrence of several copies of chromosome 12 
and, in addition, one or more iso-12p marker chromosomes in TGCTs (Atkin and Baker 1983). 
Furthermore, these results demonstrate both the high specificity of the PK-89-12 probe in 
visualizing chromosome 12 sequences in metaphase spreads and its value in monitoring the 
occurrence of chromosome 12 aberrations. 
Because no further material was available from the primary tumors tested above, M28 DNA 
was used as probe on two cell lines, NT2/D1 and Scha-1, which are considered to be typical 
representatives of TGCTs, to assess the short arm origin of the chromosome 12 sequences in 
TGCTs. NT2/D1 has previously been reported to contain, besides three copies of chromosome 12, 
a germ cell tumor-specific iso-12p chromosome (Thompson et al. 1984; Geurts van Kessel et al. 
1989). CISH with M28 DNA on metaphase spreads of this cell line indeed showed the presence of 
three chromosomes with positively staining short arms; they most likely represent copies of 
chromosome 12 (Fig. 22). In addition, two marker chromosomes twice as large as 12p stained 
12p-positive. From this result we conclude that the earlier cytogenetically defined GCT-specific 
i(12p) indeed is a true iso-12p, occurring in TGCTs, whose genuine character can be 
demonstrated by CISH using M28 DNA as a probe. Again, as found for the PK-89-12 probe, the 
specific fluorescent staining of the chromosomal arms after CISH with M28 DNA appears to be 
less dense in the centromeric and more intense in the telomeric regions. In some NT2/D1 
metaphases a tiny non-hybridizing chromosomal fragment seemed to be translocated onto one of 
the two original iso-12p chromosomes (not shown). The second TGCT cell line used, Scha-1, 
does not contain a characteristic iso-12p marker chromosome according to cytogenetic analysis 
(Vos et al. 1990). Instead, these cells contain a 12p-derived marker chromosome that in size and 
morphology is reminiscent of an iso-12p and, in addition, another larger marker presumably 
containing chromosome 12 material. These observations were confirmed by CISH with PK-89-12 
(not shown). CISH results with M28 DNA (see Fig. 23) indicate that the smaller marker 
chromosome indeed is a translocation chromosome, which is composed of a ρ arm of chromosome 
12 translocated onto another, unknown chromosomal fragment. This result definitively excludes 
the smaller marker from being an iso-12p chromosome. The larger marker chromosome clearly 
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* 4 
12 M 
Figure 24 Giemsa-banded partial karyotype from the TGCT derived cell line Scha-1 showing a 
normal chromosome 12 (left) a r"i the large marker (M; right) in which chromosome 12 is 
involved (as described in the text). The 12p positively staining region, as found in Fig. 23, 
comprises an area ranging from the centromere to about halfway up the upper chromosomal arm. 
contains 12p material, again translocated onto/into another chromosomal fragment: a 12p-positive 
fluorescent staining region in the central part of the marker chromosome, twice as large as seen 
on the normal 12p-arm, was visualized (Fig. 22, bottom right). By combining CISH data with G-
banding data (see Fig. 24) this marker can be interpreted as follows: an abnormal chromosome 
12, with a double amount of 12p and a less-than-normal amount of 12q sequences, translocated 
onto another unidentified chromosomal fragment. From these results, we conclude that, in Scha-1 
cells, chromosome 12 has undergone complex rearrangements involving both ρ and q arms. No 
typical iso-12p chromosome is present in these cells. 
Taken together, our results demonstrate that the marker chromosome of TGCTs has a 
genuine iso(12p) character, identifiable by CISH using hybrid (PK-89-12 and M28) DNA. 
Moreover, our data confirm previous observations indicating that rearrangement of chromosome 
12, particularly 12p, may play an important role in TGCT development. Although a typical i(12p) 
is frequently observed and, via this study, easily identified as such, rearrangement of chromosome 
12 does not necessarily have to result in this particular marker. These observations may indicate 
that in those cases in which no iso-12p is observed, a chromosome 12 (especially 12p) reshuffling 
may still have taken place, which can be detected by in situ hybridization techniques as described 
here. Such variant cases may be of particular value in defining the region(s) in chromosome 12 
that are specifically involved in TGCT development. Additional probes derived from, e.g., the 
centromeric region of chromosome 12 as recently isolated by Looijenga et al. (1990) and repeated 
and/or single copy fragments derived from 12p or 12q may prove to be of particular help in this 
respect. Further experiments with such probes are currently in progress. 
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ABSTRACT 
A diverse group of gonadal and extragonadal human germ cell tumors (GCTs) and GCT-
derived cell lines was examined for the presence of an i(12p) marker chromosome and/or other 
abnormalities involving chromosome 12, especially 12p, by bicolor double fluorescence in situ 
hybridization. For this purpose three probes, pBS-12, M28, and porl2H8, were used, allowing 
specific identification of the entire chromosome 12, its short arm, and its pericentromeric region, 
respectively. The presence of one or more copies of a genuine i(12p) chromosome could be 
demonstrated in three GCTs of the testis, in one ovarian GCT, in one dysgenetic GCT, and in one 
extragonadal intracranial GCT. Moreover, additional aberrations involving chromosome 12 were 
found to be present not only in i(12p)-negative but also in i(12p)-positive GCTs. These data 
suggest that the occurrence of such aberrations may be a common, although less clearly 
perceptible and frequent, phenomenon in human GCTs. 
Figures 25-39 are represented on Color Plate II. 
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INTRODUCTION 
During the past decade, evidence has accumulated indicating that tumor formation is 
accompanied by the occurrence of nonrandom chromosomal abnormalities, both in arrangement 
and number (Mitelman, 1990; Sandberg, 1990). A fundamental role for these changes in the 
neoplastic transformation has been well established in several hematological tumors, and such 
genomic changes are generally accepted to be causally related to cancer development (Rowley, 
1990). In solid tumors as well, chromosomal breakpoints tend to cluster to specific regions, and 
several recurring abnormalities have been observed (Trent, 1984; Atkin, 1989; Berger, 1989; 
Fletcher et al., 1991). The presence of a consistent chromosomal change, however, has hitherho 
been determined in only a few solid tumor types, mainly because cytogenetic analyses of these 
tumors are difficult to perform (Mitelman et al., 1989). 
Human germ cell tumors (GCTs) comprise a heterogeneous group of solid neoplasms, 
occurring in the testis, the ovary and in extragonadal sites (Mostofi and Price, 1973; Scully, 1979; 
Gonzales-Crussi, 1982). Basically, two entities can be distinguished: (1) tumors, composed of 
neoplastic germ cells called seminoma in the testis, dysgerminoma in the ovary, and germinoma in 
extragonadal sites; and (2) non-seminomatous GCTs, composed of embryonic and/or extra-
embryonic tissues (Martineau, 1969). Testicular GCTs (TGCTs) themselves are also 
heterogeneous (Atkin, 1973; De Jong et al., 1990) and can be subdivided epidemiologically in 
three groups: infantile tumors, tumors of adults, and rumors of elderly men. As initially reported 
by Atkin and Baker (1982), the isochromosome 12p, or i(12p), constitutes a highly specific and 
consistent chromosomal marker for GCTs of adults (Atkin and Baker, 1983, 1985; Delozier-
Blanchet et al., 1985, 1987; Gibas et al., 1986; Oosterhuis et al., 1986; Castedo et al., 1989a, 
1989b, 1989c; for review see De Jong et al., 1990). This marker chromosome is observed in 
about 80% of TCGTs, regardless of its histology (Bosl et al., 1989; De Jong et al., 1990; 
Samaniego et al., 1990). Furthermore, i(12p) has been found in dysgerminomas of the ovary 
(Atkin and Baker, 1987; Jenkyn and McCartney, 1987; Speleman et al., 1990) and in 
extragonadal GCTs (Dal Cin et al., 1989; Chaganti et al., 1989; De Bruin et al., 1994). In the 
remaining "i(12p)-negative" TGCTs other abnormalities involving chromosome 12 are usually 
noted (Gibas et al., 1986; Castedo et al., 1988). 
Very recently, we have introduced fluorescence in situ hybridization (FISH) techniques to 
demonstrate the presence of a genuine i(12p) chromosome in primary TGCTs and some derived 
cell lines (Suijkerbuijk et al., 1991). In addition, other abnormalities involving chromosome 12, 
which remained unrecognized after application of conventional chromosome banding techniques, 
were identified after FISH. These results indicate that the FISH method provides a sensitive and 
reliable method for confirming cytogenetic data and obtaining additional karyotypic information in 
human GCTs. 
We have extended these studies using an additional and diverse group of GCTs and GCT-
derived cell lines. This material was screened for the presence of abnormalities involving 
chromosome 12, with emphasis on 12p, using combinations of probes in bicolor double FISH 
experiments in conjunction with conventional chromosome banding analyses. We confirm the 
presence of one or more copies of a genuine i(12p) in a series of GCTs of diverse origin. 
Moreover, additional aberrations affecting chromosome 12 do occur not only in "i(12p)-negative" 
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but also in "i(12p)-positive" GCTs 
MATERIALS AND METHODS 
Cells and preparation of the slides 
The human-mouse somatic hybrid cell line M28, containing an i(12p) as the sole human 
component, was developed by Zhang et al. (1989) Eight germ cell tumor (GCT) specimen, four 
primary tumors and four GCT-derived cell lines (each used as a representative of a distinct 
TGCT), were included in this study Of these eight, six were previously shown to be i(l2p)-
positive by cytogenetic analysis: two primary tumors, i.e., an extragonadal intracranial teratoma 
and a dysgenetic gonad tumor (T2219 and Ma-90, respectively, both described in more detail 
elsewhere. De Bruin et al , 1994; Hamers et al , 1991), an ovarian GCT (Sp-90, Speleman et al , 
1992) and three TGCT-derived cell lines NT2/D1 (Thompson et al, 1984), KDK (Dr J M 
Parrington, unpublished observations), and Germa-1 (Hofmann et al., 1989) (all embryonal 
carcinomas) The other two GCTs, an extragonadal mediastinal GCT (T87-1004, Dr J W 
Oosterhuis, unpublished observations) and the TGCT-derived cell line Scha-1 (embryonal 
carcinoma Andrews et al , 1987) turned out to be i(12p)-negative 
Cells were cultured in F10-medium, RPMI-1640 medium, or Chang medium supplemented 
with antibiotics, glutamin, and 10-15% fetal calf serum (FCS) Metaphase spreads from primary 
tumors, TGCT-derived cell lines, and phytohaemagglutinin-stimulated human blood lymphocytes 
(derived from healthy donors) were prepared following standard protocols (Vos et al , 1990) Air-
dried chromosome preparations were stored in 70% ethanol at 4°C until use G-banding was 
carried out according to standard procedures (Vos et al , 1990) 
Probe labeling and preparation 
DNA from the hybrid cell line M28 was used as a probe to detect sequences of the short 
arm of chromosome 12 (Suijkerbuijk et al , 1991) The chromosome 12-specific plasmid library 
pBS-12 (Collins et al , 1991), a gift from Dr J W Gray, was used to visualize the entire 
chromosome 12 Purified DNAs were labeled with biotin-11-dUTP (Sigma, St Louis, MO) by 
nick-translation The α-satellite sequence pal2H8, isolated by Looijenga et al (1990), was used 
as a probe to detect the pericentromeric region of chromosome 12 specifically It was labeled with 
biotin-11-dUTP (Sigma) or with digoxigenin-11-dUTP (Boehnnger Mannheim, Germany) for 
single or bicolor double FISH experiments, respectively 
After purification, the labeled probes were dissolved separately in hybridization solutions, 
containing 50% (v/v) deionized formamide, 2 χ SSC (pH 5 0), 10% (w/v) dextrane sulphate, 1% 
(v/v) Tween-20, and 5 mg/ml sonicated herring sperm DNA as a carrier. The final probe 
concentrations applied were for pal2H8 DNA 1 or 2 ng//d, for M28 DNA 10 or 20 ng/μΐ, and 
for pBS-12 10 or 20 ng/μΐ single and bicolor double FISH experiments, respectively In addition, 
biotinylated M28 DNA or pBS-12 DNA was preannealed (see Landegent et al , 1987, Cremer et 
al , 1988, Lichter et al , 1988) in the presence of a 50-fold concentration of Cj 1 DNA (serving 
as competitor DNA, GIBCO BRL-Life Technologies, Gaithersburg, MD) at 37°C for 20 mm 
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In situ hybridization 
Single FISH experiments, using either biotinylated porl2H8, pBS-12, or M28 DNA as a 
probe, were each performed under identical conditions exactly as described before (Suijkerbuijk et 
al., 1991). Bicolor double FISH, using ρα12Η8 and pBS-12 or M28 DNAs in one hybridization 
mixture, may be hampered by blocking of porl2H8 sequences with excessive Coil DNA 
(Landegent et al., 1987; Cremer et al., 1988; Lichter et al., 1988). To circumvent this problem, 
two separate hybridization mixtures were made: one containing digoxigenin-labeled pal2H8 only, 
and another one containing biotinylated pBS-12 or M28 DNA in the presence of (V. 1 DNA. 
Before hybridization the chromosome slides were rinsed for 1 min in 70% acetic acid, dehydrated, 
air-dried, and heat-denatured as described previously (Collins et al., 1991). Subsequently, 5 μΙ of 
preannealed pBS-12 or M28 and S μΙ heat-denatured ρα12Η8 hybridization mixtures were added 
separately onto the slide and mixed under a 18xl8-mm coverslip. Hybridizations were performed 
in a moist chamber at 37°C for 1-3 days. After hybridization, the slides were washed three times 
in 50% (v/v) formamide, 2 χ SSC (final pH 7.0) and in 2 χ SSC (pH 7.0) at 42°C for 5 min and, 
subsequently, once in 4 χ SSC, 0.05% (v/v) Tween-20 (final pH 7.0) at room temperature (RT) 
for 3 min. 
Immunocytochemical detection 
Slides were preincubated with 5% nonfat dry milk (Protifar, Nutricia) in 4 χ SSC, 0.05% 
(v/v) Tween-20 (preincubation buffer) at RT for 10 min, as described by Kievits et al. (1990). 
The actual immunocytochemical detection of the hybridized probes in single FISH experiments 
was performed exactly as described previously (Suijkerbuijk et al., 1991). In bicolor double FISH 
experiments, immunocytochemical detection of the two simultaneously hybridized probes was 
accomplished in a four-step procedure. First, an incubation with avidin-FITC (Vector 
Laboratories, Burlingame, CA; 5 μg/ml in preincubation buffer) was performed at RT for 20 min, 
allowing binding to the pBS-12 or M28 DNA-hapten biotin. Hereafter, an incubation with mouse 
anti-digoxin monoclonal antibodies (Sigma; 1:500 dilution in preincubation buffer) was performed 
at 37°C for 45 min, allowing binding to the pal2H8 DNA-hapten digoxigenin. Next to this, an 
incubation with biotin-conjugated goat anti-avidin antibodies (Vector Laboratories; diluted 1:200) 
and Texas Red-conjugated rabbit anti-mouse antibodies (Jackson Immunoresearch Laboratories, 
West Grove, PA; diluted 1:100), made up in 5% nonfat dry milk in PN-buffer (0.1 M Na^HPO,, 
0.1 M NaH2P04, 0.05% [v/v] nonidet P-40, pH 8.0) was applied at 37°C for 45 min. 
Subsequently, another incubation with avidin-FITC (in 5% nonfat dry milk in PN-buffer, pH 8.0) 
was carried out. Two layers of FITC and one layer of Texas Red were built up to visualize target 
chromosomes hybrized with pBS-12 or M28 and pal2H8 DNA, respectively. Finally, the slides 
were mounted in antifade-medium, supplemented with l,4-diazobicyclo-(2,2,2)-octane (DABCO, 
Merck, Darmstadt, Germany) and 4,6-diamino-2-phenylindole (DAPI, Sigma) for counterstaining. 
Photography 
Preparations resulting from FISH experiments were studied using a Zeiss Axiophot 
epifluorescence microscope, equipped for DAPI, FITC, and Texas Red epifluorescence. 
Photographs were taken with Kodak Ektachrome 400 color slide film. 
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RESULTS AND DISCUSSION 
To investigate whether the probes pa)2H8 and M28 or pBS-12 can be applied in a bicolor 
double fluorescence in situ hybridization (FISH) assay, single FISH experiments were performed 
first. Therefore, either biotinylated pal2H8, pBS-12, or M28 DNA were hybridized to metaphase 
spreads obtained from healthy human blood lymphocytes using identical FISH conditions (i.e., 
hybridization at 37°C in a hybridization solution containing 50% [v/v] formamide; 
posthybridization washings at 42°C in a 50% [v/v] formamide/2 χ SSC/pH 7.0 solution). By 
using FITC-conjugates, hybridization with pal2H8, pBS-12, or M28 DNA resulted in specific 
staining of the pericentromeric region, both the ρ and q arm, or only the ρ arm of both 
chromosome 12 homologs (see Figs. 25-27: yellow/green staining, whereas nonhybridizing 
chromosomes or chromosomal segments show up in blue owing to DAPI counterstaining). Only a 
very slight or undetectable background staining was noticed on the other chromosomes. Therefore, 
under the applied conditions all three probes display a high ratio of signal to noise, indicating that 
they can be used for bicolor double FISH experiments with similar reliability. 
Subsequently, bicolor double FISH, using pal2H8 and pBS-12 or M28 DNAs as probes, 
was performed on four primary (gonadal and extra-gonadal) germ cell tumors (GCTs) and four 
testicular GCT (TGCT)-derived cell lines to discern chromosome 12, especially I2p, aberrations 
(see Figs. 28-39). In metaphase spreads of each (T)GCT, chromosomal segments hybridizing with 
either digoxigenin-labeled pal2H8 or biotin-labeled pBS-12 or M28 were visualized using Texas 
Red-conjugates (red fluorescent staining) or FITC-conjugates (yellow-green staining), respectively. 
The FISH results thus obtained were evaluated using the next criteria: only those copies of 
chromosomes 12 that were of normal size and exhibited a normal centromere index and DAPI-
staining pattern were considered normal (although minor structural aberrations such as point- and 
insertional mutations, small deletions, inversions, or amplifications may still be present). All other 
chromosomes containing chromosome 12-derived sequences were designated as marker (M) 
chromosomes. In addition, chromosome 12 material-containing chromosomes were compaired 
with their GTG-banded counterparts. 
Figures 28 and 29 show metaphase spreads of an i(12p)-positive dysgenetic gonad tumor 
(Ma-90 from a XY female, see also Hamers et al., 1991) hybridized with both pBS-12 and 
pal2H8 (28) or M28 and pal2H8 (29) probes. Two copies of a normal chromosome 12 (arrows) 
and a relatively small metacentric marker chromosome with two entirely 12p arms and a 
chromosome 12 centromeric region (arrowhead) are visualized. Because of its staining pattern, the 
latter marker may be designated as a genuine i(12p) chromosome. These findings are in full 
agreement with results obtained from GTG-banding experiments (Fig. 30), and therefore confirm 
reliably and with relative ease the conventional cytogenetic data. 
FISH experiments using metaphase spreads of the TGCT-derived cell line KDK (embryonal 
carcinoma) showed the presence of three copies of a normal chromosome 12 (Figs. 31-32; arrows) 
and, again, of a genuine i(12p) marker chromosome (Figs. 31-32; arrowheads) as was expected 
from the analysis of GTG-banded chromosomes (Fig. 33). In addition, another small metacentric 
marker chromosome, that was partly 12p-positive, could be distinguished (Figs. 31-32; m). This 
12p-positive region is almost as large as a normal 12p arm, comprises more than half of the 
respective chromosomal arm and is located distally (see also Fig. 33; m). Without these newly 
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obtained FISH data, this marker chromosome could not be identified as such Furthermore, we 
noted that in a small fraction of the cells (less than 25 %) one of the three i(12p) chromosomes 
was absent Instead, another same-sized marker chromosome (m2) was observed that contained 
only one 12p-positive arm, a chromosome 12 centromenc region, and another negatively staining 
chromosomal arm (not shown) 
Thus, using FISH we observed additional, previously undetected chromosomal 
abnormalities involving 12p-denved sequences in an i(12p)-positive TGCT Therefore, we 
examined yet another TGCT-denved cell line, Germa-1 (embryonal carcinoma), to determine 
whether such observations could be extended further After ISH, three copies of a normal 
chromosome 12, one genuine i(12p) and two other marker chromosomes, a small metacentric one 
(ml) and a large submetacentric one (m2), could be distinguished in this cell line (Figs 34-35) A 
provisional interpretation of the two partly positively staining marker chromosomes ml and m2 
was possible only after we compared them with their GTG banded counterparts (Fig 36) The ml 
possesses an entirely 12p-positive staining chromosomal arm, presumably an almost complete 12p 
arm (without a chromosome 12 centromere), whereas the m2 contains a derivative chromosome 
12q- Both markers are translocated onto other chromosomal fragments The chromosome 12 
constituent of the latter marker is fused with its telomere to a chromosomal fragment possibly 
originating from chromosome 3q, and with its (very short) 12q region to an unidentified 
chromosomal segment This means that FISH studies on metaphase spreads of this cell line 
showed anomalies remarkably similar to those observed in KDK again, additional chromosomal 
abnormalities involving 12p were shown to be present in an i(12p)-positive TGCT-denved cell 
line 
FISH analysis of the i(12p)-negative TGCT-denved cell line Scha-1 (embryonal carcinoma) 
provided further information about the presence of additional abnormalities involving chromosome 
12 (Figs 37-38) Although no i(12p) marker chromosome was found, as was expected from GTG-
banding studies (Fig 39, see also Suijkerbuijk et al , 1991), five other marker chromosomes (ml-
5), all containing sequences derived from the short arm and the pencentromeric region of 
chromosome 12, could be distinguished (Figs 37-38) Furthermore, two copies of chromosome 
12 were present (Figs 37-38, arrows) The presence of five marker chromosomes, all involving 
chromosome 12, was unexpected Using GTG-banding, only two marker chromosomes were 
previously recognized to carry chromosome 12-segments the small metacentric ml that has an 
entire 12p arm, a chromosome 12 centromenc region, and another unknown (negatively staining) 
chromosomal arm, and the submetacentric m2 that contains the chromosome 12p arm and its 
centromenc region fused to an as yet unidentified chromosomal arm (as depicted in Figs 37-38) 
The other three marker chromosomes (m3-5) appeared to be very complex and their nature could 
not be fully elucidated even after we compared them with their GTG-banded chromosomal 
counterparts They all contain a part of chromosome 12 translocated onto another unknown 
chromosomal fragment m3 possesses a chromosome 12 fragment that can be described as 12q-
and 12p+, with a 12p-positive region comprising at least two copies of 12p that appear to be 
connected by their telomeres in the middle of this region (described previously as M in 
Suijkerbuijk et al , 1991), m4 contains a region ranging from 12qter to the pencentromeric area 
including an extremely small, proximal 12p-positive band, m5 contains about the same 
chromosome 12 region, but lacks a part of 12q The presence of the 12q-denved sequences was 
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TABLE 3: Summary of the different germ cell tumors (GCTs) included in the present study, their 
origin and cytogenetic (112) constitution as revealed by FISH (see text). 
chromosome number) 
Ma-90 (n = 48) 
KDK (n = 57-60У 
Germa-1 (η = 54-57)" 
NT2/D1 (η = 57-60)* 
Sp-90 (η = 49) 
Τ2219 (η = 64) 
Scha-1 (η = 61-63)' 
Τ87-1004 (η = 77-79) 
Tumor type 
Dysgenetic GCT 
Testicular GCT embryonal carcinoma 
Testicular GCT embryonal carcinoma 
Testicular GCT embryonal carcinoma 
Ovarían GCT 
Intracranial GCT 
Testicular GCT embryonal carcinoma 
Mediastinal GCT 
#12 constitution shown by FISH 
#12 
2 
3 
2 
3 
2 
3 
2 
3 
i(12p) 
1 
3(2)b 
1 
V 
1 
2 
— 
— 
Markers 
mar (mar,mar2)b 
marl, mar2 
marl 
— 
— 
marl-marS 
— 
* Derived cell lines 
b
 Found in less than 25% of the cells 
' Not including the i(12p)+ marker chromosome (see text), which has been denoted as ml in this table 
easily confirmed by FISH using the whole chromosome 12 paint pBS-12 (see Fig 37) This latter 
case represents a good example of an i(12p)-negative TGCT that contains a variety of other 
chromosome 12 aberrations (especially involving 12p) that were noticed only after FISH 
Results from these and one additional i(12p)-negative and three i(12p)-positive GCTs (or 
GCT-denved cell lines), included in this study are summarized in Table 3 In the ovarian germ 
cell tumor Sp-90, three copies of a normal chromosome 12 and one genuine i(12p) chromosome 
were observed, which is in line with the cytogenetic data reported previously (Speleman et al , 
1992) In metaphase spreads of the i(12p)-positive TGCT cell line NT2/D1 (embryonal carcinoma 
Thompson et al , 1984) and the extragonadal intercranial GCT T2219 (De Bruin et al , 1994), 
three copies of a normal chromosome 12 and two copies of an isochromosome 12p were noted 
after FISH, as expected from GTG-banding studies Careful examination of one of the i(12p) 
chromosomes in NT2/D1, however, disclosed an additional tiny, negatively staining chromosomal 
fragment of unknown origin that was translocated distally onto the telomere of one of the lip-
arms This feature excludes the possibility that this marker chromosome [i(12p)+ marker] is a 
genuine isochromosome Again, a clear-cut discrimination between this i(12p)+ and the genuine 
i(12p) marker chromosome was difficult to make using conventional chromosome banding 
techniques only In metaphase spreads of the i(12p)-negative mediastinal GCT T87-1004, only 
three copies of a normal chromosome 12 and no structural abnormalities involving chromosome 
12-denved sequences were observed in either bicolor double FISH or in conventional chromosome 
banding studies 
Using FISH techniques, we have begun to survey a diverse group of testicular and ovarian 
germ cell tumors, their derived cell lines, and some extragonadal GCTs for the presence of 
abnormalities involving chromosome 12 With the availability of three probes (pBS-12, M28, and 
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ρα12Η8) that are highly specific for the entire chromosome 12, its short arm, and its 
(peri)centromeric region, respectively, we were able to confirm the presence of one or more 
copies of a genuine i(12p) in three TGCT-derived cell lines (KDK, Germa-1, NT2/D1; all 
embryonal carcinomas), one primary ovarian GCT, one dysgenetic gonadal GCT, and one 
intracranial GCT in a bicolor FISH assay (see Table 3). Furthermore, after combining data from 
FISH experiments with those from conventional chromosome banding analyses, other aberrations 
involving chromosome 12 were identified in three i(12p)-positive TGCT-derived cell lines (KDK, 
Germa-1, NT2/D1) and one i(12p)-negative TGCT-derived cell line (Scha-1). The FISH method 
enabled us to discriminate between a genuine i(12p), a virtually identical i(12p)-derived marker 
chromosome (in NT2/D1), and other same-sized marker chromosomes, that consist partly of 
sequences derived from the short arm and/or the (peri)centromeric region of chromosome 12 (in 
KDK, Germa-1 and Scha-1). These findings are in agreement with and further extend results 
previously obtained in a similar study on primary tumors and some derived cell lines (Suijkerbuijk 
et al., 1991) and studies by other investigators based on conventional cytogenetic analyses (Gibas 
et al., 1986; Castedo et al., 1988). In addition, they indicate that chromosome 12 aberrations in 
TGCTs, such as in Germa-1 and Scha-1, cannot in all cases be detected simply in either 
interphase or metaphase nuclei by means of FISH using a chromosome 12 centromere-specific 
repeat probe only (as described by Mukherjee et al., 1991), even if detailed cytogenetic 
information on the tumors is available. 
The i(12p) marker chromosome is highly characteristic for TGCTs (Atkin and Baker, 1982, 
1983, 1985; Delozier-Blanchet et al., 1985, 1987; Gibas et al., 1986; Oosterhuis et al., 1986; 
Castedo et al., 1989a, 1989b, 1989c; De Jong et al., 1990). It has also been found in several 
other GCTs (Atkin and Baker, 1987; Jenkyn and McCartney, 1987; Chaganti et al., 1989; Dal 
Cin et al., 1989; Samaniego et al., 1990; Speleman et al., 1990; De Bruin et al., 1994). Our 
present study underlines and extends these previous observations. The consistent presence of this 
chromosome 12 rearrangement is indicative for a prominent role in the malignant development of 
GCTs (Bosl et al., 1989; Samaniego et al., 1990). Because i(12p) formation does not lead to gross 
loss of heterozygosity of 12q, we previously argued that this chromosome aberration does not 
represent the primary step in the pathogenesis of premeiotic, neoplastic germ cells (Geurts van 
Kessel et al., 1989, 1991; De Jong et al., 1990). At present, we can only speculate about the 
exact mechanism(s) by which i(12p) might be involved in the oncogenic process: its appearance 
may disturb a fine-tuned and narrow-defined balance between 12p sequences and sequences 
derived from 12q and/or other chromosomes. Alternatively, gene(s) located near putative 
breakpoint cluster regions on 12p may be involved (i.e., deregulated). The recent finding of a 
break in the proximal 12p region in a radiation-induced GCT (Cowan et al., 1990) appears to be 
in line with this latter notion. These rearrangements of chromosome 12p, resulting in 
chromosomal aberrations other than i(12p), may be of particular value in defining such region(s) 
on chromosome 12. Together, our data suggest that chromosome 12 aberrations other than i(12p) 
are a common, although less frequent, phenomenon in both i(12p)-positive and -negative human 
GCTs. The ultimate significance of these aberrations in the process of tumorigenesis must still be 
clarified. 
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ABSTRACT 
Human testicular germ cell tumors (TGCTs) comprise a heterogeneous group of solid 
neoplasms. These tumors are characterized by the presence of a highly specific chromosomal 
abnormality, i.e., an isochromosome of the short arm of chromosome 12. At present, this i(12p) 
chromosome is found in more than 80% of TGCTs. Isochromosome 12p has also been observed 
in some ovarian and extragonadal germ cell tumors. In the remaining so-called i(12p)-negative 
TGCTs other abnormalities involving chromosome 12, mainly 12p, can be found. In order to 
establish whether 12p abnormalities other than i(12p) are a common phenomenon in TGCTs, a 
panel of eleven i(12p)-negative tumors was investigated using multicolor fluorescence in situ 
hybridization. All TGCTs examined appeared to contain chromosomal abnormalities involving 
12p, resulting in a distinct overrepresentation of short arm sequences. In addition, indications 
were obtained for a clonal evolution in one of the tumors. Our data suggest that the occurrence of 
12p abnormalities is a common phenomenon in i(12p)-negative TGCTs and that these 
abnormalities, analogous to i(12p), may contribute to the process of tumor development. 
Figures 41-49 are represented on Color Plate III. 
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INTRODUCTION 
Human testicular germ cell tumors (TGCTs) comprise a histogenetically heterogeneous 
group of neoplasms. Despite this heterogeneity, a highly specific structural chromosomal 
abnormality ,i.e., an isochromosome of the short arm of chromosome 12 [i(12p)], has been found 
in more than 80 % of all histologic varieties of TGCTs of the adult (see De Jong et al., 1990 for 
review). Moreover, i(12p) has been observed in five ovarian germ cell tumors (two 
dysgerminomas (Atkin and Baker, 1987; Jenkyn and McCartney, 1987), two yolk sac tumors and 
one mature teratoma (Speleman et al., 1990, 1992; Hoffner et al., 1992), a dysgenetic gonadal 
tumor (Hamers et al., 1991), and in some extragonadal germ cell tumors (Chaganti et al., 1989; 
Dal Cin et al., 1989; Samaniego et al., 1990; Rodriquez et al., 1992; Aly et al., 1994; De Brain 
et al., 1994). So far, the occurrence of this marker chromosome in solid neoplasms other than 
germ cell tumors has been limited to only four isolated reports (Van der Riet-Fox et al., 1979; 
Oosterhuis et al., 1989b; Rodriquez et al., 1990; Sreekantaiah et al., 1992), thus demonstrating its 
specificity for germ cell tumors. Although little is known about the exact nature and role of i(12p) 
in tumor development, there is consensus that its presence correlates with the malignant character 
of the tumor (Delozier-Blanchet et al., 1987; Bosl et al., 1989; Castedo et al., 1989a). 
A relatively small group of TGCTs lacks the i(12p). Instead, other abnormalities involving 
chromosome 12 are usually found (Gibas et al., 1986; Castedo et al., 1988). Also, some 
extragonadal germ cell tumors without i(12p) have been described (Mann et al., 1983; Oosterhuis 
et al., 1985). Because there is general acceptance that i(12p) may play an important role in the 
oncogenesis of TGCTs, it has been suggested by Castedo et al. (1988) that i(12p)-negative and -
positive TGCTs may represent different subtypes of germ cell tumors, with different clinical and 
pathological behaviors. Alternatively, a common underlying molecular mechanism leading to 
malignancy may be present in both groups of germ cell tumors. Clearly, more profound and 
detailed clinical as well as cytogenetic and molecular studies on both i(12p)-positive and -negative 
TGCTs are needed to clarify their possible pathogenetic interrelationship. 
Recently, fluorescence in situ hybridization (FISH) strategies were used to demonstrate the 
presence of genuine i(12p) chromosomes in a diverse group of gonadal and extragonadal germ cell 
tumors and their derived cell lines (Suijkerbuijk et al., 1991, 1992). Similarly, other abnormalities 
involving chromosome 12, mainly 12p, that could not be detected by conventional cytogenetic 
means were found to be present in both i(12p)-positive and -negative TGCTs using FISH, thus 
leading to a more detailed karyotypic description of these tumors. Here, we have applied FISH 
strategies to a group of i(12p)-negative TGCTs to examine them for the presence of chromosome 
12 abnormalities other than i(12p), and to determine whether such aberrations are a common 
characteristic of i(12p)-negative TGCTs. 
MATERIALS AND METHODS 
Ceils 
All tumors were collected under sterile conditions and karyotyped. Subsequently, parts of 
the tumors were shipped to the Nijmegen laboratory for FISH analysis. 
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The samples were processed according to previously described methods (Limon et al., 
1986; Parrington et al., 1992). Each tissue was disaggregated in collagenase (200 U/ml, 
overnight). The following day the suspensions were seeded in flasks and on coverslips containing 
RPMI-1640 medium supplemented with 17% bovine serum, 1% glutamine (2 mM) and 
penicillin/streptomycin (5000 U/ml, 5000 Mg/ml) and placed in a humid environment with 5% 
C02 for a period of 3-15 days. 
Harvest was performed by overnight Colcemid exposure, hypotonic shock, and fixation with 
methanol:acetic acid (v/v, 3:1). Air-dried chromosome preparations were G-banded using trypsin 
and the karyotypes were expressed according to the ISCN 1991. 
In situ hybridization 
FISH experiments were carried out essentially as described before (Suijkerbuijk et al., 
1992) using three different types of probes, i.e., pBS12, M28, and pal2H8, which allow the 
specific identification of the entire chromosome 12, its short arm, and pericentromeric region, 
respectively. In short, DNAs from the monochromosomal mouse-human somatic hybrid cell line 
M28 with an i(12p) as its sole human component (Zhang et al., 1989), kindly provided by Dr. 
J.J. Cassiman (Leuven, Belgium), and from the bluescribe plasmid chromosome 12-specific 
library pBS-12 (Collins et al., 1991), a generous gift from Dr. J.W. Gray (San Francisco, CA) 
were biotinylated with biotin-11-dUTP (Sigma, St. Louis, MO) following standard nick-translation 
protocols. Similarly, DNA from the chromosome 12-specific alpha satellite sequence porl2H8 
(D12Z1: Looijenga et al., 1990), kindly provided by Dr. L.H.J. Looijenga (Rotterdam, The 
Netherlands), was labeled with digoxigenin-11-dUTP (Boehringer Mannheim, Germany). Bicolor 
double FISH hybridizations were performed using either biotinylated M28 and digoxigenin-labeled 
pal2H8, or biotinylated pBS-12 and digoxigenin-labeled pal2H8 as a hybridization mix on 
metaphase spreads of tumor cells. 
Chromosomes and chromosomal segments hybridizing to biotin- or digoxigenin-labeled 
probes were visualized using alternating layers of fluorescein isothiocyanate (FITC)-conjugated 
avidin and biotinylated goat anti-avidin antibodies (both from Vector Laboratories, Burlingame, 
CA), or Rhodamin-conjugated sheep anti-digoxigenin antibodies (Boehringer Mannheim) and 
Texas Red-conjugated rabbit anti-sheep antibodies (Jackson ImmunoResearch, West Grove, PA), 
respectively. Counterstaining of the chromosomes was performed with the blue DNA-specific dye 
DAPI (Sigma). 
Chromosomes were studied under a Zeiss Axiophot epifluorescence microscope, equipped 
with appropriate filters for the visualization of F ITC, Rhodamin/Texas Red, and DAPI 
fluorescence, as well as the simultaneous visualization of FITC and Texas Red fluorescence 
(Omega double filter, Battlesboro, VT). Photographs were made on Kodak EL 400 colorslide film 
using double and triple exposures. Alternatively, separate digital images (for Texas Red, FITC, 
and DAPI, respectively) were recorded using a Photometries high-performance CH250/A cooled 
CCD-camera (Photometries, Tucson, AZ) coupled to a Macintosh Ilei computer. The images were 
superimposed and displayed in red-green-blue pseudocolors on the computer screen using the 
image-analysis and -processing software program BDS-image (Biological Detection Systems Inc., 
Rockville, MD). Photographs were made from the computer screen on Kodak EPP 100 plus 
colorslide film using a Polaroid Quickprint. 
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Figure 40 Representative GTG-banded karyotypes of the i(12p)-negative testicular germ cell 
tumors in case 7 (A) and case S (В). Numerical and structural chromosomal abnormalities are 
indicated by arrowheads, while chromosomes with 12p abnormalities as revealed by FISH (see 
Table 6) are denoted by asterisks. 
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RESULTS 
A group of nine primary i(12p)-negative testicular germ cell tumors (TGCTs) and two 
TGCT-derived cell lines was included in the present study. A summary of the clinical, 
histopathologic, and cytogenetic data of these primary tumors and derived cell lines is given in 
Table 4. A representative karyotypic description of each tumor as revealed by GTG-banding is 
listed in Table 5. In addition, representative karyotypes of cases 7 and 5 are shown in Figure 40 
(A and B), respectively. 
The identity of putative chromosome 12-derived marker chromosomes was established using 
multicolor fluorescence in situ hybridization (FISH) techniques. By combining "chromosome 
paints" (either pBS-12 or M28) and a repetitive probe (ραΙ2Η8) in a double FISH assay, the 
simultaneous visualization of chromosome 12- or 12p-derived sequences (green fluorescence) and 
chromosome 12-specific centromeric sequences (red fluorescence) was attained. For contrast, 
nonhybridizing chromosomes or chromosomal segments were counterstained with the blue dye 
DAPI. Evaluation of the FISH results was achieved, if possible, by comparing data on the 
relevant chromosomes from both FISH and GTG-analyses (Table 6). Fully or partly unidentified 
chromosomes containing chromosome 12-derived sequences were designated as marker (mar) 
chromosomes. In all cases where the GTG-banded counterpart could not be identified as such, 
only those chromosome 12 arms with a more or less normal size and DAPI staining pattern were 
considered to be normal. 
FISH analysis revealed that, without exception, all i(12p)-negative TGCTs included in this 
TABLE 4: Summary of the clinical and cytogenetic data on the primary tumors 
Case no. Patient age (yrs) Histology No. of cells analyzed* Modal number 
17 
28 
28 
26 
23 
36 
27 
64 
24 
25 
EC/MT/YS 
EC/MT 
EC/IT 
SE/EC/MT 
SE/EC/IT 
EC 
EC/MT/YS 
SE/EC/IT/MT 
RMT 
SE/TIn 
9 
20 
8 
10 
17 
4 
8 
9 
6 
29 
53-57 
56 
65-66 
50-56 
58 
58-61 
54 
53 
58 
63-64; I06-108C 
Abbreviations: SE, seminoma; EC, embryonal seminoma; IT, immature teratoma; MT, mature 
teratoma; Tin, intermediate teratoma; RMT, residual mature teratoma; YS, yolk sac tumor. 
* Only abnormal metaphases. 
ь
 Original tumor of the cell lines tuj and tue. 
* Concerning tumor derived cell lines. 
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TABLE 5: Karyotypic description from each case 
Case no. Representative karyotype (number of neoplastic cells analyzed) 
1 53-57 ^ ^ X ^ e c l ^ ) ^ ! ) ^ ^ ^ 6,+ 8,+ 8,-9,+ 12,-14,-15,-15,add 
(19)(ql3), + 20,+2-6mar[9] 
2 56,X, + X,-Y, + add(l)(p36), + 2, + 6, + 7, + 8, + add(9)(qll), + dic(12)t(12;?;22) 
(pl3;?;pll.2), + 16,+ 17,+21,-22, + mar[20] 
3 65<2n>,XY, + X, + 3,add(4)(pl4),+5, + add(7)(qll.2), + add(7)(q21), + add(8) 
(q24.3)x2,+add(9)(pl3), + 10, + 10,+ 12, + 12,+ 14, + add(15)(q22),add(16)(pl3.1), 
+ 17,add(18)(pll.2),+der(22)t(13;22)(pll.2;ql2),+r, + l-2mar[8] 
4 50-56,XY, + X,der(l)t(l; 13)(q25;ql2),add(2)(pl 1.2), + 3,-7, + add(8)(q24.1), 
+ add(ll)(q23),der(14)t(14;14)(pll.2;qll.2),add(14)(pll.2), + 16,+20, + add(20) 
(pl3),-21,-22,-22,+2-6mar [10] 
5 58<2n>,XY, + X, + l ,+2, + 3, + add(6)(ql3), + 7,+7, + 8, + add(12)(pl3), + 14,add 
(15)(q25), + 20,+21,-22, + mar [17] 
6 60-63<2n>,XY, + X, + Y,+2, + 3,add(4)(pl6),+7,+der(7)t(7;ll)(qll.2;ql3), + 8, 
-10,+ 12, + 14, + 16,+ 17,-20,+21,+5-8mar[4] 
7 56,XY, + X, + der(2)t(2;21)(q37;qll.2)add(2)(p25),+3,+6,+7,+7, + add(7)(qll.2), 
+ 8, + 8,-9,der(9)t(9;?;9)(9qter-9p34::?::9ql3-.9qter),-ll, + add(12)(pll.2), + der 
(12)t(?5;12)(?ql3;q21),+16,-21,+ mar [12] 
8 SS.X. + addCXXpin.-Y. + addílXpSS^.+deKOCqnj.+derClJaddClXpSS-Sóídelíl) 
(q32),+del(2)(q34),del(3)(q21),der(3)t(3;7;?3)(3qter-3p21::7q36-7qll::?3q23-* 
?3qter), + dup(3)(q21q27), + del(5)(pl2),-6, + dic(7;17)(q31;pl3), + 8, + 12,-14, 
+der(14)t(12;14)(ql3;pll),+ 16,-18,+del(20)(ql2),-21,der(21)t(21;22)(pll;qll), 
-22, +mar [9] 
9 5 8 < 2 n > , X Y , + X, + der(l) t( l ;14)(pl l ;ql l) , -2, + add(2)(p25), + 3,-6,+dup(7) 
(qll.2q21), + 8,add(ll)(ql4),+ 12, + 14, + 15,+ 15,-16,+ 19, + 20, + 21, + 22, + mar 
[6] 
10-tuc" 106-107<4n>,XXYY, + X,+ l ,+2, + 3,add(4)(q35),+6,+7, + add(7)(q32), + 8, +8, 
+ 9,del(l l)(q22),+ 12, + del(12)(q?q?), + 14,add(16)(q22), + add(17)(pl3),-18, 
+ 19,+20 [4] 
10-tuj' 63-64<2n>,XY, + X, + add(l)(p36), + 2, + 3, + add(4)(q35),+6, + 7,+add(7)(q32), 
+ 8, + 8,+9, + del(ll)(q22), + 12, + del(12)(q?q?),+ 14,+ 15, + add(16)(q22), + add 
(17)(pl3),-18,+ 19,+20[9] 
* Tumor-derived cell lines. 
study exhibit abnormalities involving the short arm of chromosome 12. These are described in 
detail in Table 6. The abnormalities appeared to vary considerably in complexity, from simple 
translocations of almost the entire 12p arm, to complex insertional translocations and/or marker 
chromosomes partly or fully consisting of 12p sequences, some examples of which are displayed 
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in Figures 41 and 42. In Figure 41 a metaphase spread of a TGCT-derived cell line (case 10-tuj) 
is shown after hybridization with pal2H8 (red) and M28 (green): three copies of a normal 
chromosome 12 and three other chromosomes partly consisting of chromosome 12 material 
(designated as mar 1-3) can easily be discerned. The marker chromosomes appear to contain one 
(mar 1-2) or two (mar3) copies of almost the entire 12p arm translocated either onto a derivative 
chromosome 18 (marl), onto the terminal part of chromosome lq (mar2), or onto both lpter and 
lqter (mar3). Based on conventional cytogenetic data only, marl was previously assumed to be a 
del(12)(q?q?) chromosome; now it can be described as add(12)(qll). Further FISH analyses using 
a variety of chromosome-specific libraries and centromeric probes (not shown), revealed that marl 
can best be interpreted as a complicated translocation product involving chromosome 12 and 18 in 
the following manner: der(12)dic(12;18)(pll;qll)inv(18)(ql0q22)addl8(ql0). Also the other two 
marker chromosomes, mar2 and mar3, could be identified as der(l)t(l;12)(q42;pll) and 
der(l)t(12;l;12)(12pter-»12pll::lp36-*cen-»lq42::12pll-» 12pter), respectively. 
Case 1 shows a somewhat different picture (Fig. 42). Besides three copies of a normal 
chromosome 12, two marker chromosomes are recognized. Marl consists of an apparently normal 
12p arm (without centromeric alphoid sequences) translocated onto a derivative chromosome 19 
with an unknown chromosomal fragment added onto its long arm: der(19)t(12;?;19) 
(12pter-»12pl?l::?::19ql3-»cen-»19pter). The other marker (mar2) appears to have a more 
complex composition: it contains two large adjacent 12p-positive regions that are interconnected 
by two chromosome 12-specific, alphoid DNA blocks. In addition, segments of unknown 
chromosomal origin are present (see insert in Fig. 42) on both chromosomal ends. Altogether, this 
mar2 can now best be considered as a der(12)idicdup(12p)add(12)(p?)(?::12p?::12pl3-» 
12cen::12cen-»12pl3::12p?::?). Highly comparable results were obtained in all other cases and 
these are listed in Table 6. 
In addition, results suggesting karyotypic evolution within one tumor (i.e., case 5) were 
obtained (see Figs. 43-47). By using the above FISH techniques, that specifically reveal well-
defined chromosome 12-specific regions, the delineation of a number of clonal lines differing in 
only one marker chromosome could be achieved. All representative tumor metaphases showed two 
copies of a normal chromosome 12 in addition to a der(15)t(12;15)(pl?0;q28), which includes a 
tiny chromosome 12-specific alphoid region. The karyotypic evolution appears to be represented 
by a second derivative chromosome 12 - add(12)(pl3) - with, in a clonal manner, an increasing 
amount of extra chromosomal segments translocated onto the original 12p arm. At least five 
different stages (Figs. 43-47), representing presumed individual steps in the evolution of the 
marker, could be distinguished by an increasing amount of 12p-derived and other, as yet 
unknown, chromosomal material. Specific FISH targeting of the separate bands on 12p by using 
region-specific "paints" for 12p (see Sinke et al., 1992) revealed no evidence for amplification of 
a specific (sub-)region on 12p (not shown). Instead, almost the entire 12p arm appears to be 
represented in each 12p-positive region of this marker, resulting in multiple (at maximum four) 
copies of 12p in the most advanced stages of its evolution. Strikingly, cells exhibiting the highest 
12p copy number appeared to be represented most frequently within the tumor cell population 
(stage 3 and 4/5, 42% and 36%, respectively). 
Taken together, our FISH results demonstrate the consistent presence of 12p abnormalities 
other than i(12p) in i(12p)-negative TGCTs. These abnormalities result in a clear 
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overrepresentation of 12p sequences as compared to those from, e.g., 12q in each i(12p)-negative 
TGCT examined so far (Table 6). 
DISCUSSION 
In the present study, we demonstrate that cytogenetically undefined or undetectable 
chromosome 12p abnormalities in human germ cell tumors of the testis (TGCTs) can be revealed 
by multicolor fluorescence in situ hybridization (FISH) using appropriate probes for the 
visualization of the whole length, the short arm, and the centramene part of chromosome 12 
(pBS-12, M28, and pal2H8), respectively. By doing so, we found that in the eleven i(12p)-
negative TGCTs and -derived cell lines included in this study, a variety of 12p abnormalities 
could be revealed, most of which had remained undefined by previous conventional cytogenetic 
banding (i.e., GTG) analyses. Each 12p abnormality, resulting from either a translocation, an 
inversion, or a multiplication event, included nearly the entire 12p arm (12pll-»12pl3) and, as 
such, gave rise to a clear-cut overrepresentation of 12p-derived sequences as compared to, e.g., 
those from 12q (Table 6). Very similar conclusions were previously drawn from the analysis of 
i(12p)-positive TGCTs (De Jong et al., 1990). It seems likely that the appearance of 12p 
rearrangements must have been preceded by chromosomal breaks at or near the telomeric and/or 
centromeric regions, as the rearrangements usually include the entire 12pll-»12pl3 region. 
Moreover, in some tumors (cases 9 and 5, see Table 6) minor stretches of alphoid satellite DNA 
specific for the centromeric part of chromosome 12 remained attached to the translocated 12p 
segment, probably as a result of a breakage-and-reunion process. Exactly how the generation of 
additional 12p segments is accomplished in TGCTs, however, remains to be established. Of 
possible relevance in this respect may be the observation that in one primary tumor, case 9, a 
clearly elevated incidence of premature chromatid separation (PCS), leading to the formation of a 
kinetochore bridging two chromosome 12 sister chromatids, was present (Figs. 48 and 49). This 
"kinetochoric bridge" may span a distance of one chromosomal length or even more, and FISH 
analysis showed the presence of both chromosome 12-specific alphoid and non alphoid-derived 
DNA sequences within such bridges. The process of premature chromatid separation may, as an 
example of mitotic error, lead to chromosomal instability, breaks, and losses. In TGCTs, such a 
mechanism may account for the generation of "free" 12p arms that, after subsequent chromosomal 
rearrangement, may contribute to an overrepresentation of 12p-derived sequences as found here in 
the i(12p)-negative TGCTs. Since PCS occurs between sister chromatids, the result would be an 
overrepresentation of 12p arms which are of uniparental origin. Recently, we and others (Sinke et 
al., 1993; Peltomäki et al., 1992) obtained evidence supporting this origin of overrepresented 12p 
sequences in TGCTs. Whether this process of premature chromatid separation is a widespread 
phenomenon in TGCTs, and thus may account for a general mechanism, still needs to be verified. 
Another intriguing question is how the presence of 12p abnormalities in TGCTs contributes 
to the process of tumor development. It is well known that the presence of i(12p) is highly 
characteristic for most TGCTs (De Jong et al., 1990) and other germ cell tumors (Atkin and 
Baker, 1987; Jenkyn and McCartney, 1987; Chaganti et al., 1989; Dal Cin et al., 1989; 
Samaniego et al., 1990; Speleman et al., 1990, 1992; Hamers et al., 1991; Hoffner et al., 1992; 
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Rodriquez et al , 1992, Aly et al , 1994, De Bruin et al , 1994) It has been suggested, therefore, 
that its prevalence points to an important role in the oncogenesis of TGCTs (Delozier-Blanchet et 
al , 1987, Bosl et al , 1989, Castedo et al , 1989a) Because aneuploidization appears to be an 
early event in the tumorigenesis of TGCTs preceding i(12p) formation (Geurts van Kessel et al , 
1989, 1991), it is tempting to suggest that i(12p) itself somehow contributes to tumor progression 
No direct information supporting a possible interrelationship between the presence of 12p 
abnormalities and tumorigenesis in TGCTs could previously be found in the so-called i(12p)-
negative TGCTs This result led others to presume that i(12p)-positive and -negative TGCTs may 
represent different subtypes of germ cell tumors, with different clinical behaviors (Castedo et al , 
1988) Our present finding, however, that 12p aberrations do occur in every i(12p)-negative 
TGCT examined, favors the option that a common molecular mechanism may lead to malignancy 
in both i(12p)-positive and -negative TGCTs The overrepresentation of 12p-denved sequences in 
i(12p)-negative TGCTs may, analogous to one or more copies of i(12p) in i(12p)-positive TGCTs, 
contribute to the process of TGCT development 
Another interesting observation in i(12p)-positive and -negative TGCTs is that virtually all 
12p abnormalities involve the (almost) entire short arm of chromosome 12 (ι e , 12pll-»12pl3) 
So far, the amplification of whole chromosomal arms has remained a rather infrequent event in 
(tumor) cytogenetics The more frequently occurring so-called amplicons are usually restricted to 
very small chromosomal segments or, even less, single genes The repeated appearance of 
multiple 12p arms in every germ cell tumor studied by FISH techniques so far, suggests the 
involvement of multiple DNA sequences spread along the length of 12p, and that each may play a 
role in tumor development, growth advantage and/or therapy resistance Although no direct 
evidence has been accumulated to support this suggestion, the visualization of a - in a clonal 
manner "growing" - chromosome 12 marker in one of the tumors leaves room for speculation in 
that direction Each of the presumed clones may represent a further step in the ongoing process of 
tumor development, resulting in several extra copies of 12p It will be worthwhile to screen these 
and other i(12p)-negative TGCTs in more detail using region-specific probes and "paints" to 
determine whether the short arm of chromosome 12 is entirely multiplied or to what extend 
indications can be found for a nonrandom involvement of particular (sub-)band(s) on 12p 
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ABSTRACT 
We present molecular data to demonstrate that the isochromosome 12p, specific for human 
germ cell tumors (GCTs), is of uniparental origin. Eight GCT-derived cell lines, containing one 
or more copies of i(12p) and/or other 12p anomalies, were analyzed with different 12p-derived 
polymorphic markers. The results from Ma-90, a near-diploid cell line with only one i(12p) in 
addition to two copies of a normal chromosome 12, clearly show an allelic 12p ratio of 
approximately 3:1, indicating that both 12p arms are of identical parental origin. These results 
were further substantiated by data obtained from the other i(12p)-positive GCT-derived cell lines. 
Therefore, we conclude that the i(12p) chromosome in GCTs constitutes a genuine isochromosome 
with genetically identical arms. The isochromosome most likely originates from a misdivision of 
the centromere rather than from a translocation or a non-sister chromatid exchange as proposed by 
others. We also found that supernumary 12p copies, as observed in i(12p)-negative GCTs, are of 
uniparental origin. These observations seem to point to an important role for certain 12p-derived 
sequences in the development of human GCTs. 
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INTRODUCTION 
The isochromosome of the short arm of chromosome 12, ¡(12p), is the most common 
structural cytogenetic aberration found in gonadal and extragonadal germ cell tumors (GCTs) of 
human adults (Atkin and Baker, 1982, 1983; Gibas et al. 1986). This isochromosome occurs in all 
histologic varieties of GCTs in about 80% of all cases (Castedo et al., 1989a; De Jong et al., 
1990; Suijkerbuijk et al., 1991; Rodriguez et al., 1992). We have argued that i(12p) formation 
must be preceded by an aneuploidization event during early stages of GCT development (Geurts 
van Kessel et al., 1989, 1991). Furthermore, it has been suggested by others that an increase in 
i(12p) copy number may be associated with tumor progression and increased resistance to therapy 
(DeLozier-Blanchet et al., 1987; Bosl et al., 1989). So far, however, little is known about the 
origin and mechanism of formation of this highly characteristic cytogenetic anomaly. Recently, 
Mukherjee et al. (1991) suggested that in GCTs the i(12p) may originate from a translocation or a 
non-sister chromatid exchange. We present a molecular study that provides evidence for a 
uniparental origin of the i(12p) (and other supernumerary 12p sequences) in human GCT-derived 
cell lines, using chromosome 12-specific polymorphic markers. 
MATERIALS AND METHODS 
Cell Lines and Culture 
Eight human germ cell tumor-derived cell lines were used. Detailed analysis of the 
chromosome 12 contents, as determined by bicolor double fluorescence in situ hybridization, is 
described elsewhere (Suijkerbuijk et al. 1992a, 1992b). Ma-90: Dysgenetic gonad tumor-derived 
(combined tumor, Hamers et al., 1991), containing two copies of a normal chromosome 12 and 
one i(12p); in total four 12p copies. NT2/D1: testicular germ cell tumor (TGCT)-derived 
(embryonal carcinoma; Andrews, 1984), containing three copies of a normal chromosome 12 in 
addition to two i(12p) chromosomes; in total seven 12p copies. KDK: TGCT-derived (embryonal 
carcinoma; J.M. Parrington, unpublished observations), containing three copies of a normal 
chromosome 12, three i(12p) chromosomes, and one abnormal chromosome containing 12p 
sequences (presumably a translocated 12p); in total ten 12p copies. Germa-1: TGCT-derived 
(embryonal carcinoma; Hofmann et al., 1989), containing two copies of a normal chromosome 
12, one i(12p), and two derivative chromosomes including 12p sequences; in total six 12p copies. 
Scha-1: TGCT-derived (embryonal carcinoma; Andrews et al., 1987), TT34DA tue and TT34DA 
tuj: TGCT-derived (combined tumors, Parrington et al., 1992), all i(12p)-negative but containing 
several derivative chromosomes including 12p sequences in addition to two to five copies of a 
normal chromosome 12; in total approximately six, eight, and seven copies of 12p, respectively. 
Haz-1: extragonadal GCT-derived (mediastinal teratocarcinoma; Oosterhuis et al., 1985), without 
chromosome 12 abnormalities, but positive for other cytogenetic anomalies; this cell line was 
included as a negative control for our studies. 
Cells were cultured in F-10 medium, RPMI-1640 medium, or Chang medium supplemented 
with glutamine, antibiotics, and 15% fetal calf serum. By the time of harvesting, all lines were 
checked cytogenetically for their chromosomal constitution. 
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TABLE 7: 
Chromosome 12-specific polymorphic markers 
and their regional localization. 
Locus 
F8VWF 
PRB1 
A2M 
IAPP 
KRAS2 
D12S2 
D12S4 
D12S6 
IGF1 
Probe 
pvWFUOO 
pPRP-1 
pha2ml 
ScIAP8 
pK42 
pl2-16 
p9Fll 
pll-1-111 
pKT218 
Localization 
1213.3-pl3.2 
12pl3.2 
12pl3.3-pl2.3 
12pl2.3-pll.2 
12pl2.1 
12pter-pl2 
12cen-ql4 
12ql4 
12q23 
RFLP analysis 
RFLP analysis of chromosome 12 alleles was performed using probes for both 12p- and 
12q-specific loci (Table 7; see HGM 11 [1991] and Sinke et al. [1992] for references). Cell line 
DNAs, 10-15 μg, were digested to completion with restriction endonucleases (Life Technologies), 
electrophoresed in 0.7-1.0% agarose gels, and transferred to Gene Screen Plus nylon membranes 
(DuPont) using standard procedures (Sambrook et al., 1989). Filters were hybridized with 
chromosome 12-specific DNA markers labeled by random priming (Feinberg and Vogelstein, 
1984) and exposed for 1-5 days using Kodak X-ray films (X-OMAT S). Densitometrie scanning of 
the X-ray films was performed with an Ultroscan XL densitometer (LKB, Sweden). 
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Figure 50 Southern blots of GCT-derived cell line DNAs cleaved with Bgftl {panel A) and Xbal 
(panel B), hybridized with pvWFUOO. Hybridizing bands representing the polymorphic alleles for 
this locus are indicated by arrows. The remaining bands represent constitutively hybridizing 
fragments. 
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VNTR analysis 
The von Willebrand factor (VWF) gene contains two highly polymorphic regions that can be 
analyzed by polymerase chain reaction (PCR) techniques (Ploos van Amstel and Reitsma, 1990, 
and references therein). Primer sets for both regions were used to amplify the VWF alleles present 
in the DNAs isolated from the different cell lines. The PCR was carried out, after end-labeling of 
the 5'-primers with 7-32P-dATP, in a DNA thermal cycler (Perkin-Elmer, Cetus). After 
denaturation of the reaction mixture at 96°C for 10 min, 2.5U Taq DNA polymerase (Cetus) was 
added to start cycling for 1 min at 92°C, 1 min at 55°C, and 1 min at 7 Г С for 35 cycles. To 
visualize the amplified fragments, 2μ1 of the reaction mixture was added to 2μ1 of sequencing dye 
and applied to a 6% PAA-gel, and electrophoresis was carried out at 30 V/cm for 3 hrs, followed 
by autoradiography for 3-16 hrs. 
RESULTS AND DISCUSSION 
Four of the eight human GCT-derived cell lines contain one or more copies of the 
characteristic i(12p) (Germa-1, KDK, Ma-90, NT2/D1). Of the remaining four cell lines, Scha-1, 
TT34DA rue, and TT34DA tuj are characterized by the presence of multiple 12p-containing 
sequences cryptically present in derivative chromosomes. The other cell line, Haz-1, is derived 
from a near-diploid extragonadal GCT without chromosome 12 aberrations. This latter cell line 
was used as a negative control. 
By using polymorphic markers located on 12q (D12S4, D12S6, IGF1) we were able to 
demonstrate that in all cell lines analyzed, heterozygosity for at least one of these loci was 
retained, which indicates that both paternal and maternal chromosome 12 alleles were present in 
these cell lines and their original tumors (not shown). In a previous study (Geurts van Kessel et 
al., 1989) very similar results were obtained with NT2/D1 and Scha-1. The present results further 
substantiate our previous observations and conclusion that during GCT development 
aneuploidization must precede i(12p) formation. Loss of a candidate tumor suppressor gene on 
12q as the initial genetic change, as suggested by Chaganti and coworkers (see Rodriguez et al. 
1992), does not appear to be a general mechanism. 
RFLP analysis using 12p-derived polymorphic markers (KRAS2, IAPP, F8VWF, A2M, 
PRB1, D12S2) was performed to discriminate between a bi- or uniparental origin of the i(12p) 
chromosome in the different GCT-derived cell lines. The Ma-90 cell line, which contains only one 
i(12p) in addition to two normal copies of chromosome 12, appeared to be particularly 
informative. As can be seen in Figures 50 and 51, in which the pvWFUOO and pK42 probes were 
hybridized to Southern blots containing, respectively, Bglll, Xbal, and Stul cleaved Ma-90 and 
other cell line DNAs, there is a clear overrepresentation of one allele over the other (Fig. 50A: 
pvWFUOO, 9.0 kb > 7.4 kb; Fig. 50B: 6.9 kb > 5.2 kb; Fig. 51B: pK42, 2.5 kb > 8.7 kb) as 
compared to the control Haz-1 and normal male blood cell DNAs (Figs. 50A and 51A). If i(12p) 
had resulted from the fusion of two different parental 12p arms, an equal allele-dose would be 
expected. Since, in contrast, an allele ratio of approximately 3:1 was observed (as estimated by 
densitometric scanning; not shown), we conclude that both ρ arms of the i(12p) in Ma-90 are of 
identical parental origin (see also below) and that, as a consequence, i(12p) most likely originates 
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Figure 51 Southern blots of control DNA from normal (male) blood cells and DNAs from GCT-
derived cell lines cleaved with Aid, hybridized with pK42. Hybridizing bands representing the 
polymorphic alleles for this locus are indicated by arrows. 
from a misdivision of the centromere rather than from a translocation or a non-sister chromatid 
exchange as suggested by Mukherjee et al. (1991). A similar result was obtained with NT2/D1, 
which contains two i(12p) chromosomes and three copies of a normal chromosome 12. As can be 
seen in Figure 51, an even more pronounced difference in allele intensity was observed (Fig. 51 A: 
2.5 > 8.7 kb), which is in agreement with the presence of additional 12p copy numbers. The 
i(12p)-positive GCTs Germa-1 and KDK, which carry 12p-containing markerchromosomes next to 
i(12p), show similar features (Germa-1: Figs. 50-52; KDK: Fig. 52, see below). Also, overall 
similar results were obtained using IAPP-, AIM-, PRB1-, or D12S2-specific polymorphisms, for 
each of which at least one of the cell lines appeared to be informative (not shown). 
The results obtained from RFLP analyses of Ma-90 and other GCT-derived cell lines were 
compared by those obtained from analysis of the 12p-specific FSVWF-linked VNTRs using PCR. 
Figure 52 shows that Ma-90 cells are heterozygous for one of these VNTRs (lane 4) and, again, 
one of the alleles seems to be overrepresented. Care must be taken not to overestimate these PCR 
results since they are difficult to quantify. However, in control Haz-1 cells both alleles are of 
equal intensity, suggesting a real difference for the allele ratios in the other cell lines (including 
Germa-1 and KDK). 
Not only in i(12p)-positive but also in i(12p)-negative GCTs (e.g., Scha-1, TT34DA tue and 
TT34DA tuj), the additional 12p sequences appear to be of uniparental origin (see Figs. 50 and 
52). This observation might indicate that one of the 12p arms confers a selective advantage over 
the other in human GCTs and, either by i(12p) formation or by some alternative mechanism (see 
also Suijkerbuijk et al., 1992, 1993), may lead to preferential outgrowth. In this manner, 
acquisition of multiple copies of these 12p sequences could lead to the greater likelihood of 
treatment failure as described by Bosl et al. (1989). The proposed selective advantage could result 
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Figure 52 FSVWF-VNTRs of various GCT-derived cell lines. Bands in each lane represent 
different 12p alleles. NT2/D1 is homozygous, whereas other tumor cell line DNAs show 12p 
heterozygosity with different allele intensities, except for the control Haz-1. 
from a dominantly acting mutation somewhere on 12p occuring prior to i(12p) formation. 
Alternatively, one could argue that, if the supernumerary 12p sequences would in all cases be 
derived from one of the parental chromosome 12 homologs (i.e., maternal or paternal), genomic 
imprinting might account for another underlying mechanism. This option, however, does not seem 
very likely since our own preliminary observations and those of others (Looijenga et at., 1994; 
R.A. Lome, personal communication) suggest both paternal and maternal origins. This latter 
alternative is currently subject to more detailed analysis. 
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ABSTRACT 
Cytogenetic analysis of a metastasis of a human testicular germ cell tumor (seminoma) 
revealed multiple numerical and structural anomalies, including an abnormally banding region 
(abr) present on the short arm of one of the chromosome 12 homologs. Fluorescence in situ- and 
comparative genomic hybridization experiments revealed that the abr results from amplification of 
12pll.2-pl2.1 derived sequences. Further DNA analyses indicated that the amplicon includes the 
12p-linked parathyroid hormone-related peptide {PTHLH) gene. We speculate that this particular 
gene may be a candidate relevant for (metastatic) seminoma development. 
Figures 55-60 are represented on Color Figure III. 
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INTRODUCTION 
Duplication of the short arm of chromosome 12, resulting in i(12p), is the most consistent 
structural chromosomal aberration observed in the heterogeneous group of human germ cell 
tumors (GCTs), including seminomas and non-seminomas. About 80% of the subgroup of 
testicular GCTs (TGCTs) of adults carries one of more copies of i(12p), regardless of their 
histology (for review see De Jong et al., 1990). In the remaining so-called i(12p)-negative TGCTs 
a consistent overrepresentation of 12p, as compared to 12q, has recently been demonstrated using 
fluorescence in situ hybridization (FISH) techniques (Suijkerbuijk et al., 1992, 1993; Rodriquez et 
al., 1993). So, in both i(12p)-positive and -negative TGCTs overrepresentation of 12p-derived 
sequences is encountered as a consequence of apparently distinct chromosomal rearrangements. 
Since it has been suggested that the occurrence of i(12p) correlates with the acquisition of 
malignant characteristics of TGCTs (Delozier-Blanchet et al., 1987; Bosl et al., 1989; Castedo et 
al., 1989a), it may be assumed that similar mechanisms involving 12p could be at work in both 
types of tumors (Suijkerbuijk et al., 1993). So far, the overrepresented 12p sequences appeared to 
encompass the (almost) entire short arm without any evidence for nonrandom involvement of a 
specific chromosomal sub-region (Rodriquez et al., 1993; Suijkerbuijk et al., 1993). These 
observations could indicate that more than one gene on 12p may be involved in the development 
of these tumors (e.g., malignant potential, growth advantage, tumor progression, treatment 
resistance) (Castedo et al., 1991). 
Here, we report the identification and preliminary characterization of a sub-region on the 
short arm of chromosome 12 which is amplified in a metastasis of an i(12p)-negative seminoma. 
This case may, for the first time, delineate genomic sequences on 12p that are specifically 
involved in tumor progression/metastasis. 
MATERIALS AND METHODS 
Case History 
A testicular tumor, histologically a typical seminoma (hematoxylin-eosin staining), was 
obtained from a 35 year-old Caucasian male after orchidectomy. There was no evidence for the 
presence of other germ cell derived components. Two years later the patient developed metastases 
in the latero-aortic lymph nodes which, subsequently, were surgically removed. Part of the tumor 
material was used for cytogenetic analysis and part of it was embedded in paraffin for sectioning. 
Thereafter, a chemotherapy regimen of bleomycin, etoposide and cis-platinum (ВЕР: 4 cycles) 
was initiated. No evidence of residual disease was found up till six months after lymph node 
removal as based on CT scans and serum biological markers. 
Immunohistochemistry 
Immunohistochemical stains were performed on paraffin sections (5 μΐή) using an indirect 
immunoperoxidase procedure with a monoclonal antibody against cytokeratin 8 (CAM 5.2; Becton 
and Dickinson, Etten Leur, The Netherlands) and a peroxidase-anti-peroxidase procedure with 
polyclonal antibodies against human choriogonadotropin (hCG; 1TK Diagnostics, Uithoorn, The 
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Netherlands), placental-like alkaline phosphatase (PLAP; ITK Diagnostics) and vimentin 
(Organon, Oss, The Netherlands). In the second incubation step rabbit anti-mouse and swine anti-
rabbit antibodies conjugated with horseradish peroxidase (Dakopatts, Glostrup, Denmark) were 
applied, respectively. Staining was performed using DAB (Sigma-Aldwich, Bomem, Belgium) and 
hydrogen peroxidase as substrate. 
Cytogenetic analysis 
A small fresh and sterile tumor fragment was mechanically minced in RPMI 1640 medium, 
supplemented with 17% fetal calf serum, glutamin and antibiotics. Tumor cells were harvested for 
karyotyping after addition of colcemid to a final concentration of 0.01 μg/ml and incubation of the 
cells in a rotating flask during 1 hour. The resulting cell suspension was subjected to a hypotonic 
solution (0.06 M KCl, IS min at 37°C) and, subsequently, fixed in methanol:acetic acid (3:1). 
After 3 washes in fixative, cells were applied to cold wet slides and air-dried. Chromosomes were 
GTG banded according to standard methods and the resulting karyotypes were described according 
to the International System for Human Cytogenetic Nomenclature (ISCN, 1991). 
DNA extraction from paraffin embedded tissue 
Tissue was removed from paraffin blocks with a surgical blade or, alternatively, via thin 
sectioning ( a 10 /xm). Excess of paraffine was removed. Then, the tissue was cut into small 
pieces and transferred to a 50 ml tube after which 5 ml lysis buffer (10 mM Tris pH 8.0, 100 mM 
NaCl, 1 mM EDTA) was added, followed by an incubation of the tube at -70°C for 30 min. After 
thawing, 5 ml lysis buffer supplemented with 2% sarcosyl and 50-100 μg/ml proteinase К was 
added, whereupon the tube was set to rotate overnight at 65°C. Phenol extractions were carried 
out using a solution saturated with 0.5 M Tris (final pH between 6 and 7). An equal volume (10 
ml) of phenol was added to the lysis suspension (65°C) and left to rotate at 37°C for 30 min. 
After removal of phenol, 10 ml phenolxhloroform (1:1) solution was added, followed by rotation 
at room temperature for 30 min. After removal of the organic phase, 10 ml chloroform was added 
and the tube was rotated again at room temperature. Finally, the DNA was precipitated using 
sodium-acetate/isopropanol (-20°C, 30 min. or overnight). After washing once with 70% ethanol 
the pellet was dissolved in TE (10 mM Tris pH 7.6, lmM EDTA) and, finally, the DNA 
concentration was estimated. 
Slot blot analysis 
DNA slot blots were produced using standard techniques. DNAs were loaded onto a 
milliblot apparatus (Millipore) after denaturation in blotting buffer (0.5 M NaOH, 1.5 M NaCl; 5 
min. at 65°C) and, subsequently, transferred to nylon filters (Gene Screen plus, Dupont). These 
filters were hybridized with several chromosome 12-specific probes in 0.5 M NaH2P04, lmM 
Na^EDTA and 7% SDS (w/v) at 65°C. Blots were washed till 10 mM NaH2P04, 0.1% SDS at 
65°C and exposed to X-ray films at -80°C for 1-3 days using intensifier screens. The probes were 
labeled using random primer extension (Feinberg and Vogelstein, 1983). 
In situ hybridization 
Fluorescence in situ hybridization (FISH) experiments were carried out using various 
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different chromosome 12-specific probes: (1) chromosome 12-centromeric alphoid probe pal2H8 
(Looijenga et al., 1990); (2) chromosome 12-specific plasmid library pBS-12 (Collins et al., 1991: 
kindly provided by Dr. J. Gray, San Francisco, CA); (3) chromosome 12p-specific paint M28 
(Suijkerbuijk et al., 1991) derived from a mouse-human hybrid cell line containing an i(12p) as 
sole human component (Zhang et al., 1991: kindly provided by Dr. J.J. Cassiman, Leuven, 
Belgium); (4) the 12p region-specific paints (radiation-reduced somatic cell hybrids) WgM6B, 
WgM8B, WgM22C and WgM28.1, which together cover almost the entire 12p-arm (Sinke et al., 
1992; (5) the 12p-specific YACs 5 and 17 (Paulien et al., 1991; Craig et al., 1992: kindly 
provided by Dr. R. Gemmili, Denver, CO). 
Multicolor FISH was performed as described previously (Suijkerbuijk et al., 1992, 1993; 
Sinke et al., 1992; De Leeuw et al., 1993, 1994) with some minor modifications. In short, DNAs 
were labeled with either biotin-14-dATP (Life Technologies, Gaithersburg, MA) or digoxigenin-
11-dUTP (Boehringer, Mannheim, Germany) following standard nick-translation. All labeled 
probes, except the alphoid repeat probe pal2H8, were subjected to preannealing to compete out 
reiterated sequences using 25-50 fold excess of Q/.l DNA (Life Technologies, Gaithersburg, 
MA). For efficient hybridizations, 10 ng labeled pal2H8, 100-150 ng labeled pBS-12 and M28, 
200 ng labeled BK33-PCR amplified WgM and 200 ng labeled YAC DNAs were applied under a 
20x20 mm coverslip onto metaphase spreads of tumor cells as described elsewhere. 
Visualization of hybridizing DNAs was accomplished using Texas Red-conjugated avidin 
and biotinylated goat anti-avidin antibodies (both from Vector Laboratories, Burlingame, CA) for 
biotin-labeled probes and fluorescein-conjugated sheep anti-digoxigenin (Boehringer, Mannheim, 
Germany) and fluorescein-conjugated donkey anti-sheep antibodies (Jackson Immunoresearch, 
West Grove, PA) for digoxigenin-labeled probes. Slides were immersed in antifade-solution 
(Suijkerbuijk et al., 1991), supplemented with the blue DNA-specific dye DAPI (Sigma, St. 
Louis, MO) for counterstaining of the chromosomes. 
Comparative Genomic in situ Hybridization 
Comparative Genomic in situ Hybridization (CGH) experiments (see Kallioniemi et al., 
1992; Du Manoir et al., 1993) were carried out as described before (Suijkerbuijk et al., 1994). In 
short, 400 to 1000 ng of biotin labeled tumor DNA, extracted from paraffin blocks, was used as 
test DNA. Since testicular germ cell tumors usually have a hypo- to hypertriploid (i.e., peri-
triploid) chromosomal complement, a similar amount of differentially labeled DNA isolated from 
a 69,XXY triploid cell line was used as reference DNA to facilitate the CGH analyses. 
Hybridization patterns of both test and reference DNAs were visualized as described above. 
Evaluation of FISH and CGH results 
Evaluation of the resulting slides was performed using a Zeiss Axiophot ep¡fluorescence 
microscope, equipped with appropriate filters for the visualization of fluorescein, Texas Red and 
DAPI fluorescence. Digital images were recorded using a Photometries high-performance 
CH250/A cooled CCD-camera (Photometries, Tucson, AZ) interfaced onto a Macintosh Quadra 
950 computer. Image-acquisition, -processing, -superimposement, and -display (in red-green-blue 
pseudocolors) was accomplished using the BDS-image™ F.I.S.H. software package (Biological 
Detection Systems Inc., Rockville, MD). Photographs were made from the computer screen on 
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Figure 53 Histology of the seminoma metastasis after hematoxylin-eosin (HE) staining (150x). 
The inset shows details of the tumor cells at higher magnification (500x). 
Kodak EPP 100 Plus color slide film using a Polaroid Quick-Print. 
Results of CGH experiments were analyzed using the Comparative Genomic Hybridization 
applications within the BDS-image™ F.I.S.H. software package. These applications allow the 
direct reproduction of fluorescence ratios (tumor DNA-versus-normal DNA) of normalized Texas 
Red (e.g., tumor DNA hybridization pattern) and fluorescein (e.g., normal DNA hybridization 
pattern) fluorescence intensities of each chromosome within a recorded metaphase spread by 
pseudocolor indication. In this way, at least 10 metaphase spreads were studied and chromosomal 
homologs consistently showing (regions of) over- or underrepresentation of tumor DNA as 
compared to reference DNA were subjected to further examination. These chromosomes were 
isolated and longitudinally stretched, whereupon chromosome fluorescence intensity profiles for 
each fluorochrome were generated. By doing so, both the identification of a given chromosome by 
DAPI fluorescence and the detection of genomic regions that are over- or underrepresented in the 
tumor DNA on that very same chromosome were established. Photographic recordings of these 
results were performed as described above. 
RESULTS 
Histologic, immunohistochemical and karyotypic analyses 
Histologically, the tumor was characterized by sheets of uniform large polygonal cells 
separated by thin fibrovascular septa into lobules (Fig. 53). In these septa, lymphocytic infiltrates 
of variable density were present. The tumor cells contained clear cytoplasms and large nuclei with 
irregular chromatin structures and prominent nucleoli. Mitotic figures were frequent. No 
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Figure 54 GTG-banded karyotype of the seminoma metastasis. The add(12)(pl3) chromosome is 
marked by an arrowhead and the add(17)(q25) by an small arrow. 
syncytiotrophoblastic giant cells or other non-seminoma components were observed. 
Immunohistochemical staining for placental-like alkaline phosphatase (PLAP) and vimentin were 
positive. In contrast, cytokeratin, alpha fetoprotein (AFP) and human choriogonadotropin (hCG) 
were negative (not shown). Together, these characteristics are indicative for pure seminoma. 
Cytogenetic analyses were carried out after direct harvesting of the tumor cells. Twenty 
metaphases were analysed. The chromosomal counts ranged from 46 to 64. One of the 
representative karyotypes was interpreted as follows: 64,X,-Y,+X,+del(l)(p36),+2,+3,+5,+6, 
+7,+dic(7;21)(ql0;p22), + 8> + 8, + 10, + i(12)(pl0),+add(12)(pl3), + 15,add(17)(q25),+add(17) 
(pll), + 19,+ 19,+20,+22. 
Chromosome painting 
Metaphase spreads were subjected to fluorescence in situ hybridization (FISH) analyses 
using DNAs extracted from plasmid libraries specific for chromosomes 12, 17 and 21 (pBS-12, -
17, and -21; chromosome painting), in order to confirm and clarify the constitution of some of the 
rearranged chromosomes observed (in particular, those involving chromosome 12). By doing so, 
the presumed i(12p) was found to lack chromosome 12-derived sequences all together (see Fig. 
55). Instead, it fully consists of chromosome 21-derived material and, finally, could be recognized 
as an isochromosome of the long arm of chromosome 21, i.e., i(21q) (results not shown). The 
chromosome described above as add(17)(q2S) consists of chromosome 17 material, as expected 
(not shown), and additional chromosome 12 material added onto band 17q2S (Fig. SS, small 
arrow). The add(12)(pl3) chromosome appeared to be composed almost entirely of chromosome 
12 materia] except for its distal part, of which the origin was not elucidated (Fig. SS, arrowhead). 
Based on these data, further experiments with the chromosome 12p-specific paint M28 (in 
110 
Ρ 
q 
12 + + - -
Figure 61 Diagrammatic representation of the 12p content of the WgM radiation-reduced hybrid 
probes used in this study, and their hybridization results on the add(12)(pl3) chromosome (marked 
by +/-). 
combination with the chromosome 12-specific centromeric repeat probe port2H8) were carried out 
(Fig. 56). The results obtained indicated that the chromosome 12-positive part of the add(17)(q25) 
chromosome contains 12p-positive material only (Fig. 56, small arrow). The most likely 
interpretation of the combined GTG-banding and FISH results is that three copies of an almost 
entire 12p-arm have been translocated onto 17q25. In case of the add(12)(pl3) chromosome, the 
additional segment that was previously shown to consist of extra chromosome 12 material only, 
appeared to be 12p-positive over its whole length (Fig. 56, arrowhead). Although the size of this 
extra 12p-positive segment was large enough to potentially contain at least 8-10 copies of ал entire 
12p-arm, careful re-examination of the GTG-banding pattern of this particular segment failed to 
indicate that 12p copies were present in such a configuration. Instead, it can best be defined as an 
abnormally banding region (abr). Altogether, the FISH analyses led to a correction of the original 
karyotype as follows: 64,X,-Y,+X,+del(l)fo36),+2,+3,+5,+6,+7,+dic(7;21)(ql0;p22), + 8, 
+ 8, + 10, + add(12)(pl3),+ 15,der(7)t(17;12;12;12)(17pter-17q25::12pl3-12pll::12pll-
12pl3::12pll-»12pl3),+add(17)(pll), + 19, + 19,+20, + i(21)(ql0),+22(Fig. 54). 
Detailed FISH analysis of the add(12)(pl3) chromosome 
Since the above cytogenetic and FISH analyses provided no definite clues about the 
chromosomal constitution of the abr on the 12p+ chromosome, further FISH analyses were 
carried out to delineate this segment in more detail. Therefore, region-specific probes that in total 
cover the almost entire length of the short arm of chromosome 12 were used. Specifically, (1) 
WgM6B: the entire 12pll band and the distal part of the 12pl3 band; (2) WgM22C: most of the 
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12pl2 band, except for its proximal part; (3) WgM8B: a small distal part of the 12pll band and 
most (if not all) of the 12pl3 band; (4) WgM28.1: the almost entire 12pl3 band. Hybridization 
with the WgM6B probe resulted in complete painting of the extra 12p-positive material. In 
contrast, the WgM8B probe was only partially positive and the WgM22c and WgM28.1 probes 
gave no hybridization signals at all in this particular chromosomal segment (diagrammed in Fig. 
61). These results indicate that the additional material on the 12p+ marker most likely originates 
from the 12pll-pl2 boundary region. 
Further focusing on 12pll-pl2, using as probe a yeast artificial chromosome (i.e., YAC5) 
that we previously mapped in the region 12pll.2-pl2.1 (Craig et al., 1992), revealed that 
multiple, but non-contiguous, copies of YAC5 hybridizing DNA sequences are present in the 
additional segment (Fig. 57). These results nicely agree with the above FISH data obtained with 
the WgM probes. In addition, YAC5 hybridization patterns were visible as scattered fluorescent 
signals within confined regions of interphase nuclei (Fig. 58). Since the YAC hybridizations do 
not result in even "painting" of the entire additional 12p+ segment, the chromosomal sub-region 
that constitutes this segment must contain human sequences in addition to those present in YAC5. 
FISH with another YAC (YAC17), which we previously mapped in band 12p 11.1 -p 11.2 (Craig et 
al., 1992), did not reveal any hybridization signal on the 12p+ segment (not shown), indicating 
that the corresponding 12pll sequences must be excluded from it. Taken together, we conclude 
that the additional segment on the 12p+ chromosome comprises sequences that originate from the 
more distal sub-region of band 12pll and/or the proximal part of 12pl2. These sequences appear 
to be present in multiple copies (i.e., as ampi icon). 
Comparative Genomic in silu Hybridization 
To define the localization (and size) of the amplified 12p-segment in the genome of the 
seminoma metastasis more exactly, comparative genomic in situ hybridization (CGH) analysis was 
performed. This novel FISH approach provides information on over- and underrepresented 
chromosomes or chromosomal segments in test (tumor) genomes. Therefore, DNA extracted from 
a paraffin-embedded formalin-fixed tumor specimen, which was the only source of tumor DNA 
available, was used as test DNA and hybridized simultaneously with reference DNA onto BrdU-
incorporated high-resolution metaphase spreads derived from a healthy 46,XY male. The 
hybridization patterns of test and reference DNAs were visualized using two different 
fluorochromes, recorded by digital imaging microscopy, normalized and, subsequently, analyzed 
using the Comparative Genomic Hybridization applications within the BDS-image™ F.I.S.H. 
software package as described in material and methods. By doing so, an obvious 
overrepresentation of only one genomic region, ranging from 12pll.2 to 12pl2.1, was identified 
in the tumor DNA (Figs. 59 and 60). The size of this region may even be smaller because its 
precise localization was partly hampered by the slight overall overrepresentation of 12p sequences 
in the tumor DNA (see Fig. 60 and above). However, some metaphase spreads gave relatively 
bright hybridization signals in the 12pl 1.23 subband only, indicating that this particular segment 
is predominantly amplified in the tumor DNA. No other (sub-)chromosomal segment was found to 
be amplified, although some chromosomes appeared slightly over- or underrepresented (not 
shown) as might be expected from the cytogenetic constitution of the tumor (Fig. 54). Control 
CGH analyses using constitutional DNA of the patient, isolated from peripheral leucocytes, as test 
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Figure 62 Slot blot analysis of control normal patient leucocyte (lanes A,C) and tumor (lanes 
B,D) DNAs using KRAS2 (left panel) and PTHLH (right panel)-specific probes. DNAs were 
loaded in different concentrations, i.e., from top to bottom 0.0S, 0.1, 0.5, 1.0 μg in each lane, 
respectively. 
DNA and reference (i.e., 46.XY) DNA did not reveal any genomic region that was subjected to 
genomic imbalance (not shown), indicating that the 12p-derived ampi ¡con is indeed tumor-specific. 
Slot blot analysis 
DNAs extracted from the patient's tumor (paraffin block, see above) and normal blood cells 
were applied onto filters in different concentrations (i.e., 1.0, 0.S, 0.1, 0.05 /ig) via slot blotting 
procedures. After hybridization of the blots with different chromosome 12-specific markers 
(including PTHLH, KRAS2, IAPP, VWF8) (see Sinke et al., 1992), a clear difference in signal 
intensities for the tumor samples versus the normal control samples was observed only for 
PTHLH (probe pBRF50; Fig. 62, lane D). The PTHLH gene maps within the region 12pl 1.2-
pl2.1. 
DISCUSSION 
A metastasis of a testicular germ cell tumor (TGCT) occurring in the latero-aortic lymph 
nodes was subjected to histologic, cytogenetic, fluorescence in situ hybridization (FISH) and 
comparative genomic hybridization (CGH) analyses. The tumor was recognized as a metastasis of 
a seminoma, that did not display the standard marker chromosome of TGCTs, i.e., i(12p), but 
instead, exhibited two other chromosomal abnormalities involving the short arm of chromosome 
12. Further FISH and CGH analyses revealed amplification of a specified region on the short arm 
of chromosome 12, i.e., 12pll.2-pl2.1, within the tumor genome which occurred as an 
abnormally banding region (abr) in one of the two rearrangements. This amplification was not 
found in constitutional DNA of the patient, indicating that it is tumor-specific. 
Most cases (5: 80%) of TGCT display one or more copies of an i(12p) chromosome (De 
Jong et al., 1990. To a lesser extent, other chromosomal rearrangements involving 12p can be 
found (Gibas et al., 1986; Castedo et al., 1988, 1989a; Sandberg, 1990; Suijkerbuijk et al., 1991; 
Reilly et al., 1993). In addition, i(12p) has been observed in some ovarian and extragonadal germ 
cell tumors, indicating that its prevalence may point at an important role in the pathogenesis of 
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germ cell rumors (Delozier-Blanchet et al., 1987; Castedo et al., 1989a, 1991; De Jong et al., 
1990). Furthermore, the occurrence of i(12p) may be correlated with the malignant character of 
TGCTs (Delozier-Blanchet et al., 1987; Castedo et al., 1989a; Dmitrovsky et al., 1991), possibly 
via a relative increase of certain 12p-derived gene(s). If so, such a correlation may exist for 
i(12p)-negative TGCTs as well, since also in this group of TGCTs overrepresentation of 12p has 
consistently been found (Suijkerbuijk et al., 1992, 1993; Rodriquez et al., 1993). In this view, the 
identification and characterization of a 12p-derived amplicon in a metastasis of a seminoma, as 
described in this study, could provide a first clue to the chromosomal sub-localization of gene(s) 
that contribute to tumor progression. 
Genes that are most frequently found to be amplified in tumor cells belong to the class of 
proto-oncogenes. These amplifications are always specifically encountered in the tumor genomes 
and are absent from constitutional DNAs of patients, indicating that the genes involved are 
selected for during tumor growth. Various molecular studies on several tumor models (e.g., colon 
carcinomas, neuroblastomas, gliomas, gastric adenocarcinomas, lung carcinomas, breast tumors) 
provided evidence that proto-oncogene amplifications may occur late in tumor development, and 
that associations between tumor progression and the extend of proto-oncogene amplification can be 
established (reviewed in Brison, 1993). Our observation of a 12p-derived amplicon in a metastasis 
of a seminoma may very well fit into this scheme. Unfortunately, there was no material of the 
primary tumor available for our studies. Therefore, no retrospective comparisons could be made 
between the primary tumor and its metastases to definitely correlate amplification to tumor 
progression. However, an association between i(12p) (i.e., increase in copy number of 12p-
derived sequences) and malignancy (i.e., tumor progression) in TGCTs has been stated more than 
once (Delozier-Blanchet et al., 1987; Bosl et al., 1989; Castedo et al., 1989a; Dmitrovsky et al., 
1991; Suijkerbuijk et al., 1993). Moreover, molecular studies on TGCTs and -derived cell lines 
(Geurts van Kessel et al., 1989, 1991) and cytogenetic analyses of primary carcinoma-in-situ 
(CIS) lesions (Vos et al., 1990) have indicated that i(12p) formation may be a secondary genetic 
event and, thus, not associated with tumor initiation. Teleologically, therefore, it is tempting to 
assume that the occurrence of a 12pll.2-pl2.1 amplicon in a metastasis of a seminoma is 
correlated with metastatic progression of the primary tumor, and that this process may be 
associated with the amplification of a gene(s) in this region that has the characteristics of a proto­
oncogene. In this respect, the KRAS2 oncogene (12pl2.1) (see HGM 11, 1991) can be excluded as 
a candidate, because slot blot analyses failed to show amplification of this gene. This observation 
is in agreement with our previous finding that the gene is not included in the 12p-derived 
fragment present in the radiation-reduced hybrid cell line (i.e., reverse paint probe) WgM6B 
(Sinke et al., 1992). On the other hand, a gene like the one encoding parathyroid hormone-related 
peptide (gene symbol: РТН1Л) (Moseley et al., 1987; Stewart et al., 1987; Pausova et al., 1993), 
which maps exactly within the 12p-derived amplicon, must be considered as a candidate. This 
suggestion is strengthened by the recent observations that this same gene, whose product is an 
onco-fetal hormone with endocrine and probably autocrine/paracrine functions (Martin et al., 
1989), is specifically expressed (nuclear localization) in seminomas (but not in non-seminomas; 
Shimogaki et al., 1993), and was found to be amplified (together with KRAS2) in a human lung 
cancer cell line (Rudduck et al., 1993). Obviously, such a putative association requires further 
investigation. 
114 
ACKNOWLEDGEMENTS 
The authors thank Drs. H.H. Ropers, J.W. Oosterhuis, B. de Jong, L. Looijenga, D. de 
Bruijn and B. Defize for advice and support, and Dr. S. Castedo for referring tumor material to 
us. Dr. С Rudduck is acknowledged for generous gift of PTHLH probe pBRF50, and the 
Biological Detection Systems Inc. (Rockville, MD) for providing the BDS-image™ F.I.S.H. 
software package for the acquisition of digital images, image-analysis, and -processing. This work 
was supported by the Dutch Cancer Society (Koningin Wilhelmina Fonds), and grant Ro 389/15-4 
(to H.H. Ropers) of the Deutsche Forschungsgemeinschaft. 
115 

REFERENCES 
Albrecht S, Amstrong DL, Mahoney DH, Cheek WR, Cooley LD (1993): Cytogenetic demonstration of 
gene amplification in a primary intracranial germ cell tumor. Genes Chromos. Cancer 6.61-63. 
Aly MS, Dal Cin P, Jiskoot P, Deneffe G, Marynen P, Van Den Berghe H (1994): Competitive ш situ 
hybridization in a mediastinal germ cell tumor. Cancer Genet. Cytogenet. (in press). 
Andrews PW, Gonczol E, Plotkin SA, Dignazio M, Oosterhuis JW (1986): Differentiation of tera-2 human 
embryonal carcinoma cell into neurons and HCMV permissive cells. Differentiation 31:119-126. 
Andrews PW, Oosterhuis JW, Damjanov I (1987): Cell lmes from human germ cell tumors. In: 
Teratocarcinomas and embryonal stem cell lines, E Robertson ed. IRL Press, Oxford, pp 207-248. 
Atkin NB (1973): High chromosome numbers of seminomata and malignant teratoma of the testis: A review 
of data on 103 tumours. Br. J. Cancer 28:275-279. 
Atkin NB (1989): Solid tumor cytogenetics. Progress since 1979 (10th anniversary article). Cancer Genet. 
Cytogenet. 40.3-12. 
Atkin NB, Baker MC (1982): Specific chromosome change, i(12p), in testicular tumours'7 Lancet ii: 1349. 
Atkin NB, Baker MC (1983): i(12p). Specific chromosomal marker m seminoma an malignant teratoma of 
the testis? Cancer Genet. Cytogenet 10:199-204. 
Atkin NB, Baker MC (1985): Chromosome analysis of three seminomas. Cancer Genet. Cytogenet. 17:315-
323. 
Atkin NB, Baker MC (1987): Abnormal chromosomes involving small metacentrics in 14 ovarian cancers. 
Cancer Genet. Cytogenet. 26.355-361 
Atkin NB, Baker MC (1988): Small metacentric marker chromosomes, particularly isochromosomes, m 
cancer. Hum. Genet. 79:96-102. 
Berger CS, Pennington RD, Dobbs R, Haddad FS, Sandberg AA (1987): Cytogenetic aspects of germ cell 
tumors of (he testis. Cancer Genet. Cytogenet. 28:43. 
Berger R (1989): Overview. First European Workshop on Cytogenetics and Molecular Genetics of Human 
Solid Tumors. Cancer Genet. Cytogenet. 38:147-152. 
Bosl GJ, Dmitrovsky E, Reuter VE, Samaniego F, Rodnquez E, Geller NL, Chaganti RSK (1989): 
Isochromosome of chromosome 12: clinically useful marker for male germ cell tumors. J. Natl. 
Cancer Inst. 81:1874-1878. 
Bnson О (1993): Gene amplification and tumor progression. Biochim. Biophys. Acta 1155:25-41. 
Brodsky GL (1991)' Pathology of testicular germ cell tumors. Haematology/Oncology climes of North 
America 5:1095-1126. 
Castedo SMMJ (1988): Pathogenesis of testicular germ cell tumors. A cytogenetic and pathological study. 
Thesis, University of Groningen. 
Castedo SMMJ, de Jong B, Oosterhuis JW, Seruca R, Idenburg V, Buist J, Sleijfer DTh (1988): i(12p) 
negative testicular germ cell tumors. A different group? Cancer Genet. Cytogenet. 35:171-178. 
Castedo SMMJ, de Jong B, Oosterhuis JW, Seruca R, te Meerman G, Dam A, Schraffordt Koops H 
(1989a). Cytogenetical analysis of ten human seminomas, two of them lacking i(12p). Cancer Res. 
49:439-443. 
Castedo SMMJ, de Jong B, Oosterhuis JW, Idenburg V, Seruca R, Buist J, te Meerman G, Schraffordt 
Koops H, Sleijfer DTh (1989b): Chromosomal changes in mature residual teratomas following 
poly chemotherapy. Cancer Res. 49:672-676. 
117 
Castedo SMMJ, de Jong B, Oosterhuis JW, Seruca R, Idenburg V, Dam A, (e Meerman G, Schraffordt 
Koops H, Sleijfer DTh (1989c): Chromosomal changes in primary testicular nonsemmomas. Cancer 
Res. 49.5696-5701. 
Castedo SMMJ, Oosterhuis JW, De Jong В (1991): Cytogenetic studies of testicular germ cell tumors: 
pathogenetic relevance. In: Paleobiology of human germ cell neoplasia Recent results in cancer 
research Vol. 123, JW Oosterhuis, H Walt, I Damjanov eds. Springer-Verlag, Berlin-Heidelberg, pp. 
101-106. 
Chaganti RSK, Ladanyi M, Samaniego F, Offit K, Reuter VE, Jhanwar SC, Bosl GJ (1989): Leukemic 
differentiation of a mediastinal germ cell tumor. Genes Chromos. Cancer 1:83-87. 
Collins С, Kuo WL, Segraves R, Fuscoe J, Pinkel D, Gray JW (1991): Construction and characterization of 
plasmid libraries enriched in sequences from single human chromosomes. Genomics 11:997-1006. 
Cortes D, Thorup J, Graem N (1989): Bilateral prepubertal carcinoma in situ of the testis and ambiguous 
external genitalia. J. Urol. 142:1065-1068. 
Cowan JM, Beckett MA, Tarbell NJ, Weichselbaum RR (1990): Monosomy 12p in a radiation-induced 
germ cell tumor. Genes Chromos. Cancer 2.186-190. 
Craig I, Gemmili R, Kucherlapati R (1992): Report of the first international workshop on human 
chromosome 12 mapping. Cytogenet. Cell Genet. 61:244-251. 
Cremer T, Lichter Ρ, Borden I, Ward DC, Manuehdis L (1988). Detection of chromosome aberrations in 
metaphase and interphase tumor cells by m situ hybridization using chromosome-specific library 
probes. Hum. Genet. 80:235-246. 
Dal Cm P, Drochmans A, Moerman Ρ, Van Den Berghe Η (1989): Isochromosome 12p m mediastinal germ 
cell tumor. Cancer Genet. Cytogenet. 42.243-251. 
Damjanov (1991): Paleobiology of human germ cell neoplasia. In: Pathobiology of Human Germ Cell 
Neoplasia. Recent results in Cancer Research Vol. 123, JW Oosterhuis, H Walt, I Damjanov eds. 
Berlin, Springer, pp 1-19. 
Damjanov I (1993) Pathogenesis of testicular germ cell rumors. In: Management and Biology of Carcinoma 
m situ and Cancer of the Testis. European Urology Vol. 23, NE Skakkebxk, KM Gngor, A 
Giwercman, M Rath eds. S Karger, Basel, Switzerland, pp 2-7. 
Damjanov I, Horvat В, Gibas Ζ (1994): Retinole acid induced differentiation of a keratin-negative, 
developmentally pluripotent human teratocarcinoma-denved cell Ime. Lab. Invest, (in press). 
De Brum TWA, Slater RM, Defferren R, Geurts van Kessel A, Suijkerbuijk R, Jansen G, de Jong В, 
Oosterhuis JW (1994): Isochromosome (12p) positive pineal germ cell tumor. Cancer Res. (in press). 
De Jong B, Oosterhuis JW, Castedo SMMJ, Vos A, te Meerman GJ (1990): Pathogenesis of adult testicular 
germ cell tumors. A cytogenetic mode (10th anniversary article). Cancer Genet Cytogenet. 48:143-
167. 
De Leeuw В, Suijkerbuijk RF, Balemans M, Sinke RJ, de Jong B, Molenaar WM, Meloni AM, Sandberg 
AA, Geraghty M, Hofker M, Ropers HH, Geurts van Kessel A (1993): Sublocalization of the 
synovial sarcoma-associated t(X;18) chromosomal breakpoint in Xpll.2 usmg cosmid cloning and 
fluorescence m situ hybridization. Oncogene 8:1457-1463. 
De Leeuw В, Suijkerbuijk RF, Olde Weghuis D, Meloni AM, Stenman G, Kindblom G, Balemans M, van 
den Berg E, Molenaar WM, Sandberg AA, Geurts van Kessel A (1994)- Distinct Xpll.2 breakpoints 
m synovial sarcomas revealed by metaphase and interphase fluorescence in situ hybridization' 
relationship to histologic subtypes. Cancer Genet Cytogenet. (in press) 
DeLozier-Blanchet CD, Engel H, Walt H (1985). Isochromosome 12p in malignant testicular tumors. 
Cancer Genet Cytogenet. 15:375-376. 
DeLozier-Blanchet CD, Walt H, Engel E, Vaugnat Ρ (1987) Cytogenetic studies of human testicular germ 
118 
cell tumours. Int. J. Androl. 10:69-78. 
Dixon FJ Jr, Moore (1953): Testicular tumors. A chmco-pathologic study. Cancer 6:427-454. 
Dmilrovsky E, Rodriguez E, Samaniego F, Reuter VE, Miller WH Jr, Geller NL, Bosl GJ, Cbaganti RSK 
(1991): Analysis of chromosome 12 abnormalities in male germ ell cancers. In: In: Pathobiology of 
Human Germ Cell Neoplasia. Recent results in Cancer Research Vol. 123, JW Oosterhuis, H Walt, I 
Damjanov eds. Berlin, Springer, pp 119-123. 
Ewing J (1911): Teratoma testis and its denvates. Surg. Gynecol. Obstet. 12:230-261. 
Fawcett DW (1961): Intercellular bridges. Exp. Cell Res. [Suppl] 8:174-187. 
Feinberg AP, Vogelstem В (1983): A technique for radiolabeling DNA restriction endonuclease fragments 
to high specific activity. Anal. Biochem. 132:6-13. 
Feinberg AP, Vogelstem В (1984): A technique for radiolabeling DNA restriction endonuclease fragments 
to high specific activity. Addendum. Anal. Biochem. 137:266-267. 
Fletcher JA, Kozakewich NP, Hoffer FA, Lage JM, Weidner N, Tepper R, Pinkus GS, Morton CC, 
Corson JM (1991): Diagnostic relevance of clonal cytogenetic aberrations in malignant soft-tissue 
tumors. New Eng. J. Med 324:436-442. 
Floyd C, Ayala AG, Logothetis CJ, Silva EG (1988): Spermatocyte seminoma with associated sarcoma of 
the testis. Cancer 61:409-414. 
Forman D (1986): Testicular tumors - The maternal effect. Adv. Biosci. 55:109-114. 
Friedman NB (1951): The comparative morphogenesis of extragenital and gonadal teratoid tumors. Cancer 
4:265-275. 
Friedman NB, Moore RA (1946): Tumors of the testis. A report of 922 cases. Milit. Surg. 99:573-593. 
Fujimolo T, Ukeshima A, Kiyofuji R (1975): The origin, migration and morphology of the primordial germ 
cells in the chick embryo. Anat. Ree. 185:139-154. 
Geurts van Kessel A, Turc-Carel C, de Klein A, G ros veld G, Lenoir G, Bootsma D (1985): Translocation 
of oncogene с-JÍJ from chromosome 22 to chromosome 11 in an Ewing sarcoma derived cell Ime. 
Mol. Cell Biol. 5:427^29. 
Geurts van Kessel A, van Drunen E, de Jong B, Oosterhuis JW, Langeveld A, Mulder MP (1989): 
Chromosome 12q heterozygosity is retained in i(12p)-positive testicular germ cell tumor cells. Cancer 
Genet. Cytogenet. 40:129-134. 
Geurts van Kessel A, Suijkerbuijk R, de Jong B, Oosterhuis JW (1991): Molecular analysis of 
isochromosome 12p in testicular germ cell tumors. In: Pathobiology of Human Germ Cell Neoplasia. 
Recent results m Cancer Research Vol. 123, JW Oosterhuis, H Walt, I Damjanov eds. Berlin, 
Springer, pp. 113-118. 
Gibas Ζ, Prout GR, Pontes JE, Sandberg AA (1986): Chromosome changes in germ cell tumors of the 
testis. Cancer Genet. Cytogenet. 19:245-252. 
Gmsburg M, Snow MHL, McLaren A (1990): Primordial germ cells in the mouse embryo during 
gastrulation. Development 110:521-528. 
Giwercman A, Müller J, Skakkebsek N (1988): Carcinoma in situ of the undescended testis. Semin. Urol. 
6:110-119. 
Giwercman A, Müller J, Skakkebxk NE (1991): Carcinoma in situ of the testis: possible origin, clinical 
significance, and diagnostic methods. In: In. Pathobiology of Human Germ Cell Neoplasia. Recent 
results m Cancer Research Vol. 123, JW Oosterhuis, H Walt, I Damjanov eds. Berlin, Springer, pp. 
21-36. 
Giwercman A, Von der Maasse H, Skakkebsk NE (1993): Epidemiological and clinical aspects of 
carcinoma in situ of the testis. Management and Biology of Carcinoma m situ and Cancer of the 
Testis. European Urology Vol. 23, NE Skakkebxk, KM Gngor, A Giwercman, M Rath eds. S 
119 
Karger, Basel, Switzerland, pp. 104-110. 
Gondos В (1986): Intratubular germ cell neoplasia. Ultrastructure and pathogenesis. In: Pathology of the 
Testis and Its Adnexa, A Talerman, LM Roth eds. Churchill Livingstone, New York, pp. 47-79. 
Gondos В (1993): Ultrastructure of developing and malignant germ cells. In: Management and Biology of 
Carcinoma in situ and Cancer of the Testis. European Urology Vol. 23, NE Skakkebsk, KM Grigor, 
A Giwercman, M Roth eds. S Karger, Basel, Switzerland, pp 68-75. 
Gonzales-Crussi F (1982): Extragonadal teratomas. AFIP Atlas of Tumor Pathology, second series, fascicle 
18, Washington, D.C. 
Gonzales-Crussi F (1986): Testicular and paratesticular tumors of childhood. In: Pathology of the Testis and 
Its Adnexa, A Talerman LM Roth eds, Churchill Livingstone. New York, p. 131. 
Goss SJ, Harris H (1975): New method for mapping genes in human chromosomes. Nature 255:1445-1458. 
Guinand S, Hedinger С (1981): Cellules germinales atypiques întratubulaires et tumeurs germinales 
testiculaires de l'enfant. Annal. Pathol. 1:251-257. 
Haddad FS, Sorini PM, Somsin AA, Nathan ΜΗ, Dobbs, RM, Berger CS, Sandberg AA (1988): Familial 
double testicular tumors: identical chromosome changes in seminoma and embryonal carcinoma of 
the same testis. J. Urol. 139:748-750. 
Hamers A, de Jong B, Suijkerbuijk RF, Geurts van Kessel A, Oosterhuis JW, van Echten J, Evers J, 
Bosman F (1991): A 46,XY female with mixed gonadal dysgenesis and a 48,XY,+7,+i(12p) 
chromosome pattern in a primary gonadal tumor. Cancer Genet. Cytogenet. 57:219-224. 
Harms D, Jänig U (1986): Germ cell tumours of childhood. A report of 170 cases including 59 pure and 
partial yolk sac tumours. Virchows Arch. (A) 409:223-239. 
Harris H (1986): The genetic analysis of malignancy. J. Cell Sci. [Suppl] 4:431-444. 
Hilscher W (1974): Kinetik der PräSpermatogenese und Spermatogenese. Verh. Anat. Ges. 68:39-62. 
Hoffner L, Shen-Schwarz S, Deka R, Chakravarti A, Suiti U (1992): Genetics and biology of human 
ovarian teratomas. III. Cytogenetics and origins of malignant ovarian germ cell tumors. Cancer 
Genet. Cytogenet. 62:58-65. 
Hofmann MC, Jetsch W, Brecher J, Walt H (1989): Alkaline phosphatase isoenzymes in human testicular 
germ cell tumors, their precancerous stage, and three related cell lines. Cancer Res. 49:4696-4700. 
Hôppener I, de Pagter-Holthuizen P, Geurts van Kessel A, Jansen M, Kittur S, Antonarakis S, Lips С, 
Sussenbach I (1985): The human gene encoding insulin-like growth factor 1 is located on 
chromosome 12. Hum. Genet. 69:157-160. 
Human Genome Mapping 11 (1991). Cytogenet. Cell Genet. 58:555-579. 
Ilson HI, Bosl GJ, Motzer R, Dmitrovsky E, Chaganti RSK (1991): Genetic analysis of germ cell tumors: 
current progress and future perpectives. Hematology/Oncology Clinics of North America 5:1271-
1283. 
ISCN (1991): Guidelines for Cancer Cytogenetics, Supplement to An International System for Human 
Cytogenetic Nomenclature, F. Mitelman (ed); S. Karger, Basel 1991. 
Jacobsen GK, Henriksen OB, von der Maasse HV (1981): Carcinoma in situ of testicular tissue adjacent to 
malignant germ-cell tumours: a study of 105 cases. Cancer 47:2660-2662. 
Jacobsen GK, №rgaard-Pedersen В (1984): Placental alkaline phosphotase in testicular germ cell tumours 
and in carcinoma-in-situ. Acta Pathol. Microbiol. Scan. [A] 92:323-329. 
Jenkyn DJ, McCartney AJ (1987): A chromosome study of three ovanan tumors. Cancer Genet. Cytogenet. 
26:327-337. 
Jergensen N, Müller J, Giwercman A, Skakkebsk NE (1990): Clinical and biological significance of 
carcinoma of the testis. Cancer Surveys 9:287-302. 
Kaplan CG, Ashn FC, Bemirschke К (1979): Cytogenetics of extragonadal tumors. Teratology 19:261-266 
120 
Kievits Τ, Devile« Ρ, Wiegant J, Wagenaar MC, Comelisse Cl, van Ommen GJB, Pearson PL (1990): 
Direct nonradioactive in situ hybridization of somatic cell hybrid DNA lo human lymphocyte 
chromosomes. Cytometry 11:105-109. 
Koide O, Iwai S, Baba К, In Η (1987): Identification of testicular atypical germ cells by an 
lmmunohistochemical technique for placental alkaline phosphatase. Cancer 60:1325. 
Ladanyi M, Samamego F, Reuter VE, Motzer RJ, Jbanwar SC, Bosl GJ, Chaganti RSK (1990): 
Cytogenetic and lmmunohistochemical evidence for the germ cell origin of a subset of acute 
leukemias associated with mediastinal germ cell tumors. J. Natl. Cancer Inst. 82:221-227. 
Landegent JE, Jansen ш de Wal Ν, Dirks RW, Baas F, van der Ploeg M (1987): Use of whole cosmid 
genomic sequences for chromosomal localization by non-radioactive m situ hybridization. Hum. 
Genet. 77:366-370. 
Lengauer C, Riehtman H, Cremer Τ (1990): Painting of human chromosome with probes generated from 
hybrid cell lmes by PCR with Alu and LI primers. Hum Genet. 86:1-6. 
Lichter Ρ, Cremer Τ, Borden J, Manuehdis L, Ward DC (1988): Delineation of individual human 
chromosomes in metaphase and interphase cells by m situ suppression hybridization using 
recombinant DNA libraries. Hum. Genet. 80.224-234. 
Lichter Ρ, Ledbetter SA, Ledbetter DH, Ward DC (1990): Fluorescence ш situ hybridization with Alu and 
LI polymerase chain reaction probes for rapid characterization of human chromosomes in hybrid cell 
lmes. Proc. Natl. Acad. Sci. USA 87:6634-6638. 
Limon J, Dal Cm P, Sandberg AA (1986): Application of long-term collagenase disaggregation for the 
cytogenetic analysis of human solid tumors. Cancer Genet. Cytogenet. 23:305-313. 
Looijenga LHJ, Smils VTHBM, Wessels JW, Mollevanger Ρ, Oosterhuis JW, Comelisse CJ, Devilee Ρ 
(1990): Localization and polymorphism of a chromosome 12-specific alpha satellite DNA sequence. 
Cytogenet. Cell Genet. 53:216-218 
Looijenga LHJ, Gillis AJM, Hoekstra JW, Sinke RJ, Geurts van Kessel A, Oosterhuis JW (1994): 
Involvement and parental origin of chromosomes 12 and 22 m testicular germ cell tumors of adults. 
Genes Chromos. Cancer (in press). 
Lothe RA, Fossa SD, Stenwig AE, Nakamura Y, White R, Barrcsen AL, Bragger 
A (1989): Loss of Эр or l ip alleles is associated Wim testicular cancer tumors. Genomics 5:134-138. 
Lothe RA, Hastie Ν, Heimdal К, Fossa SD, Stenwig AE, Berrresen AL (1993): Frequent loss of ПрІЗ and 
11р15 loci in male germ cell tumours. Genes Chromos. Cancer 7 96-101. 
Mangln M, Ikeda К, Dreyer BE, Broadus AE (1989): Isolation and characterization of the human 
parathyroid hormone-like peptide gene. Proc. Natl. Acad Sci USA 86:2408-2412. 
Manivel JC, Jessurun J, Wick MR, Dehner L (1987): Placental alkaline immunoreactivity in testicular germ 
cell neoplasms. Am. J. Surg. Pathol. 11-21-29. 
Manivel JC, Simonton S, Wold LE, Dehner LP (1988): Absence of lnlratubular germ cell neoplasia in 
testicular yolk sac tumors m children: a histochemical and lmmunohistochemical study. Arch. Pathol. 
Lab. Med. 112:641-645. 
Mann BD, Sparkes RS, Kern DH, Morton DL (1983): Chromosomal abnormalities of a mediastinal 
embryonal carcinoma in a patient with 47.XXY Klinefelter syndrome: Evidence for the premeiotic 
origin of a germ cell tumor. Cancer Genet Cytogenet. 8:191-196 
Martmeau M (1969): Chromosomes in human testicular tumours. J. Pathol. 99:271-282. 
Martin TJ, Allan EH, Caple 1W, Care AD, Danks JA, Diefenbach-Jagger H, Ebeling PR, Gillespie MT, 
Hammonds G, Heath JA, Hudson PJ, Kemp BE, Kubota M, Kukreja SC, Mosely JM, Ng KW, 
Raisz LG, Rodda CP, Simmons HA, Suva U , Wettenhall REH, Wood WI (1989): Parathyroid 
hormone-related protein: Isolation, molecular cloning and mechanisms of action. Recent Prog. Horm. 
121 
Res. 45:467-506. 
Mitelman F (1985): Catalog of Chromosome Aberrations m Cancer, 2nd edition Ed. Alan R. Liss, New 
York. 
Mitelman F (1990): Catalog of Chromosome Aberrations ш Cancer, 3rd edition Ed. Alan R. Liss, New 
York. 
Mitelman F, Heim S, Mandahl N (1989): Chromosome abnormalities in solid tumors. In: Human Tumor 
Markers, SW Ting, JS Chen, MK Schwartz, eds, Elsevier, New York, pp. 75-87. 
Melier H (1993): Clues to the aetiology of testicular germ cell tumours from descriptive epidemiology. In: 
Management and Biology of Carcinoma ш situ and Cancer of the Testis. European Urology Vol. 23, 
NE Skakkebaek, KM Gngor, A Giwercman, M Ruth eds. S Karger, Basel, Switzerland, pp. 8-15. 
Moseley JM, Kubota M, Diefenbach-Jagger HD, Wettenhall REH, Kemp BE, Suva U, Rodda CP, Ebeling 
PR, Hudson PJ, Zajac JD, Martin TJ (1987): Parathyroid hormone-related protein purified from a 
human lung carcinoma cell Ime. Proa Natl. Acad. Sci. USA 84-5048-5052. 
Mostofi FK, Pnce EB (1973): Tumors of the male genital system. AFIP Atlas of Tumor Pathology, second 
senes, fascicle 8, Washington, D.C. 
Mostofi FK, Sesterhenn IA, Davis CJ Jr (1987): Immunopathology of germ cell tumors of the testis. Semin. 
Diagn. Pathol. 4:320-341. 
Mukherjee AB, Murty VWS, Rodngues E, Reuter VE, Bosl GJ, Chaganti RSK (1991): Detection and 
analysis of ongin of i(12p), a diagnostic marker of human germ cell tumors, by fluorescence ш situ 
hybridization. Genes Chromos. Cancer 3.300-307. 
Muller J, Skakkebaek NE (1981): Microspectrophotometnc DNA measurements of carcinoma-in-situ germ 
cells ш the testis. Int. J. Androl. [Suppl] 4.211-221. 
Müller J, Skakkebaek NE, Nielsen OH, Greem N (1984): Chryptorchidism and testicular cancer, atypical 
infantile germ cells followed by carcinoma ш situ and invasive carcinoma in adulthood. Cancer 
54.629-634. 
Müller J, Skakkebaek NE, Ritzen M, Plöen L, Petersen К (1985): Carcinoma-in-siru ш the testis ш children 
with 45,V/46,XY gonadal dysgenesis. J. Pediatr. 106:431-436. 
Müller J, Skakkebaek NE, Parkinson MC (1987): The spermatocyte seminoma: views on pathogenesis. Int. 
J. Androl. 10:146-156. 
Murty VVVS, Houldsworth J, Baldwin S, Reuter V, Ншшкег W, Besmer P, Bosl G, Chaganti RSK 
(1992): Allelic deletions in the long arm of chromosome 12 identify candidate tumor suppressor 
genes in male germ cell tumors. Proc. Natl. Acad. Sci. USA 89:11006-11010. 
Nochomowitz LE, Rosai J (1978): Current concepts on the histogenesis, pathology and 
immunohistochemistry of germ cell tumors of the testis. Pathol. Annu 13327-362. 
Oliver RTD (1987): HLA phenotype and clmicopathological behaviour of germ cell tumours' possible 
evidence for clonal evolution from seminomas to nonseminomas Int. J. Androl. 10:85-94. 
Oosterhuis JW, de Jong B, Van Dalen I, Van der Meer I, Visser M, Mesander G, Collard JG, Schraffordt 
Koops H, Sleijfer DTh (1985): Identical chromosome translocations involving the region of the c-myb 
oncogene in four metastases of a mediastinal teratocarcinoma. Cancer Genet Cytogenet 15:99-107. 
Oosterhuis JW, de Jong B, Comelisse CJ, Molenaar WM, Meinng A, Idenburg VJS, Schraffordt Koops H, 
Sleijfer DT (1986): Karyotyping and DNA flow cytometry of mature residual teratoma after intensive 
chemotherapy of disseminated nonsenunomatous germ cell tumor of the testis' A report of two cases. 
Cancer Genet. Cytogenet. 22:149-157. 
Oosterhuis JW, Dam A, Comelisse CJ, Molenaar WM, de Jong В (1987): Difference in ploidy ш subtypes 
of testicular germ cell tumors. Cancer Genet Cytogenet. 28.43. 
Oosterhuis JW, Castedo SMMJ, de Jong B, Comelisse CJ, Dam A, Sleijfer DT, Schraffordt Koops H 
122 
(1989): Ploidy of pnmary germ cell tumors of the testis. Pathogenetic and clinical relevance. Lab. 
Invest. 60:14 21. 
Oosterhuis JW, Castedo SMMJ, de Jong B, Seruca R, Dam A, Vos A, de Koning J, Schraffordt Koops H, 
Sleijfer DTh (1989b): A malignant mixed gonadal stromal tumor of the testis with heterologous 
components and i(12p) in one of its metastases. Cancer Genet. Cytogenet. 41:105-114. 
Oosterhuis JW, Castedo SMMJ, de Jong В (1990): Cytogenetics, ploidy and differentiation of human 
testicular, ovarian and extragonadal germ cell tumours. Cancer Surveys 9:321-332. 
Omitz DM, Hammer RE, Messing A, Palmiter RD, Bruister BL (1987): Pancreatic neoplasia induced by 
SV40 T-antigen expression ш acinar cell of transgeme mice. Science 238:188-193. 
Pamngton JM, West LF (1985): Loss of chromosome and enzyme markers in cultures from testicular 
tumours. Clin. Genet. 27:326. 
Partington JM, West LF, Povey S (1985): Chromosome changes in germ cell tumours. In: Proceedings of 
the Second Germ Cell Conference, WG Jones, A Milford Ward, CK Anderson eds. Leeds, pp. βί­
ο?. 
Pamngton JM, West LF (1986): Different chromosome no. 1 markers and loss of lp material m separate 
cell linas from the same testicular teratoma. Seventh International Congress on Human Genetics, 
Berlin. 
Partington JM, Al Jehani R, Wells D, Fox M (1992): Characterisation of marker chromosomes m testicular 
tumours by banding, RFLP analysis and fluorescence in situ hybridisation. (Abstract) Cancer Genet. 
Cytogenet 63:149. 
Paulien S, Suijkerbuijk R, Liao M, Geurts van Kessel, Gemmili R (1991): Construction of a human 
chromosome 12 specific YAC library. Cytogenet. Cell Genet. 58:[A2748I). 
Pausova Z, Morgan K, Fujiwara M, Bourdon J, Goltzman D, Hendy GN (1993): Molecular characterization 
of an intragenic mimsatellite (VNTR) polymorphism m the human parathyroid hormone related 
peptide gene m chromosome region 12pI2.1-pl 1.2. Genomics 17:243-244. 
Peltomäki Ρ, Lothe RA, Berresen AL, Fossa SD, Bragger A, de la Chapelle A (1992): Chromosome 12 ш 
human testicular cancer: dosage and their parental origin. Cancer Genet Cytogenet. 64:21-26. 
Pierce GB, Abell MR (1970)· Embryonal carcinoma of the testis. Pathol. Annu. 5.27-60. 
Pierotti MA, Radice Ρ, Lacérenla S, Mondini Ρ, Radice MT, Pilotli S, Della Porta G (1989): Loss of 
heterozygous DNA markers m human germ cell neoplasms. Cancer Genet. Cytogenet. 38:176. 
Pmkel D, Straume T, Gray JW (1986)- Cytogenetic analysis using quantitative, high sensitivity, 
fluorescence hybridization. Proc. Natl. Acad. Sci. USA 83.2934-2938. 
Pinkel D, Landegent J, Collins C, Fuscoe J, Segraves R, Lucas J, Gray I (1988): Fluorescence in situ 
hybridization with human chromosome-specific libraries, detection of trisomy 21 and translocations 
of chromosome 4. Proc. Natl Sci. Acad. USA 85:9238-9242. 
Pitot HC (1991): Characterization of the stages of progression m hepatocarcinogenesis in the rat. In: 
Boundaries between Promotion and Progression during Carcinogenesis. Basic Life Sciences Vol. 57, 
О Sudilovsky, HC Pilot, LA Liotta eds. Plenum Press, New York, pp. 3-18. 
Ploos van Amstel HK, Reitsma PH (1990): Tetranucleotide repeat polymorphism m the vWF gene. Nucleic 
Acids Res 18:4957. 
Pugh RCB (1979) Combined tumours. In: Pathology of the Testis, RCB Pugh ed. Blackwell, Oxford, pp. 
245-258. 
Raghavan D, Sullivan AL, Peckham MJ, Neville AM (1982): Elevated serum alphafetoprotein and 
seminoma. Clinical evidence for a histologic contmuum? Cancer 50.982-989. 
Reilly PA, Heerema NA, Sledge Jr. GW, Palmer CG (1993): Unusual distribution of chromosome 12 in a 
testicular germ-cell tumor cell Ime (833K) and its cisplatin-resistant derivative (64CP9). Cancer 
123 
Genei. Cytogenet. 68 114-121. 
Rodriguez E, Roa PH, Ladanyi M, Altorlu Ν, Albino AP, Kelsen DP, Jhanwar SC, Chaganti RSK 
(1990): 1 lpl3-15 is a site of specific chromosome rearrangement in gastric and esophageal 
adenocarcinoma. Cancer Res. 50:6410-6416. 
Rodriguez E, Mathew S, Reuter V, Ilson DH, Bosl GJ, Chaganti RSK (1992)- Cytogenetic analysis of 124 
prospectively ascertained male germ cell tumors. Cancer Res. 52.2285-2291. 
Rodriguez E, Houldsworth J, Reuter VE, Meltzer Ρ, Zhang J, Trent JM, Bosl GJ, Chaganti RSK (1993): 
Molecular cytogenetic analysis of i(12p)-negative human male germ cell tumors. Genes Chromos. 
Cancer 8230-236. 
Rowley JD (1990): Recurring chromosome abnormalities in leukemia and lymphoma Seminars in Hemalol. 
27:122-136. 
Rudduck C, Duncan L, Center R, Garson OM (1993): Co-amplification of the gene for parathyroid 
hormone-related protein (PTHRP) and KRAS2 m a human lung cancer cell line. Genes Chromos. 
Cancer 7:213-218. 
Sager R (1986): Genetic suppression of tumor formation: a new frontier in cancer research Cancer Res. 
46:1573-1580. 
Samamego F, Rodnquez E, Houldsworth J, Murty VVVS, Ladanyi M, Pele KP, Chen Q, Dmitrovsky E, 
Geiler NL, Reuter V, Jhanwar SC, Bosl GJ, Chaganti RSK (1990): Cytogenetic and molecular 
analysis of human male germ cell tumors: chromosome 12 abnormalities and gene amplification. 
Genes Chromos Cancer 1:289-300 
Sambrook J, Fntsch EF, Mamatis Τ (1989): Molecular cloning, a laboratory manual. Second edition, Cold 
Spring Harbor Laboratory Press, Cold Spring Harbor, NY, USA. 
Sandberg AA (1990): The chromosomes in human cancer and leukemia, 2nd Ed. Elsevier, New York, 
Amsterdam. 
Schimke RT (1982): Gene amplification. Cold Spring Harbor, NY 
Scully RE (1979): Tumors of the ovary and maldeveloped gonads. AFIP Atlas of Tumor Pathology, second 
series, fascicle 16, Washington, D.C., p. 16. 
Shimogaki H, Kitazawa S, Maeda S, Kamidono S (1993): Venable expression of hst-1, int-1, and 
parathyroid hormone-related protein in different histological types of human testicular germ cell 
rumors. Cancer Journal 6*81-86. 
Silverman E (1982): Cancer in young adults. CA 32.32. 
Sinke RJ, Suijkerbuijk RF, Herbergs J, Janssen H, Cassiman JJ, Geurts van Kessel A (1991): Generation of 
a panel of somatic cell hybrids containing fragments of human chromosome 12p by X-ray irradiation 
and cell fusion. Genomics 12:206-213. 
Sinke RJ, Suijkerbuijk RF, de Jong B, Oosterbuis JW, Geurts van Kessel A (1993): Uniparental ongin of 
i(12p) ш human germ cell tumors Genes Chromos. Cancer 6:161-165. 
Skakkebaek NE, Berthelsen JG (1978) Carcinoma m situ and orchiectomy. Lancet ii:204-205. 
Skakkebsk NE, Berthelsen JG (1981) Carcinoma-in-situ of the testis and invasive growth of different types 
of germ cell tumours. A revised germ cell theory. Int. J. Andrai [Suppl] 4:26-34. 
Skakkebek NE, Berthelsen JG, Giwercman A, Müller J (1987)· Carcinoma-in-situ of the testis: possible 
ongin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. Int. J. 
Androl. 10:19-28 
Speleman F, de Potter, Dal Cm P, Mangelschots K, Ingelaere H, Laureys G, Benoit Y, Leroy J, Van Den 
Berghe H (1990): i(12p) in malignant ovarian tumor. Cancer Genet. Cytogenet. 45:49-53. 
Speleman F, Laureys G, Benoit Y, Cuvelier С, Suijkerbuijk RF, De Jong В (1992)· i(12p) m a near diploid 
mature ovarian teratoma Cancer Genet. Cytogenet 60:216. 
124 
Sreekantaiah С, Rao UNM, Sandberg (1992): Complex karyotypic aberrations, mcluding i(12p), ш 
malignant mixed Mullenan tumor of uterus. Cancer Genet. Cytogenet. 60:78-81. 
Stewart AF, Wu T, Goumas D, Burtis WJ, Broadus AE (1987): N-temunal amino acid sequence of two 
novel tumor-denved adenylate cyclase-stimulating proteins: identification of parathyroid hormone-like 
and parathyroid hormone-unlike domains. Biochem. Biophys. Res. Commun. 146:672-678. 
Suijkerbuijk RF, van der Veen AY, van Echten J, Buys CHCM, de Jong B, Oosterhuis JW, Warburton 
DA, Cassiman JJ, Schonk D, Geurts van Kessel A (1991): Demonstration of the genuine iso(12p) 
character of the standard marker chromosome of testicular germ cell tumors and identification of 
further chromosome 12 aberrations by competitive in situ hybridization. Am. J. Hum. Genet. 
48:269-273. 
Suijkerbuijk RF, Looijenga L, de Jong B, Oosterhuis JW, Cassiman JJ, Geurts van Kessel A (1992): 
Verification of isochromosome 12p and identification of other chromosome 12 aberrations in human 
germ cell tumors by bicolor double fluorescence in situ hybridization. Cancer Genet. Cytogenet. 
63:8-16. 
Suijkerbuijk RF, Sinke RJ, Meloni AM, Partington JM, Echten J van, Jong В de, Oosterhuis JW, Sandberg 
AA, Geurts van Kessel A (1993): Overrepresentation of chromosome 12p sequences and karyotypic 
evolution in i(12p)-negative testicular germ cell tumors revealed by fluorescence in situ hybridization. 
Cancer Genet. Cytogenet. 70:85-93. 
Suijkerbuijk RF, Olde Weghuis D, Berg M van den, Pedeutour F, Forus A, Myklebost O, Glier C, Ture-
Carel С, Geurts van Kessel A (1994) Comparative genomic hybridization as a tool to define two 
distinct chromosome 12-denved amplification units in well-differentiated liposarcomas. Genes 
Chromos. Cancer (in press). 
Swerdlow AJ (1986): Recent findings ш the epidemiology of testicular cancer. Adv. Biosci 55.101-107. 
Teyssier JR (1989): The chromosomal analysis of human solid tumors: A triple challenge. Cancer Genet. 
Cytogenet. 37:103-125. 
Thompson S, Stem PL, Webb M, Walsh FS, Engstrom W, Evans EP, Shi WK, Hopkins B, Graham CF 
(1984): Cloned human teratoma cells differentiate into neuron-like cells and other cell types m 
retinole acid. J. Cell Sci. 72:37-64. 
Trent JM (1984): Chromosomal alterations ш human solid tumors: Implications of the stem cell model to 
cancer cytogenetics. Cancer Res. 3:395-422. 
Tnbukait В (1987): Flow cytometry m assessing the clinical aggressiveness of genito-unnary neoplasms. 
World J. Urol. 5:108. 
Trosko JE, Chang CC, Medcalf A (1983): Mechanisms of tumor promotion: potential role of intercellular 
communication. Cancer Invest. 1:511-526. 
True LD, Otis CN, Dezpardo W, Scully RE, Rosai L (1988): Spermatocyte seminoma of testis with 
sarcomatous transformation. A report of five cases. Am. J. Surg. Pathol. 12:75-82 
Van der Riet-Fox M, Relief AE, van Niekerk WA (1979): Chromosome changes in 17 human neoplasms 
studied with banding. Cancer 44:2108-2119. 
Verma RS (1986): Oncogenetics: A new emergmg field of cancer Mol. Gen. Genet. 205385-389. 
Vorechovsky I, Mazanec К (1991)- Cytogenetic investigation of gonadal carcinomas in situ syndromes of 
abnormal differentiation. In: Pathobiology of human germ cell neoplasia. Recent results m cancer 
research Vol. 123, JW Oosterhuis, H Walt, I Damjanov eds. Springer-Verlag, Berlin-Heidelberg, pp. 
45-49. 
Vos A, Oosterhuis JW, de Jong B, Buist J, Schraffordt Koops H (1990): Cytogenetics of carcinoma m situ 
of the testis. Cancer Genet. Cytogenet. 46-75-81. 
125 
Walt H, Arrenbrecht S, Delozier-Blanchet CD, Keller PJ, Nauer R, Hedinger CE (1986): A human 
testicular germ cell tumor with borderline histology between seminoma and embryonal carcinoma 
secreted beta-human chorionic gonadotropin and alpha-fetoprotem only as xenograft. Cancer 48:139-
146. 
Wang N, Trend B, Bronson DL, Fraley ЕЕ (1980)° Nonrandom abnormalities ш chromosome 1 in human 
testicular cancers. Cancer Res. 40.796-802. 
Wang N, Perlons KL, Bronson DL, Fraley ЕЕ (1981): Cytogenetic evidence for premeiotic transformation 
of human testicular cancers Cancer Res 41:2135-2140. 
Warburton D, Gersen S, Yu MT, Jackson C, Handelm B, Housman D (1990). Monochromosomal rodent-
human hybrids from microcell fusion of human lymphoblastoid cells containing an inserted dominant 
selectable marker. Genomics 6:358-366. 
Waterhouse JAH (1986): Epidemiology and aetiology of germ cell tumours Adv. Biosci 55:115-122. 
Wyhe CC (1993): The biology of primordial germ cells In: Management and Biology of Carcinoma in situ 
and Cancer of the Testis. European Urology Vol. 23, NE Skakkebxk, KM Gngor, A Giwercman, M 
Rath eds. S Karger, Basel, Switzerland, pp. 62-67. 
Zhang J, Marynen P, Devnendt K, Fryns JP, Van den Berghe H, Cassiman 33 (1989)· Molecular analysis 
of the isochromosome 12p in the Palhster-Killian syndrome. Construction of a mouse-human hybrid 
cell containing an i(12p) as the sole human chromosome. Hum. Genet. 83359-363. 
126 
CHAPTER 
IDENTIFICATION 
AND CHARACTERIZATION 
OF RECURRENT CHROMOSOMAL 
ABNORMALITIES IN SOFT TISSUE 
AND RENAL TUMORS 

CHAPTER 4.1 
INTRODUCTION 
Solid tumors are most prevalent among all human malignancies in their incidence and 
mortality. In spite of this fact, however, relatively little is known about the occurrence of 
nonrandom chromosomal alterations in these tumors (Heim and Mitelman, 1987, 1992; Sandberg, 
1990). Still it is believed that, in analogy to hematological neoplasms, the cytogenetics of solid 
tumors will soon become of major relevance for the diagnosis, prognosis and classification of 
these malignancies and for the elucidation of the molecular mechanisms underlying cancer 
development. Indeed, lineage-specific chromosomal abnormalities (e.g., translocations) have 
already been detected in mesenchymal neoplasms (or son tissue tumors), though their diagnostic 
value is limited (see Heim and Mitelman, 1987, 1992; Sandberg et al., 1990). As amply 
demonstrated in several hematological malignancies (Cleary et al., 1991), the detailed 
characterization of chromosomal regions that are involved in recurring chromosomal aberrations 
may ultimately lead to the identification of genes that, if rearranged or mutated, contribute to 
tumorigenesis. In fact, within the past two years the molecular-cytogenetic characterization of such 
chromosomal rearrangements has led to the identification of cancer-causing gene alterations in 
three distinct soft tissue tumors: 
In Ewing's Sarcoma (ES) and peripheral neuro-epithel¡ornas the t(ll;22)(q23;ql2), which is 
characteristic for these tumors, has been shown to result in the fusion of two genes, the EWS gene 
on chromosome 22 and the Hum-Fli-1 gene on chromosome 11 (Turc-Carel et al., 1983; Delattre 
et al., 1992). Through this translocation, the open reading frame of Hutn-Fli-1 is altered via 
substitution of its DNA binding domain by a sequence encoding a putative RNA binding domain. 
In myxoid liposarcoma a specific t(12;16)(ql3;pll) is observed (Turc-Carel et al., 1986). 
Recently Aman et al. (1992) have demonstrated that the transcription factor gene CHOP (a highly 
conserved homolog of the mouse GADD153 leucine zipper gene) is rearranged in t(12;16)-positive 
mixoid liposarcomas. In this case the CHOP gene on chromosome 12, which is a member of the 
CCAAT/enhancer binding protein (C/EBP) family and which has been shown to be important in 
the normal control of fat cell differentiation and proliferation, is interrupted by this translocation 
at its 5' end, presumably interfering with its normal function. Also very recently it was found by 
Barr and coworkers (1993) that the PAX3 gene (83) is disrupted by the t(2;13)(q35;ql4) 
translocation in alveolar rhabdomyosarcomas. This latter finding is of particular interest since 
PAX3 is a human gene whose murine homologue has been associated with the Splotch mutation, a 
defect that results in neural tube defects and craniofacial abnormalities. Also, recent studies of 
Waardenburg's syndrome (Tassabehji et al., 1992; Baldwin et al., 1992), a human disorder 
characterized by deafness and pigmentary disturbances, have shown that patients with this 
disorder may have mutations within the DNA binding domain of PAX3. Other than in 
Waardenburg's syndrome, the rearrangement of PAX3 in alveolar rhabdomyosarcoma leaves the 
DNA binding domain intact, again resulting in a chimaeric transcript containing the 5' portion of 
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PAX3 ftised to part of a gene on chromosome 13 (Galili et al., 1993). 
In the vast majority of solid tumors, however, the identification and detailed 
characterization of chromosomal changes is still in its infancy, but extensive work is in progress 
and both the quantity and the quality of relevant cytogenetic data is steadily increasing. As a 
result, several other chromosomal anomalies that are associated with specific histological tumor 
(sub)types could recently be identified (Heim and Mitelman, 1992). In addition, the application of 
newly developed fluorescence in situ hybridization (FISH) techniques (see Chapter 2) will 
facilitate and considerably improve the precision of chromosomal analyses and, finally, bridge the 
gap between cytogenetics and molecular genetics. In this chapter preliminary studies will be 
presented which aim at the characterization of consistent chromosomal alterations that may be 
encountered in some selected soft tissue tumor (sub)types. These alterations include 
supernumerary ring and giant rod-shaped marker chromosomes in well-differentiated liposarcomas 
(see Chapters 4.2-4.4) and balanced translocations, t(X;18)(pll;qll), in synovial sarcomas 
(Chapter 4.5). In addition, t(X;l)(pll;q21), which appears to be specific for a subgroup of renal 
adenocarcinomas (i.e., papillary renal cell carcinomas), has been included for detailed FISH 
analysis (Chapter 4.6). The cytogenetically detectable breakpoint on the X chromosome in these 
latter tumors resides in the very same (sub)band (Xpll.2) as the one encountered in synovial 
sarcomas. This fact raises intriguing questions concerning the structure and function of the DNA 
sequences involved in these rearrangements and their role in the etiology of these two completely 
different histologic tumor types. 
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LETTER TO THE EDITOR 
One of the principal types of liposarcoma (LPS) is the well-differentiated LPS (WDLPS). 
WDLPS can grow to large size and, after excision, recur locally but almost never metastasize. In 
contrast to this low-grade malignant behavior, the cytogenetic features of WDLPS are quite 
dramatic and include supernumerary rings and giant marker chromosomes of undetermined origin 
(Karakousis et al., 1987; Sreekantaiah et al., 1992; Stephenson et al., 1992). 
A case of WDLPS reported in your Journal by Stephenson et al. (1992) in which the sole 
cytogenetic anomaly appeared to be addition of a giant marker chromosome to an otherwise 
normal diploid karyotype. Fluorescence in situ hybridization (FISH), using centromeric probes to 
chromosomes 1-4, 6-12, 16, 17, and X and a shared satellite probe to chromosome 1, 5, and 19 
could not identify the origin of the giant marker. 
We have studies five cases of WDLPS, each with supernumerary ring or giant marker 
chromosomes and have used several FISH techniques to determine the origin of these remarkable 
chromosome rearrangements characteristic of WDLPS. We report results indicating that 
chromosome 12 may consistently be involved in formation of these rings and giant markers. 
The cytogenetics were performed by R- or G-banding of short-term cultured cells from each 
of the five tumor samples. Three WDLPS samples had supernumerary rings, and two WDLPS 
samples had supernumerary giant marker chromosomes. The karyotype of these five cases (which 
correspond to our laboratory specimen numbers LPS1, LPS2, 91132, 91131, and 92295, 
respectively) are case 1, 48,XY,+2r/48,idem,4p+; case 2, 47-50,X,-Y,i(8q), + l-3r; case 3, 47-
50,XX, + l-4r; case4, 47,XX, + mar; and case 5, 48,XY, + marl, + mar2, where mar, marl, and 
mar2 all represent giant marker chromosomes. 
The only detectable change in cases 3-5 was the acquisition of a ring or giant rod-shaped 
marker chromosome. These cases provide strong evidence that the rings and rods may be key 
primary changes and that chromosome duplication is crucial to the development of WDLPS. 
Our FISH studies so far have involved use of probes specific for the centromeres of 
eighteen chromosomes and whole chromosome painting (WCP) probes specific for eleven 
chromosomes. The details concerning provenance, nature, use, and results with FISH will be 
reported when all studies are completed. The gist of the FISH analysis to date is that WCP shows 
clear involvement of chromosome 12 in formation of every ring and giant marker in these five 
cases of WDLPS. It is of interest that the chromosome 12 centromeric probe failed to show any 
hybridization to one of these markers, and results from hybridizations with WCP probes indicated 
that at least five other chromosomes have played roles in the creation of these extraordinary 
rearrangements in WDLPS. 
We are aware of the implications of chromosome 12 involvement in WDLPS. Another type 
of LPS, i.e., myxoid LPS, is characterized by a t(12;16)(ql3;pll) (Turc-Carel et al., 1986) and 
rearrangement of the transcription factor gene CHOP (Aman et al., 1992). Moreover, the 12ql3 
region harbors the SAS sequence and the MDM2 gene which are amplified in LPS (Meltzer et al., 
1991; Oliner et al., 1992). Thus, the knowledge that chromosome 12, almost surely 12q, is 
consistently involved in WDLPS adds a further element of complexity to the association between 
chromosome 12 and adipose tissue tumors. 
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ABSTRACT 
Extra abnormal chromosomes (rings and giant rods) containing chromosome 12 sequences 
are characteristic of well-differentiated liposarcoma (WDLPS). By whole chromosome painting we 
found in six WDLPS that minimally 5 chromosomes had contributed to the formation of the extra 
abnormal chromosomes. To the constant chromosomes 12 contribution, sequences were variably 
added from chromosomes 1, 4, and 16. Material from chromosome 1, 4 and 12 was identified by 
chromosome painting in interphase nuclear projections ("blebs") and in micronuclei consistent 
with the concept that blebs are precursors to micronuclei. The complexity of the mechanisms 
generating the extra abnormal chromosomes in WDLPS was also attested by the diversity and, in 
some cases, intricacy of the patterns of fluorescence. To fathom out the function of the extra 
abnormal chromosomes we examined the amplification of genes, including SAS, MDM2 and 
GADD 153/CHOP, known to be in the region 12ql3-14. SAS and MDM2 demonstrated constant 
co-amplification. GADD 153/CHOP, which is critically rearranged in myxoid liposarcoma, was 
not amplified in WDLPS. 
Figures 66-76 are represented on Color Plate III. 
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INTRODUCTION 
One of the major categories of liposarcoma (LPS) is the well-differentiated LPS (WDLPS). 
WDLPS has flamboyant cytogenetic features that include bizarre marker chromosomes: 
supernumerary ring and giant rod marker chromosomes. These markers have been observed as the 
sole cytogenetic change, or in addition to other chromosome abnormalities (Turc-Carel et al., 
1993). Cytogenetic studies with banding and fluorescence in situ hybridization (FISH) with 
centromeric alpha-satellite DNA probes did not allow the determination of their chromosomal 
origin (Stephenson et al., 1992). Preliminary observations using FISH with whole chromosome 
painting (WCP) probes indicated that chromosome 12 sequences were present in these markers 
(Pedeutour et al., 1993). The 12ql3-15 region has been specifically identified in such markers 
(Dal Cin et al., 1993). Here we report the application of FISH with a large battery of WCP 
probes to metaphase chromosomes and interphase nuclei from six WDLPS cases to learn which 
chromosomes other than chromosome 12 are involved in these marker chromosomes. Since large 
marker chromosomes with abnormally banded regions (ABR) such as those in WDLPS have been 
suggested to carry gene amplification(s) (Stark and Wahl, 1984), we have investigated in the same 
tumors the amplification status of genes from chromosome 12, including SAS and MDM2, known 
to be amplified in sarcomas (Oliner et al., 1992; Smith et al., 1992). 
MATERIALS AND METHODS 
Pathology 
The tumors, 3 primary and 3 recurrent, were excised from 4 males and 2 females aged 50-
80 years (Table 8). The histopathologic diagnosis submitted to peer review (except in case 1) was 
uniformly WDLPS. 
Tissue culture and cytogenetics 
Cell culture and cytogenetics were carried out as previously described (Turc-Carel et al., 
1984; Limon et al., 1986; Sreekantaiah et al., 1991). Briefly, the surgical specimens were 
received in the laboratory within 1 to 2 days, submitted to mechanic and enzymatic dissociation, 
cultured in flasks and/or on glass coversiips in Petri dishes. Chromosome analyses were 
performed on short-term cultures (3-12 days). Air-dried preparations were RHG-, GTG- and 
CTG-banded by standard techniques. Results were expressed according to the International System 
for Human Cytogenetic Nomenclature (ISCN, 1991). 
Fluorescence in situ hybridization (FISH) 
Biotinylated WCP probes specific to chromosomes 1-4, 6, and 12 (Imagenetics, USA), and 
to 11, 16, and 17 (Oncor, USA) were used. Direct labeled orange spectrum WCP DNA probes 
specific to chromosomes 1-4, 6-9, 12, 13, 15, and 18 and green spectrum WCP DNA probe 
specific to chromosome 12 were purchased from GIBCO-BRL (France). DNA from the 
monochromosomal somatic hybrid cell line M28 (Zhang et al., 1989) was used as a probe to paint 
specifically the short arm of chromosome 12 (Suijkerbuijk et al., 1991, 1992a). 
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Table 8. Clinical and cytogenetic characteristics of six cases of weH-differentlsted llposarcoma (WDLFS) 
Case 
1 
2 
3 
4 
5 
6 
Laboratory 
identification 
920317 AS 
LPS1 
920210 AD 
LPS2 
91132 
91131 
92295 
92334 
Sex/ 
Age 
(yr) 
M/73 
M/80 
F/65 
F/60 
M/50 
M/77 
Location 
Retropentoneal 
Retropcntoneal 
Retropentoneal 
Retropentoneal 
Left arm, 
deep seated 
Right thigh, 
deep seated 
Pnmary/ 
recurrence 
Recurrence 
Pnmary 
Recurrence 
Pnmary 
Pnmary 
Recurrence 
Siz 
(cm) 
30 
11 5 
14x8 
33x28x60 
14x6 
16 5x2 2x1 
Histological 
ofWDLPS 
Sclerosing 
Sclerosing and 
lipoma like with 
dedifferentiated 
component 
Sclerosing/ 
dedifferentiated 
Lipoma like/ 
sclerosing 
Sclerosing 
Lipoma like 
Cytogenetics 
abnormalities 
(no of cells) 
47-48,XY, + l-2r[13] 
48-49,XY,add(4) 
(pl5), + l-2r[2] 
48-49,X,-Y,i(8)(ql0) 
+2-3r[91/49,X,-Y, 
+i(8)(ql0),+2r, 
-1- mar[2]/vanant 
cells[9] 
47-50.XX. + l-4r[2] 
79-95,idemx2[3] 
47,XX,+mar(10] 
48,XY,+marl, 
+ mar2[9]/96, 
idemx2[2] 
39-101,+ 1 2r, 
+ l-2mar,4-7dmin, 
numerous complex 
unidentified markers 
[10] 
The biotinylated alpha-satellite DNA probes D1Z5, D2Z, D3Z1, D4Z1, D5Z2/D1Z7, 
D6Z1, D7Z2, D8Z1, D9Z, D10Z1, D11Z1, D12Z3, D13Z1/D2Z1Z1, D14Z1/D22Z1, D15Z1, 
D16Z2, D17Z1, D18Z1, D20Z1, DXZ1 were purchased from Oncor In addition, another 
chromosome 12-specific alphoid probe, D12Z1 (ι e , ρα12Η8 Looijenga et al , 1990) was used 
Hybridization and detection were done by the method of Pinkel et al (1986) with minimal 
modifications (Suijkerbuijk et al , 1992a, 1992b, 1993) or by the manufacturers' 
recommendations Fixed metaphase spreads were stored in 70% ethanol at 4°C After overnight 
hybridization, sequential washes and revelation with avidin-FITC (step omitted for the direct 
labeled WCP probes from GIBCO-BRL) slides were examined using a Zeiss Axiophot microscope 
and photographed on Kodak 400 EL colorslide film In cases of faint hybridization signals, a high 
performance Photometries CH2S0/A cooled CCD camera, interfaced to a Macintosh Ilei 
workstation and controlled by the image-analysis and -processing software program BDS-Image 
(Biological Detection Systems Ine , Rockville, MD), was used (cases 1 and 2) to produce yellow-
red pseudocolor images with optimized signal-versus-background ratios Because we were working 
with a limited number of metaphases, we used some slides for multiple hybridization after a first 
hybridization, slides were washed twice in 4 χ SSC to remove mounting medium, then stored in 
70% ethanol until denaturation under the same conditions as the first hybridization This method 
yielded good results especially for the centromenc probes 
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Southern blot analysis 
cDNA probes for MDM2 (Oliner et al., 1992) were provided by George and Vogelstein. 
Alu repeats were removed from the full length cDNA by purification of a 3.1 kb Seal fragment. 
Vector DNA contamination was then removed by a second purification, after excision with Xhol. 
The probe for SAS (Meltzer et al., 1991) was the clone pSJP2 provided by Meltzer. As probes for 
A2MR some of the partial cDNA clones or a complete cDNA ligated together from the original 
partial clones were used (Herz et al., 1988). The genomic probe for GU (pKK 36P1) (Kinzler et 
al., 1987) was provided by Kinzler and Vogelstein. As probe for the GADD153/CHOP gene we 
used a human GADD153 cDNA clone (Park et al., 1992) provided by Holbrook. 
Solid tumor samples cut in small pieces and stored at -70°С were pulverized in liquid 
nitrogen and incubated overnight at 65°C in 0.25 M EDTA/1% Na Sarkosyl and 500 μg/ml 
proteinase K. Subsequently, DNA was extracted by an Applied Biosystems 340 DNA Extractor as 
described by the manufacturer. Aliquots (7/ig) of each sample were digested with 50 units of the 
restriction enzyme Hindlll and separated on 0.8% agarose gels. Gels were denatured in 1.5 M 
NaCl/0.5M NaOH for 2 hrs, and blotted overnight by capillary action onto Hybrond N+ filters, 
using the same solution. After blotting, the filters were neutralized in 50 mM sodium phosphate, 
pH 7.2, and baked for 2 hrs at 80°C before UV irradiation under a germicidal lamp (260 nm) at 
about 50 д> /ст г. Blots were hybridized with DNA probes labeled with 32P by random primer 
technique (Feinberg and Vogelstein, 1983). Hybridization conditions were as described by Church 
and Gilbert (1984). For multiple hybridizations, the probe was removed by incubating filters for 
15 min in 100 mM NaOH/1 mM EDTA. Calibration of DNA loading, and thus diploidy control, 
was achieved using three probes: A2M clone pHLA2M.l (12pl3-pl2) (ATCC), the anonymous 
segment D12S4 (12qll-ql4) (ATCC clone p9Fll) and the ApoB clone pB27 (2p24-p23) (Huang 
et al., 1985) provided by Breslow. 
RESULTS 
Cytogenetics 
Supernumerary ring chromosomes were found in cases 1-3 (Fig. 63) and 6 (Fig. 64), and 
rod marker chromosomes were present in cases 4-6 (Fig. 65) and in a sideline of case 2 (Table 8). 
Case 6 exhibited complex abnormalities, double minute chromosomes, random telomeric 
associations, and ring and marker chromosomes of various sizes. The constant finding was the 
presence of giant rod marker or large ring chromosomes in all metaphases. In none of the cases 
could the banding techniques identify the origin of any of the ring or marker chromosomes, all 
showing ABR patterns. 
FISH analysa 
1. Fluorescence painting pattern of rings and giant rod marker chromosomes 
Results are summarized in Table 9. In both cases 1 and 2, the ring chromosomes were 
found to be homogeneously painted over their entire length with the chromosome 12 WCP probe 
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Figure 63 Extra ring chromosome (arrowhead) in a full, otherwise normal G-banded karyotype 
from case 1 (losses of chromosome 18 and 21 are random) (a). Clonal abnormal chromosome 4 
(arrow) from a sideline (b) 
(Figs. 66 and 67). In case 3, although the chromosome 12 WCP probe hybridized homogeneously 
over the entire ring chromosomes (Fig. 68), the intensity of the paint was weaker than on the two 
normal chromosomes 12. Similarly, in case 3, the chromosome 16 WCP probe painted the rings 
less brightly that the normal chromosomes 16 (data not shown). 
With the WCP probe specific for chromosome 12, signals were distributed in an alternating 
fashion with painted and unpainted bands over the length of the giant rod chromosome, of the two 
rod markers (marl and mar2), and both the rod markers and large rings characterizing cases 4, 5 
and 6 respectively (Figs. 69-71). Using WCP probes in addition to the 12 probe, positive signals 
were observed on the chromosome 12-painted rod markers from cases 4 to 6. The WCP 1 and 8 
probes (Fig. 72 and data not shown) revealed fluorescent bands organized in a striped fashion 
along the entire length of the giant rod from case 4, analogous with the result of the WCP 12 
probe. Unfortunately, multicolor FISH with these three WCP probes could not be applied to co-
localize precisely the involvement of chromosomes 1, 8, and 12 in this rod marker. After 
hybridization with the WCP 1 probe, signals were also observed on the chromosome 12-painted 
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Figure 64 Large extra ring chromosome (arrow) in a partial R-banded metaphase for case 6. 
Arrowheads point to other abnormalities reflecting chromosome instability (double minutes, 
dicentric chromosomes) 
large markers and rings identified in case 6 (Fig. 73). With the WCP 4 probe, signals were found 
on both distal regions of both chromosome 12-painted rod markers characterizing case 5, 
indicating that one of the markers derives from the other (Figs. 71 and 74). Biotinylated DNA 
from the M28 cell line, which specifically paints the short arm of chromosome 12 was used in 
cases 1, 2 and 6, but did not paint the rings and the rod markers (data not shown). 
2. Fluorescence painting of micronuclei and nuclear blebs 
Micronuclei formation was observed in all the WDLPS cases. A significant number (more 
that 20%) of these micronuclei contained chromosome 12-positive domains, most of them entirely 
filling the micronucleus (Fig. 75). Besides the presence of two other chromosome 12-positive 
domains, large interphase nuclei showed nuclear "blebs" (Ruddle, 1962) including chromosome 12 
material (Fig. 76). The presence of other chromosomes involved in the formation of the rod 
markers (chromosomes 1 and 4 in cases 4 and 5) could also be observed altogether with 
chromosome 12, in blebs and micronuclei (data not shown). 
3. Alpha-satellite centromeric DNA probes 
Although all ring and giant rod marker chromosomes contained chromosome 12 sequences, 
none of them showed a positive signal with α-satellite centromeric probes specific to chromosome 
12. In addition, there was no positive signal with any of the centromeric probes specific to 
chromosomes 1, 4, 8 and 16, which are the other chromosomes shown to be involved in these rod 
marker and ring chromosomes. 
У 
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Figure 65 Supernumerary giant rod marker chromosome (arrow) from case 4 in a R-banded full, 
otherwise normal, karyotype (a) and a partial R-banded metaphase (b) 
Molecular studies 
DNA from the six WDLS samples was examined for the amplification of five gene loci 
mapped to the 12ql3-14 region (Table 10 and Fig. 77). Amplification of MDM2 and SAS were 
detected in all 6 samples. Unexpectedly, in one sample (case 4), the control probe A2M was found 
to be amplified, while other control probes showed a normal copy number (compared to normal 
leukocytes). 
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Table 9. Fluorescent signals on ring and giant marker chromosomes with whole 
chromosome painting (WCP). 
Probes on six cases of well-differentiated liposarcoma (WDLPS) 
WCP probes 
to chromosomes 
Case of WDLPS 
3 4 
1 
2 
3 
4 
6 
7 
8 
9 
11 
12 
12p(M28) 
13 
15 
16 
17 
18 
X 
Y 
— 
+ 
— 
— 
— 
+ 
— 
— 
— 
— 
— 
+ 
— 
— 
+ 
— 
+ 
— 
+ 
+ 
— 
— 
+ 
— 
+ 
— 
— 
— 
— 
— 
— 
+ 
+ 
— 
— 
(+) : positive signal; (— ) : negative signal; 
Table 10. Amplication of genes located at the 12ql3-14 region in six WDLPS cases 
Case 
1 
2 
3 
4 
5 
6 
MDM2 
Amp" 
Amp 
Amp 
Amp 
Amp 
Amp 
Genes and anonymous 
SAS 
Amp 
Amp 
Amp 
Amp 
Amp 
Amp 
Test 
GADO 153/CHOP 
Nb 
N 
N 
N 
N 
N 
single 
GU 
N 
N 
N 
N 
N 
N 
copy DNA 
A2MR 
N 
N 
N 
N 
N 
N 
segments 
A2M 
N 
N 
N 
Amp 
N 
N 
Control (a)c 
D12S4 
N 
N 
N 
N 
N 
N 
ApoB 
N 
N 
N 
N 
N 
N 
"Amp : a signal at least three-fold more intense than signals from samples with a normal copy 
number was scored as amplified. 
bN : normal gene dosage. 
ca : A2M (12pl3-pl2), D12S4 (12ql l-ql4), and ApoB (2p23-24) were used as control 
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MDM2 SAS А2М A2MR 
Figure 77 Amplification status of various genes in case 4: DNA from case 4 (left lane) and from 
a control lipoma (right lane) were hybridized with probes corresponding to genes MDM2, SAS, 
A2M, and A2MR. 
DISCUSSION 
All the adipose tissue tumors studied were diagnosed as WDLPS. The diagnosis was 
unambiguous in the four tumors located in the retroperitoneum (Enzinger and Weiss, 1988; 
Coindre et al., 1992). The remaining two tumors which were peripherally located in the limbs but 
deeply seated in the soft tissues were classified as WDLPS, according to the recommendations of 
Weiss and Rao (1992). All the six WDLPS were characterized by ring or very large rod marker 
chromosomes such as those previously described in adipose tissue tumors (Turc-Carel et al., 1993; 
Dal Cin et al., 1993). 
Composite nature of ring and giant rod chromosomes with consistent involvement of 
chromosome 12 sequences 
The WCP 12 probe hybridized to the ring and rod chromosomes of the six WDLPS (Table 
9), demonstrating the consistent involvement of chromosome 12. The fluorescence pattern differed 
in the various tumors; it was homo- or heterogeneous with a brightness equal or inferior to that of 
the normal chromosome 12, or heterogeneous with alternating stripes of fluorescent and non-
fluorescent bands. The stripes, observed mainly on the giant rods, indicated the presence of 
additional chromosome sequences. Chromosomes 1, 4, 8, and 16 sequences were shown to 
contribute together with chromosome 12 to their constitution. The most complex marker found 
was the giant rod in case 4 composed of sequences from at least 3 different chromosomes. How 
such a complex and suprisingly stable chromosomal structure could have evolved remains 
unanswered. Rings showing intense and homogeneous painting by WCP 12 (cases 1 and 2) may 
be simply composed of sequences from this chromosome. In case 3, a homogeneous pattern in 
rings independently shown with chromosome 12 and 16 sequences, could be the consequence of 
very short alternating stretches of DNA from each of the donor chromosomes. Their extension all 
over the rings gave rise to a hybridization pattern that was apparently continuous but less intense 
than on the normal chromosome. FISH analysis with a probe specific to chromosome 12ql3-ql5 
region that Dal Cin et al. (1993) performed on rings and large rod markers from adipose tissue 
tumors showed the consistent presence of sequences from the 12ql3-ql5 region in the markers. 
The painting pattern was extensive but discontinuous on the rings and restricted to a much smaller 
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part of the large rod chromosomes. The use of a chromosome 12-specific probe (WCP 12) 
containing DNA homologous to the entire chromosome in our study may explain the different 
hybridization patterns observed. Absence of 12p sequences was demonstrated in the three tumors 
studied suggesting the presence of only 12q-derived sequences in at least a subset of marker 
chromosomes. 
Sequences from chromosome 12 in rings and giant rods contain selected amplified genes of the 
12ql3-ql4 region 
Gene amplification was suspected in rings and giant rod markers because of their 
characteristically abnormally banded regions (ABR). The consistent involvement of chromosome 
12 in these markers led us to investigate the copy number of gene(s) from this chromosome. 
Moreover, amplification of SAS or MDM2 genes, mapped to the chromosome 12ql3-ql4 region, 
has been shown in liposarcomas (Oliner et al., 1992; Smith et al., 1992). Among the five genes 
mapped to 12ql3-ql4 that we analyzed, only SAS and MDM2 were consistently amplified in the 
six WDLPS cases. GADD 153/CHOP, which is rearranged in myxoid LPS (Aman et al., 1992) 
was notably not amplified. The systematic co-amplification of SAS and MDM2 is striking, 
especially since the two genes are at least 500 kb apart (Gemmili et al., 1992). Does one (or both) 
of these genes represent the target gene, or are they merely passengers in a larger ampi icon? In 
fact, a second consistent amplification unit on the long arm of chromosome 12 has been 
demonstrated clearly by means of the comparative genomic hybridization (CGH) strategy in six 
cases of WDLPS including cases 1 and 2 from this report (Suijkerbuijk et al., 1994). Co-
amplification of genes belonging to different chromosomes has been described to occur in one 
marker chromosome and double minute chromosomes (Bar-Am et al., 1992; Lafage et al., 1992). 
Co-amplifications with SAS/MDM2 still have to be investigated for genes from chromosome 1, 4, 
8, and 16 since sequences from these chromosomes were shown to be part of the rings and giant 
rods. 
Sequences corresponding to the rings and rod markers are present in blebs and micronuclei 
Another intriguing phenomenon is the presence of nuclear blebs and micronuclei which 
were shown to be labeled by sequences from chromosomes 1, 4, and 12, chromosomes involved 
in the rings and large rods. Blebs, also called "projections" (Hsu et al., 1974) or "buds" (Miele et 
al., 1989), have been observed in cell lines possessing an extra-long chromosome (Toledo et al., 
1992). In model systems of cells resistant to cytotoxic drugs, blebs were shown to contain 
amplified genes (Miele et al., 1989; Toledo et al., 1992). Our observations demonstrate that such 
a topological distribution of marker chromosomes containing amplified sequences may similarly 
occur in short-term cultured tumor cells. It has been proposed that blebs are precursors of 
micronuclei (Miele et al., 1989; Toledo et al., 1992). In WDLPS, the inclusion of chromosomes 
1, 4, and 12 sequences in micronuclei, as well as in blebs, strongly suggests the elimination of 
supernumerary chromosomes 1, 4, and 12 sequences in micronuclei via the formation of blebs. 
Centromere of markers not identified 
A chromosome is classically defined by its centromere. Like Stephenson et al. (1992), we 
were unable to identify the origin of the ring and giant rod chromosomes by hybridization of 
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centromeric alpha-satellite probes, even those corresponding to known contributing chromosomes. 
Although not every possible centromeric probe was available, we interpret our data as indicating 
that there may have been a systematic alteration of centromeres in these markers. This alteration 
could involve a dramatic shortening of alphoid satellite DNA. 
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ABSTRACT 
Well-differentiated liposarcomas (WDLPS) are frequently characterized by a near-diploid 
karyotype with supernumerary ring and/or giant rod-shaped marker chromosomes. We have 
shown, using fluorescence in situ hybridization (FISH) and molecular strategies, that these 
markers contain chromosome 12-derived sequences. Here we report the analysis of six WDLPS 
for the presence of amplified DNA segments by means of the recently developed comparative 
genomic hybridization (CGH) strategy. Two distinct chromosome 12-derived amplification units 
could be identified in all tumors examined, one being located in the ql4-ql5 region as expected, 
the second unexpectedly mapping to q21.3-q22. Our results indicate that the concerted 
amplification of these two distinct regions on the long arm of chromosome 12 may be a consistent 
characteristic of WDLPS. These amplifications are most likely directly related to the presence of 
supernumerary ring and/or giant marker chromosomes in this group of soft tissue tumors. 
Figures 78 and 79 are represented on Color Plate IV. 
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SHORT COMMUNICATION 
The characteristic presence of supernumerary ring and/or giant rod-shaped marker 
chromosomes as sole cytogenetic abnormalities in human well-differentiated liposarcomas 
(WDLPS: see Sreekantaiah et al., 1992) suggests an important role for these markers in the 
development of this type of soft tissue tumors. Recently, we and others have demonstrated by 
FISH the consistent involvement of chromosome 12-derived sequences in the formation of rings 
and giant marker chromosomes in WDLPS (Pedeutour et al., 1993; Dal Cin et al., 1993). In 
addition, our studies indicated the participation of one (or more) other chromosomes (i.e., 
chromosome 1, 4, 8, and 16) in most of these rearrangements (Pedeutour et al., 1994). No 12p-
derived sequences were found in the markers of three out of three WDLPS examined, suggesting 
overrepresentation of only 12q-derived material. The observation of a consistent amplification of 
selected 12q-derived genes, i.e., the SAS and MDM2 genes, but not the GADD153/CHOP gene 
(Meltzer et al., 1991; Oliner et al., 1992; Pedeutour et al., 1994) in WDLPS, supports this 
suggestion. To ascertain that (some of) these amplification events represent non-coincidental 
features in WDLPS rather than random DNA amplifications due to genomic instability, we have 
examined a series of six WDLPS for the presence of common regions of DNA amplification by 
means of comparative genomic hybridization (CGH) (Kallioniemi et al., 1992; Du Manoir et al., 
1993). 
DNAs of eight tumor samples, i.e., six primary WDLPS cases (including cases 1 and 2 
presented by Pedeutour et al., 1993) which had been shown to have ring and/or giant marker 
chromosomes by cytogenetic analysis, and two primary myxoid liposarcomas with rearrangements 
of the GADD153/CHOP gene (see Aman et al., 1993), were isolated using standard protocols and 
used for CGH analyses. CGH allows a comprehensive screening of test DNA for gained or lost 
genomic regions by quantitatively comparing the hybridization patterns of test (tumor) and 
reference (normal human) DNAs in a single hybridization experiment (Kallioniemi et al., 1992). 
Therefore, tumor and reference (46,XY) DNAs were differentially labeled with biotin-14-dATP 
(BRL, Gaithersburg, USA) and digoxigenin-11-dUTP (Boehringer Mannheim, Germany), 
respectively, using commercially available nick translation systems. An amount of 150-400 ng of 
both DNAs was coprecipitated in the presence of 50-100 χ C,/.l DNA (BRL, Gaithersburg, MD), 
dissolved in 10 μΐ hybridization mixture (Suijkerbuijk et al., 1991), denatured, preannealed at 
37 °C for 30 min and, finally, used for hybridization to denatured BrdU-incorporated high-
resolution metaphase spreads obtained from a normal male. Routinely prepared chromosomal 
slides (stored in 70% ethanol at 4°C until use) were immersed in 70% acetic acid (1 min), washed 
in PBS (pH 7.2; 3 x 5 min), dehydrated in an ethanol series and air-dried. Subsequently, the 
slides were treated with RNase A (100 /ig/ml) in 2 χ SSC (pH 7.0) at 37°C for 1 hr. After 
sequential washings with 2 χ SSC, dehydration in an ethanol series, and air-drying, the slides 
were denatured in 70% formamide/2 χ SSC/final pH 7.0 at 70°C for 2 min (Suijkerbuijk et al., 
1992, 1993). Finally, hybridization was carried out at 37°C for 3-4 days in a moist chamber. 
Posthybridization washings of the slides and immunocytochemical detection of the two 
differentially labeled DNAs with two different fluorochromes was accomplished according to 
Suijkerbuijk et al. (1992), with some modifications. Detection of the biotin molecules was carried 
out with alternating incubations with Texas Red-conjugated avidin (dilution 1:200; Vector 
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Laboratories, Burl ingame, PA) and biotin-conjugated goat anti-avid in antibodies (dilution 1:200; 
Vector Laboratories). Digoxigenin-labeled DNA was visualized after subsequent incubations with 
monoclonal mouse anti-digoxin antibodies (dilution 1:250; Sigma, St. Louis, MO), digoxigenin-
conjugated sheep anti-mouse antibodies (dilution 1:200; Boehringer Mannheim) and FITC-
conjugated sheep anti-digoxigenin antibodies (dilution 1:25; Boehringer Mannheim). Afterwards, 
chromosomal slides were counterstained with an antifade-solution, supplemented with 0.5 /ig/ml 
4,6-diamino-2-phenyl indole (DAPI; Sigma). 
For visual examination of the chromosomal slides, a Zeiss epifluorescence microscope 
equipped with a double small bandpass filter (Omega, Bratti eboro, VP), that allows simultaneous 
visualization of both Texas Red and FITC fluorescence, was used. An accurate screening of the 
metaphase spreads was attained using a high-performance cooled CCD camera (Photometries, 
Tucson, USA), interfaced to a Macintosh Ilei computer. All digital image-acquiring, -processing 
and -analysis functions (including the automated generation of chromosome fluorescence intensity 
profiles for each fluorochrome) were accomplished by means of the BDS-Image™ F.I.S.H. 
software package (Biological Detection Systems Inc., Rockville, USA) and will be described in 
more detail elsewhere. By doing so, extraction of fluorescence intensity profiles of a given 
chromosome allows both the identification of that particular chromosome by DAPI fluorescence 
and the detection and isolation of genomic regions that are over- or underrepresented in the tumor 
DNA on that very same chromosome via an increased or decreased Texas Red-versus-FITC (i.e., 
tumor-versus-normal) fluorescence ratio. In this way, at least ten metaphases (i.e., twenty 
chromosome homologs) were evaluated per case. 
A comprehensive description of all CGH results, as well as pathological-, cytogenetic- and 
molecular findings will be presented in more detail elsewhere. Here we report our preliminary, 
but consistent CGH findings on the presence of chromosome 12 anomalies in WDLPS. In 
particular, we found in all six WDLPS tumor DNA samples studied a clear amplification of the 
chromosome 12 long arm segment ql4-ql5, which is visualized as a bright staining of this region 
after hybridization with labeled tumor DNA (Fig. 79a, 79b). This result is completely in line with 
previous findings on the amplification of 12ql4-derived sequences (i.e., the SAS and MDM2 
genes) in WDLPS (Oliner et al., 1992; Smith et al., 1992; Pedeutour et al., 1994). Surprisingly, a 
second amplification unit on 12q, encompassing the q21.3-q22 region, was also found in all 
WDLPS examined (Fig. 79a, 79b). In three cases this latter staining appeared to be less bright 
and smaller in size than the more proximal q 14-q 15 amplicon. The fluorescence intensities and 
sizes of both amplicons, however, differed from tumor to tumor, with one case showing only a 
single broad fluorescent segment ranging from band ql4 to band q22. In addition, a few other 
chromosomes were found to contain amplified regions in all but one tumor (Fig. 78). More 
specifically, chromosome 1 was involved in five out of six cases (the sequences involved do not 
always appear to be the same). In one tumor, only two discrete thin fluorescent strips could be 
discerned on the long arm of chromosome 12 (again, one in ql4-ql5 and the other in q21.3-q22), 
indicating the specific presence of only two relatively small 12q-derived amplification units in this 
particular tumor sample. This latter finding underscores the importance of these two distinct 
genomic regions in the development of WDLPS. In contrast, no evidence for any amplification 
could be found after CGH with DNAs isolated from the two myxoid liposarcomas that contained 
the specific t(12;16)(ql3;pll) translocation and that were included as controls in this study (data 
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not shown). 
Taken together, our results demonstrate the consistent amplification in WDLPS of two 
distinct chromosomal areas located on the long arm of chromosome 12, i.e., in the regions ql4-
ql5 and q21.3-q22, by means of the recently developed CGH technique. Based on their physical 
map locations, these two regions do not seem to include the GADD153/CHOP gene, which is 
rearranged in myxoid liposarcomas and is located in band ql3 (for comparisons, see also Forus et 
al., 1991). 
Although CGH does not provide any direct information on the nature of the chromosomal 
abnormalities that harbor amplified genomic regions, it does demonstrate the presence of 
ampi icons in test DNAs via an increased fluorescence intensity at the chromosomal site from 
which the ampi icons originate. In case of WDLPS, it is tempting to assume that these ampi icons 
must be contained within the supernumerary ring and/or rod shaped giant marker chromosomes, 
since these extraordinary structures represent the sole cytogenetic anomalies present and are 
known to contain 12q-derived sequences. As such, they specifically distinguish the WDLPS 
karyotypes from other liposarcomas (Sreekantaiah et al., 1992; Stephenson et al., 1993; Pedeutour 
et al., 1993, 1994). Further FISH studies with region-specific YACs (Craig et al., 1992) and 
micro!ibraries from microdissected fragments of the 12ql3-ql5 segment (Meltzer et al., 1992; 
Schoenmakers et al., 1993) and the 12q21.3-q22 segment may test the assumptions stated above 
and may reveal whether these chromosomal regions are either organized in a tandem repeat array, 
are dispersed over the chromosome length, or both (Dal Cin et al., 1993). Moreover, it still needs 
to be confirmed (using additional WDLPS cases) whether the involvement of both the 12ql4-ql5 
and 12q21.3-q22 regions is a consistent phenomenon in WDLPS, is specific for this type of 
sarcomas, or may be a feature of some other soft tissue tumors as well. 
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ABSTRACT 
Fluorescence in situ hybridization (FISH) and molecular analyses of synovial sarcomas with 
cytogenetically similar (X;18)(pll.2;qll.2) translocations have revealed two alternative breakpoint 
regions in Xpll.2, one residing in the ornithine aminotransferase-like 1 (OATL1) region and the 
other one next to the related but distinct OATL2 region. As these results were obtained by 
different groups, we set out to evaluate an extended series of tumors with special emphasis on the 
two possible X-related breakpoint regions. Together, seven synovial sarcomas were identified with 
a break in the OATL1 region and six with a break near OATL2, thereby confirming the actual 
existence of the two alternative Xp breakpoint regions. We speculate that there seems to be a 
relationship between the occurrence of these breakpoint regionss and the histologic phenotype of 
the tumors, with a predominance of OATL1-related breakpoints in the classical biphasic tumors 
and of OATL2-related breakpoints in the monophasic fibrous tumors. 
Figures 80-85 are represented on Color Plate IV. 
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INTRODUCTION 
Synovial sarcoma is a soft tissue tumor which occurs mainly in adolescents and young 
adults. Next to rhabdomyosarcoma, synovial sarcoma is the most common solid tumor in children 
under 18 years of age (Schmidt et al., 1991; Dillon et al., 1992). The patients' ages range from 
11 months to 78 years, whereas the mean age at the time of operation is 37 years (Kester, 1990; 
Santavirta, 1992). About 90% of the primary tumors are found in the extremities, especially the 
lower limbs (Dillon et al., 1992), whereas 3-10% are found in the head and neck region, heart, 
and mediastinum (Marc'hadour et al., 1991; Sutsch et al., 1991; Carillo et al., 1992). In spite of 
its name, which arose from the light microscopic resemblance of the classic biphasic type to 
synovial tissue, the exact histogenetic origin of synovial sarcoma is, as yet, unknown. Electron 
microscopic and immunologic data clearly distinguish the cells from true synovial cells (Miettinen 
et al., 1983; Ordonez et al., 1990). Also, the tumors may arise at places where normally synovial 
cells are not present (Carillo et al., 1992). For this reason suggestions have been made to change 
the name to carcinosarcoma (Miettinen et al., 1983; Ordonez et al., 1990). 
Histologically, synovial sarcomas can be devided into two major groups: the classical 
biphasic type, containing an epithelial and a spindle cell component, and the monophasic type, 
containing only spindle cells, although some areas may express epithelial markers like EMA, 
keratin, CEA, S100 and others (Miettinen et al., 1983; Ordonez et al., 1990). The tumors differ 
in a graded fashion, however, which has led some authors to subdivide the biphasic type into 
totally biphasic (or glandlike) and focali y biphasic (Oda et al., 1993). Occasionally, two other 
types of synovial sarcoma are mentioned, namely the undifferentiated type and the monophasic 
epithelial type. These latter tumors are presumed to represent extreme and rare cases of 
monophasic and biphasic synovial sarcomas, respectively (Schmidt et al., 1991; Oda et al., 1993). 
The monophasic spindle cell and biphasic subtypes are thought to occur with similar frequencies 
(Dal Cin et al., 1992), although some authors state that the monophasic type is predominant, 
comprising about 60% of all cases (Ordonez et al., 1990). 
A characteristic chromosomal translocation, t(X;18)(pll.2;qll.2), has been found in 
synovial sarcoma cells (Turc-Carel et al., 1987). Sometimes this translocation is the only 
cytogenetic abnormality present, which is indicative for a primary causal event in tumor 
development. Recently, we (De Leeuw et al., 1993a, 1993b) and others (Knight et al., 1992) have 
identified yeast artificial chromosomes (YACs) containing human genomic fragments that span the 
breakpoint region on the X chromosome in different tumors. Both YACs (#2 and Ш) contain 
ornithine aminotransferase (OAT)-like sequences (OATL1 and OATL2, respectively) that are 
located at different sites on the short arm of the X chromosome (Lafrenière et al., 1991). Here we 
report the analysis of a new series of synovial sarcomas in some of which the OATL1 YAC#2 is 
split by the translocation, whereas in others the OATL2 YAC/C7 appears to be split. These 
findings confirm that indeed two distinct breakpoints on the X chromosome occur in synovial 
sarcoma. In addition we show that, with these breakpoint-spanning probes at hand, it has now 
become possible to identify the tumor-associated breakpoints not only in metaphase spreads, but 
also in interphase nuclei isolated from frozen tissue sections. We speculate that the observed 
differences in breakpoints on the X chromosome may correlate with the occurrence of different 
histologic tumor phenotypes. 
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MATERIALS AND METHODS 
Tumors and their cytogenetic constitution 
Two previously unreported synovial sarcomas used in the present study were completely 
karyotyped: no. T92/12236: 44,t(X;18)(pll;qll),-Y,add(19)(ql3.3),-22 and no. ST-88-20756: 72-
75,Y,t(X;18)(pll.2;qll.2),+t(X;18)(pll.2;qll.2), + l, + 2, + 2,+4, + 5, + 6, + 7, + 7, + 8, + 8,-l-9, 
+ 9,+ 10,+ 12, + 12,+ 13, + 14, + 15,+ 16, + 20,der(21)t(17;21)(qll.2;pl3),-(-t(21;21)(pl3;qll), 
+5-8mar. 
In addition, frozen samples from five other tumors were included in this study, of which the 
diagnosis synovial sarcoma could unambiguously be established but of which the cytogenetic 
constitution is unknown: no.'s 20521/88; 2374/90; 28775/90; 23303/91; 4873/92. 
Fluorescence in situ hybridization (FISH) on metaphase spreads 
All fluorescence in situ hybridization (FISH) procedures on metaphase spreads were 
essentially as described previously (De Leeuw et al., 1993a, 1993b). The probes used were: the 
centromere X-specific alphoid sequence probe pBamX5, the OATL1 YAC #2 and the OATL2 
YAC #7 (De Leeuw et al., 1993a, 1993b). Briefly, all probes were labeled with either biotin-11-
dUTP (Sigma, St. Louis, MO) or digoxigenin-11-dUTP (Boehringer Mannheim, Germany) using 
a nick-translation kit (GIBCO Life Technologies, Gaithersburg, MD). The labeled DNA was 
purified through a Sephadex G50 column and precipitated in the presence of sonicated herring 
sperm DNA (50-fold concentration). In the case of the YACs, a 50-fold amount of sonicated total 
human DNA (Landegent et al., 1987; Driesen et al., 1992) was coprecipitated for preannealing 
purposes. This mixture was dissolved in 10 μ\ of a hybridization solution (50% v/v deionized 
formamide, 10% w/v dextran sulphate, 2 χ SSC, 1% v/v Tween-20, pH 7.0). Prior to hybridizati­
on, the probe was denatured at 80°C for 10 min, chilled on ice, and incubated at 37°C for 4 hrs 
(200 ng YAC DNA per reaction) allowing preannealing. In case of centromeric probes, no prean­
nealing was performed and the probe concentration was 10 ng per reaction. Metaphase spreads 
were prepared using standard procedures. The slides were pretreated with RNase A (100 μg/ml in 
2 χ SSC at 37°C for 1 hr) and, eventually, porcine pepsine (Serva: 0.01% [w/v] in 0.01 M HCl, 
10 min at 37°C), followed by formaldehyde postfixation (1% [v/v] in PBS, pH 7.2: 10 min at 
37°C) (Arnoldus et al., 1989). Subsequently, the slides were denatured in 70% formamide, 2 χ 
SSC, pH 7.0, at 70°C for 2-3 min and incubated with the probes under an 18xl8-mm coverslip in 
a moist chamber for 1-3 days. 
FISH on interphase nuclei isolated from frozen tissue sections 
The probes were prepared as described above, with the only difference that instead of a 50-
fold amount of total human DNA a 50-fold amount of С</.1 DNA (GIBCO) was used as 
competitor and that preannealing was carried out for 1 hr at 37°C. Slides were prepared by 
cutting 50 /im sections from the frozen tissue and transferring them onto a microscope slide. A 
drop of PBS was added and the sections were minced further. Subsequently, the tissue suspension 
was transferred to a tube, whereby the larger particles were allowed to sink. The supernatant, 
containing the smaller tissue fragments, was then transferred to another tube. Fixation was 
preformed by quickly adding 10 ml of 70% ethanol. This fixation was repeated 2 or 3 times in 
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case of large yields of nuclei. Finally, the nuclei were spun down at 225 g for 7-10 minutes. 
Ethanol was removed except for the volume needed to make slides. The slides were dried at 65°C 
during 30 min before use. Pepsine treatment followed by formaldehyde post-fixation and 
denaturation was performed as described above. 
¡mmunocytochemical detection 
Immunocytochemical detection of the hybridizing probes was achieved using fluorescein 
isothiocyanate (FITC)-conjugated avidin (Vector laboratories, Burlingame, CA; 1:500 diluted) 
followed by an amplification step using goat anti-avidin (Vector laboratories; 1:200 diluted) and 
another FITC-avidin step (Pinkel et al., 1986) in case of biotinylated probes (green signals), or 
Rhodamin-conjugated sheep anti-digoxigenin (Boehringer Mannheim; dilution 1:20) and 
amplification with Texas Red-conjugated rabbit anti-sheep (Jackson Immunoresearch, West Grove, 
PA; dilution 1:100) in case of digoxigenin-labeled probes (red signals). Whenever necessary, a 
further amplification step was accomplished using another cycle of biotinylated goat anti-avidin 
and avidin-FITC, or Texas Red-conjugated donkey anti-rabbit (Jackson Immunoresearch; 1:100 
diluted) amplification. The slides were mounted in antifade medium (1.4% w/v di-azobicyclo-(2,2-
,2)-octane, DABCO; Merck, Darmstadt, Germany) containing 4,6-diamino-2-phenylindole (DAPI, 
0.5 μglm\, Sigma) for counterstaining of the chromosomes. 
Slides were viewed under a Zeiss Axiophot epifluorescence microscope equipped with 
appropriate filters for the visualization of FITC, Rhodamin/Texas Red, and DAPI fluorescence as 
well as the simultaneous visualization of FITC and Texas Red fluorescence (Omega double band 
pass filter, Brattlesboro, VT). Photographs were made on Kodak EL 400 colorslide film using 
double and triple exposures. Alternatively, separate digital images (for Texas Red, FITC and 
DAPI, respectively) were recorded using a Photometries high-performance CH250/A cooled 
CCD-camera interfaced onto a Macintosh Ilei computer. The images were superimposed and 
displayed in red-green-blue pseudocolors on the computerscreen using the image analysis and 
processing software program BDS-image (Biological Detection Systems, Rockville, MD). 
Photographs were made from the computer screen on Kodak EPP 100 plus colorslide film using a 
Polaroid Quickprint. 
RESULTS 
Tumor ST-88-20756 was diagnosed as a synovial sarcoma of the right humerus of a male 
patient. Cytogenetically t(X;18)(pll.2;qll.2) was confirmed. Fluorescence in situ hybridization 
(FISH) was preformed on metaphase spreads with either OATL1 YAGC2 or OATL2 YAC#7 
labeled with biotin and detected with a yellow fluorochrome (FITC; visible as light blue owe to 
DAPI pseudocolor overlay). Concomitantly, the X-centromere probe was applied, labeled with 
digoxigenin, and detected in red (Rhodamin/Texas Red; see Materials and Methods). As can be 
seen clearly in Fig. 80, the human sequences contained within OATL1 YAC#2 are split as a result 
of the translocation. Interestingly, this tumor has retained a double set of der(X) and der(18) 
chromosomes per cell (see also Materials and Methods for karyotype), which is nicely reflected by 
the FISH signals observed in both metaphases and interphases. The OATL2 YAC#7 hybridization 
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Figure 86. 
Diagram representing the proximal part of the X chromosome short arm and the location of a 
number of DNA markers (see, e.g., De Leeuw et al., 1993a and references therein), including 
OATL1 and OATL2. The positions of the two alternative synovial sarcoma-associated breakpoints 
(designated SSI and SS2) are marked by arrows. 
signal is not split and remains entirely on the der(X) chromosome (Fig. 81). This latter 
observation is in agreement with the more proximal localization of the OATL2 cluster on Xp (Fig. 
86). 
Tumor ST-88-04017 was initially diagnosed as an undefined solid tumor in a male patient, 
but upon repeated careful histologic examinations, the diagnosis of monophasic synovial sarcoma 
was ultimately established. Cytogenetic analysis revealed a t(X;18)(pll.2;qll.2), characteristic of 
synovial sarcoma. FISH was carried out as described for ST-88-20756. In this case, the OATL1 
YAC#2 signal moves completely to the der(18) chromosome (Fig. 82) indicating that the break 
has occurred at a site on Xp proximal to the OATL1 cluster. In contrast, however, the OATL2 
YAC#7 reveals a split signal resulting from the X; 18 translocation in this tumor (Fig. 83). 
In Figures 84 and 85 examples of FISH results obtained with tumor cell nuclei extracted from 
frozen tissue sections are shown. Cases 23-303/91 (female) and 28775/90 (male) show breaks in 
the OATL2 and OATL1 regions, respectively, using both corresponding OAT YACs for analysis. 
The results of all breakpoint analyses that we have carried out so far (including those reported 
previously [De Leeuw et al., 1993a, 1993b]) and of their corresponding tumor phenotypes are 
summarized in Table 11. One of the tumors that has been reported by the group of Knight and 
coworkers, and of which the histologic phenotype was known (Knight et al., 1992), has also been 
included in this table. Strikingly, all of the biphasic (both focally and total) synovial sarcomas are 
found to have a break in the OATL1 region, whereas most of the tumors diagnosed as monophasic 
exhibit a break in the OATL2 region, the only exceptions being tumors ST-91-01731 and 2374/90 
(Table 11). 
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TABLE 11: 
Summary of synovial sarcomas exhibiting OATL1- or OATL2-related breakpoints as revealed by 
metaphase and interphase FISH, and their corresponding histologic phenotypes (i.e., biphasic 
versus monophasic). 
OATLl-positive breakpoint: 
Metaphase In situ hybridization: 
ST-88-20756: 
Hlsynsarc: 
ST-91-01731: 
T91 12083: 
T91 9079: 
Interphase in situ hybridization: 
28775/90: 
2374/90: 
biphasic (F) 
biphasic (De Leeuw et al., 1993a) 
monophasic (De Leeuw et al., 1993b) 
biphasic (F) (De Leeuw et al., 1993b) 
biphasic (Olde Weghuis et al., 1994) 
biphasic 
monophasic 
OATL2-posùive breakpoint: 
Metaphase in situ hybridization: 
ST-88-04017 
T92 12236: 
SS255 (Bax): 
Interphase in situ hybridization: 
4873/92: 
23-303/91: 
20521/88: 
monophasic 
monophasic (E) 
monophasic (Knight et al., 1992) 
monophasic 
monophasic 
monophasic 
Abbreviations: (F), focally biphasic; (E), epithelial 
DISCUSSION 
Our present results indicate that two distinct breakpoints on the short arm of the human X 
chromosome may occur in t(X;18)(pll.2;qll.2)-positive synovial sarcomas (Fig. 86). This 
observation confirms earlier seemingly contradictory reports made by us (De Leeuw et al., 1993a, 
1993b) and others (Knight et al., 1992) and rules out the possibility of technical artifacts due to 
different experimental procedures applied in the different laboratories. So far, seven cases have 
been identified with a break in the OATL1 and six cases with a break near the OATL2 region. 
Both OAT-corresponding YACs (#2 and /C7, respectively) have been tested on the tumors 
reported, except for the cases ST-91-01731 and T92/12236 (Knight et al., 1992; De Leeuw et al., 
1993b; this paper). 
It is tempting to try to correlate the two breakpoint regions with the two histologic 
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phenotypes that have been described for synovial sarcoma: the monophasic and the biphasic 
subtypes. Our analyses clearly indicate that all five tumors of the biphasic subtype (total biphasic 
or focal) display a break in the OATL1 region. The only case that may deviate from this finding 
is the monophasic epithelial tumor T92-12236, which is considered to be an extreme form of 
biphasic synovial sarcoma. However, this tumor may well represent yet another subtype. Two out 
of eight tumors that were diagnosed as monophasic synovial sarcomas exhibit a break in the 
OATL1 region (ST-91-01731, 2374/90), whereas in all other cases a break in the OATL2 region 
could be revealed. It is possible, however, that these two exceptional cases may in fact represent 
focally biphasic tumors with a very small epithelial fraction that was overlooked at the time of 
diagnosis. Alternatively, as tumor phenotypes may differ in a graded fashion, these cases could 
represent true monophasic tumors exhibiting relatively high levels of epithelial characteristics. 
Taking these considerations and results together, there appears to be a clear predominance of 
OATLl-related breaks in the biphasic tumors and of OATL2-related breaks in the monophasic 
types. Such a correlation suggests that distinct chromosomal breakpoints at the molecular level 
may result in differences in tumor characteristics at the histologic level. Obviously, there may also 
be other as yet undefined factors that could play a predominant role in determining the final tumor 
phenotype. Careful investigation of additional tumor material is required to either confirm or rule 
out each of these possibilities. In this respect, it is of relevance to note that such analyses can now 
be carried out on archival (frozen) tissues, as has been demonstrated in this report. Thus, in this 
way the amount of tumor material potentially accessible for breakpoint analysis has expanded 
considerably. 
The OATL1 and OATL2 regions on the X chromosome have a number of characteristics in 
common (Lafrenière et al., 1991), which suggests that these regions may have evolved from each 
other during evolution. This also could mean that the sequences involved in the different 
translocations may have some characteristics in common. Once these sequences are identified in 
further detail, comparisons at the molecular level may reveal clues about their significance and 
possible roles in the establishment of differences in histologic tumor phenotypes. 
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ABSTRACT 
Recently, a specific chromosome abnormality, t(X;l)(pll;q21), was described for a 
subgroup of human papillary renal cell carcinomas. The translocation breakpoint in Xpll is 
located in the same region as that in t(X;18)(pll;qll)-positive synovial sarcoma. We use 
fluorescence in situ hybridization (FISH) and somatic cell hybridization techniques to demonstrate 
1) that the Xpll translocation breakpoint in papillary renal cell carcinoma differs from that 
observed in synovial sarcoma and has a more proximal location, and 2) that an ornithine 
aminotransferase (OAT)L2 containing yeast artificial chromosome (YAC) spans the X;l 
translocation. This YAC provides an ideal starting point from which the breakpoint itself and the 
gene(s) involved can be isolated and characterized. 
Figures 88 and 89 are represented on Color Plate IV. 
157 
INTRODUCTION 
Renal cell carcinomas represent 85% of all primary renal tumors (Dickersin and Colvin, 
1988). Histogenetically, these carcinomas can be subdivided into two major groups: papillary and 
nonpapillary tumors. Renal cell carcinomas generally are sporadic, but familial cases have been 
reported (Meloni et al., 1992). All of these familial cases have chromosome 3 anomalies in 
common, suggesting a primary role for this chromosome in renal cancer causation, particularly 
the nonpapillary type. This notion has now been firmly established by molecular analysis of tumor 
material in both familial and sporadic cases, but the critical chromosome 3 sequences involved in 
this group of tumors have not yet been identified completely (Van der Hout et al., 1988; 
Yamakawa et al., 1992). At the cytogenetic level, the papillary renal cell carcinomas differ 
distinctly from the nonpapillary tumors in that they do not involve chromosome 3. 
Numerical abnormalities also are common in the various subtypes of renal tumors, 
particularly +7 and +10. Recently, however, several groups of investigators reported that these 
aneuploidies may also be observed in surrounding (normal) kidney tissue and, as such, may not be 
tumor specific (Casalone et al., 1992; Emanuel et al., 1992). In addition, Dal Cin et al. (1992) 
demonstrated that the observed trisomies may be a characteristic of infiltrating inflammatory (T) 
lymphocytes. 
In 1986 De Jong et al. reported a case of trabecular papillary renal adenocarcinoma in a 
two-year-old boy. The tumor cells were characterized by a unique cytogenetic abnormality 
involving chromosomes X and 1. That this t(X;l)(pll;q21) may actually characterize a subtype of 
renal tumors with papillary features arose from the observation of several additional cases with the 
same translocation, sometimes as the sole anomaly (Fig. 87) (Meloni et al., 1993). This 
cytogenetic abnormality has not been described in any malignant disorder other than renal tumors 
with papillary characteristics and, as such, should be considered a specific primary change. 
Occurrence of a very similar breakpoint in band Xpll was previously reported in t(X; 18)-positive 
synovial sarcomas (Turc-Carel et al., 1987) and more recently in two cases of renal cell 
carcinoma with a t(X;17)(pll;q23) and a t(X;l)(pll;p34), respectively (Yoshida et al., 1985; 
Tomlinson et al., 1991). In a previous study, using a combination of somatic cell hybrids and 
fluorescence in situ hybridization (FISH), we noted that the Xpll breakpoint in synovial sarcomas 
maps within the ornithine aminotransferase (0AT)L1 cluster (De Leeuw et al., 1993a, 1993b). 
Using similar techniques, we have now identified a yeast artificial chromosome (YAC) clone that 
spans the papillary renal cell carcinoma-associated t(X;l) breakpoint. In addition, our results 
define the relative positions of the different tumor-specific breakpoints in Xpll and may 
contribute to the physical ordering of DNA markers in the proximal Xp region. 
MATERIALS AND METHODS 
Tumor material and somatic celi hybrids 
Two primary papillary renal cell carcinoma cultures (CL-89-12117 and CL-89-17872) were 
used in the present study. In CL-89-12117 the characteristic t(X;l)(pll;q21) was present as the 
sole cytogenetic anomaly, whereas in the second tumor some numerical changes were observed in 
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Figure 87 GTG-banded karyotype of the renal tumor CL-89-12117 exhibiting the characteristic 
t(X;l)(pll;q21). 
addition to the X;l translocation (Meloni et al., 1993). Both tumors have been maintained in 
culture for more then ten passages, and their cytogenetic constitution appears to be stable. 
Tumor CL-89-12117 was used for fusion with the Chinese hamster cell lines A3 (thymidine 
kinase deficient) and Wg3-h (hypoxanthine phosphoribosyltransferase deficient). This fusion 
resulted in a panel of somatic cell hybrids in which the translocation chromosomes segregate. For 
our present study we selected one hybrid cell line (WgRe5) that has retained the der(X) in absence 
of other (normal) chromosomes X or 1 material. Fusion and hybrid selection procedures 
essentially were those reported before, using Sendai virus as fusogen and a combined 
HAT/ouabain protocol for hybrid selection (Geurts van Kessel et al., 1983). 
The isolation of the hybrid cell line Hlsynsarc, after fusion of t(X;18)(pll;qll)-positive 
synovial sarcoma cells with the Chinese hamster cell line CH3S, was reported previously 
(Gilgenkrantz et al., 1990). This cell line has retained the X-derivative of the translocation in the 
absence of a normal X or 18. As reference, a hybrid cell line (578) containing a complete X 
chromosome as its sole human constituent was used (Wieacker et al., 1984). The chromosomal 
constitution of the somatic cell hybrids was evaluated by cytogenetic analysis with R-banding after 
heat denaturation and by FISH with a combination of centromere specific probes and whole 
chromosome paints (De Leeuw et al., 1993a, 1993b). 
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FISH 
All FISH procedures used were essentially as described previously (Suijkerbuijk et al., 
1991, 1992a). Probes were labeled with biotin-14-dATP (GIBCO-BRL Life Technologies, 
Gaithersburg, MD) or digoxigenin-11-dUTP (Boehringer Mannheim, Germany) by standard nick-
translation according to the manufacturers' protocols. The labeled DNA was purified through a 
Sephadex G50 spin column and precipitated in the presence of sonicated herring sperm DNA (50-
fold). Then, for each incubation, a mixture of 200 ng YAC probe DNA and 10/ig sonicated total 
human DNA was coprecipitated and subsequently dissolved in 10 μΐ of a hybridization solution 
(50% v/v deionized formamide, 10% w/v dextrane sulphate, 2 χ SSC, 1% v/v Tween-20, pH 
7.0). Before hybridization, the probe was denatured at 80°С for 10 min, chilled on ice, and 
incubated at 37°C for 4 hrs allowing preannealing. For centromeric probes and chromosome 
libraries, no preannealing and preannealing for 20 min (the latter in the presence of 50 fold Q/.l 
DNA: GIBCO-BRL) were performed, and the probe concentrations were 20 ng and 100 ng per 
reaction, respectively. Metaphase spreads were prepared by standard procedures. Before 
hybridization, the slides were pretreated with RNase A (100 μg/ml in 2 χ SSC at 37°C for 1 h). 
Subsequently, the slides were denatured in 70% formamide, 2 χ SSC (final pH 7.0) at 70°C for 
2-3 min and incubated with the probes under an 18xl8-mm coverslip in a moist chamber for 1-3 
days. 
Immunocytochemical detection of the hybridizing probes was achieved using FITC-
conjugated avidin (Vector laboratories, Burlingame, CA) followed by an amplification step using 
biotinylated goat anti-avidin (Vector laboratories) and another FITC-avidin step (Pinkel et al., 
1986, 1988) for biotinylated probes or rhodamin-conjugated sheep anti-digoxigenin (Boehringer 
Mannheim) and amplification with Texas Red-conjugated rabbit anti-sheep (Jackson 
Immunoresearch Laboratories, West Grove, PA) for digoxigenin-labeled probes. The slides were 
mounted in antifade medium (1.4% w/v di-azobicyclo-(2,2,2)-octane: DABCO, Merck, 
Darmstadt, Germany) containing 4,6-diamino-2-phenylindole (DAPI, 0.5 /tg/ml: Sigma, St. Louis, 
MO) or propidium iodide (0.5 μg/ml: Sigma) for chromosome counterstaining. 
Chromosomes were studied under a Zeiss Axiophot epifluorescence microscope equipped 
with appropriate filters. Digital images were recorded using a Photometries high-performance 
CH250/A cooled CCD-camera (Photometries, Tucson, AZ) interfaced to a Macintosh Ilei 
computer, using the image-analysis and -processing program BDS-image (Biological Detection 
Systems Inc., Rockville, MD). 
Southern blot analysis 
DNAs of hybrid and parental cell lines were isolated according to procedures described by 
Jeffreys and Flavell (1977), digested to completion with restriction endonucleases (Life 
Technologies) and, after agarose gel electrophoresis, blotted onto Genesereen Plus membranes 
(Dupont) using standard protocols. Subsequently, the blots were hybridized with the cDNA probe 
Huoat-6 Gabeled by random-priming) (Feinberg and Vogelstein, 1984) in 0.5 M P0 4, ImM 
Na^DTA, and 7% sodium dodecyl sulfate (SDS, v/v) at 65°C overnight, washed in 40 mM and 
10 mM P04 > 0.1% SDS at 65°C and exposed to X ray films for 1-3 days at -80°C using 
intensifier screens as described previously (De Leeuw et al., 1993a). 
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RESULTS AND DISCUSSION 
Xpll.24inked DNA marters and their localization 
Previously, we reported a most likely probe order in the Xpll.2 region based on both 
literature data (HGM, 1991) and our own analysis of a panel of radiation-reduced cell hybrids 
(Berger et al., 1992). Subsequently, this information was used to map the synovial sarcoma-
associated t(X;18) breakpoint between the markers ΉΜΡ and DXS266 (De Leeuw et al., 1993). 
This same region was believed to contain the ornithine aminotransferase-like 1 (OATL1) cluster 
(Ramesh et al., 1987; Lafrenière et al., 1991; Berger et al., 1992), further breakpoint analysis 
showed that this cluster is split as a result of the translocation. All known sequences contained 
within a second OAT-like (OATL2) cluster appeared to be located proximal to the t(X; 18) 
breakpoint on Xp. Analysis of OATL1- and OATL2-specific YACs and cosmids on primary 
tumor material using both FISH and Southern blotting techniques confirmed and substantiated 
these preliminary observations (De Leeuw et al., 1993b). This mapping information on the 
proximal Xp arm is used and extended further in the present analysis of a cytogenetically similar 
breakpoint in Xpll.2 specifically observed in a subgroup of renal cell adenocarcinomas, i.e., 
papillary renal cell carcinoma (Meloni et al., 1993). 
Analysis of OAT-specific YACs on t(X;l)-positive papillary renal cell carcinomas 
Essentially, two OAT-specific YACs, one corresponding to the OATL1 (YAC#2; insert size 
550 kb)- and the other corresponding to the OATL2 (YAC#7; insert size 600 kb)-cluster on the 
human X chromosome, were used. These two YACs were selected from a larger pool of OAT-
containing YACs (Larin et al., 1991) based on their correct and respective localization on Xp and 
their lack of (cross-)hybridization to other human chromosomes. The latter phenomenon is 
frequently observed and is usually due to the chimaeric nature of the YAC concerned (De Leeuw 
et al., 1993a). Metaphase spreads of the t(X;l)-positive papillary renal cell carcinomas CL-89-
12117 and CL-89-17872 were analyzed with YACs #2 and #7 in conjunction with FISH, 
according to methods described previously (De Leeuw et al., 1993a, 1993b). As shown in Figure 
88, all sequences contained within YAC#2 (i.e., OATL1) are translocated to the 
der(l)t(X;l)(pll;q21) in tumor CL-89-12117. In contrast, YAC#7 (containing OATL2) displays 
hybridization signals on both the der(l) and der(X) of the translocation (Fig. 89), indicating that 
human sequences contained within YAC#7 are split as a result of the (X;I) translocation. Identical 
results were obtained with the second tumor (CL-89-17872; not shown). These findings are in full 
accordance with the above OATL1 results and also are in agreement with the known, more 
proximal localization of OATL2 on Xp (Lafrenière et al., 1991). In addition, these observations 
indicate that the OAT-specific YACs #2 and #7 do not show cross-hybridization among each other 
or with other chromosomal regions under the stringency conditions applied in our FISH 
experiments. The validity of these FISH results with the OATL2 YAC was tested further using a 
set of different cosmid clones derived from YAC#7 (full details of YAC subcloning into cosmids 
will be published elsewhere). Our initial results indicate that some of these cosmids map distal, 
whereas others map proximal to the t(X;l) breakpoint (not shown). These latter findings are in 
accordance with the above notion that human sequences in YAC#7 are split as a result of the 
tumor-specific chromosome translocation. 
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Figure 90 Southern blot containing Hindlll digested Chinese hamster (HAM), X-only hybrid 578 
(X-tot), der(X)-containing synovial sarcoma-derived hybrid Hlsynsarc (X;18) and der(X)-
containing papillary renal cell carcinoma-derived hybrid WgRe5 (X;l) DNAs, hybridized to 
cDNA probe Huoat6. 1, OATL1-specific; 2, OATL2-specific; and H, hamster-specific fragments. 
OATL1-specific bands partly or completely absent in (X;18) and (X;l), respectively, are marked 
by arrows. 
Localization of the t(X;l) breakpoint relative to the OATL2 cluster 
To establish further the exact position of the t(X;l) breakpoint relative to the OATL2 
sequences on Xp, a panel of somatic cell hybrids was generated via fusion of CL-89-12117 tumor 
cells with the Chinese hamster cell lines A3 and Wg3-h. These cell hybrids were characterized 
using both cytogenetic (R-banding) analysis of metaphase spreads and FISH with chromosome X-
and 1-specific centromeric probes and whole chromosome libraries ("paints"; not shown). As a 
result, one hybrid (WgRe5) was selected for our present analysis. This hybrid has retained a 
der(X) and, in addition, 3-4 other human chromosomes. DNA was extracted from this hybrid and 
from another cell hybrid (578) containing an intact X chromosome as the sole human component, 
and from the parental hamster cell line Wg3-h. For comparison, hybrid cell line Hlsynsarc, 
containing the synovial sarcoma-associated der(X)t(X;18)(pll.2;qll.2) [13,17], was used. The 
different DNAs were cleaved with Hindlll and subjected to Southern blotting. The resulting blot 
was hybridized to the human OAT-specific cDNA probe Huoat-6 (Mitchell et al., 1988; De 
Leeuw et al., 1993a). As shown in Figure 90, a number of hybridizing bands are detected by 
Huoat-6 corresponding to both the OATL1 (marked by 1) and OATL2 (marked by 2) clusters. 
Some of the bands (marked by 1.2) co-migrate. A Chinese hamster cross-hybridizing fragment 
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also is apparent (marked by H). All these bands are present in the control hybrid cell line 578, as 
expected. In Hlsynsarc, with the der(X)t(X;18)(pll;ql 1), some of the OATL1-specifics bands are 
present and others are absent (Figure 90), exactly as reported previously (De Leeuw et al., 
1993a). In the hybrid WgRe5 [containing the der(X)t(X;l)(pll;q21)], however, all OATL1-
specific fragments are absent (arrows). This result is also in complete accordance with the FISH 
experiments using YAC#2 (described herein) and indicates that in papillary renal cell carcinomas 
the breakpoint is proximal to OATL1. In contrast, all OATL2-specific fragments, as revealed by 
Huoat-6, are still present in WgReS, indicating that the breakpoint maps distal to the OATL2 
cluster on Xp. 
Our results indicate that the papillary renal cell carcinoma-associated t(X;l) breakpoint in 
Xpll.2 differs from the one we previously identified in t(X;18)(pll;qll)-positive synovial 
sarcoma and that it has a more proximal localization. Recently, however, Knight et al. (1992) 
reported that in their synovial sarcoma material the breakpoint could be mapped just 
centromerically to the OATL2 cluster on Xp. These apparently conflicting results may indicate 
that two different breakpoints in Xpll.2 exist in synovial sarcoma. If so, these breakpoints may 
involve related sequences present in both the OATL1 and OATL2 regions (De Leeuw et al., 
1993b). The breakpoint we describe here for papillary renal cell carcinomas also differs from the 
second possible synovial sarcoma-associated breakpoint: in t(X;l)-positive cells the break occurs 
telomerically to the OATL2 cluster. Further analysis of the available breakpoint-spanning YACs 
in both tumor types and molecular characterization of the breakpoints will eventually elucidate the 
gene(s) involved and their possible interrelationship(s) and role(s) in the process of neoplastic 
transformation in these two different tumors. 
Whether other renal cell carcinoma-associated breakpoints, such as t(X;17)(pll;q23) and 
t(X;l)(pll;p34) (Yoshida et al., 1985; Tomlinson et al., 1991), are identical to or different from 
that observed in the standard t(X;l)(pll;q21) and whether the respective breakpoint positions may 
have consequences in the clinical behavior of the corresponding tumors is not yet known. With 
identification of YAC#7, we now have the tools available to perform such studies. 
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GENERAL DISCUSSION AND FUTURE PERSPECTIVES 
Overrepresentation of 12p sequences in testicular germ cell tumors 
FISH analysis of a series of human testicular germ cell tumors (TGCTs) revealed the 
presence of a specific duplication of the short arm of chromosome 12, i(12p), and, less frequently, 
of other chromosomal rearrangements involving 12p (Chapters 3.3-3.5; Atkin and Baker, 1982, 
1983; De Jong et al., 1990; Sandberg et al., 1990). The i(12p) chromosome most likely originates 
from a "horizontal" division of the centromere rather than from a translocation or non-sister 
chromatid exchange as suggested by Mukherjee et al. (1991) (Chapter 3.6). Multiple copies of the 
chromosome 12 short arm were found to be present in all tumors examined, suggesting that in 
i(12p)-positive and (the smaller group of) so-called i(12p)-negative TGCTs common mechanisms 
may lead to malignancy (Chapter 3.5; see also Castedo et al., 1989a; Rodriguez et al., 1993). The 
consistent overrepresentation of the almost entire 12p-arm in (gonadal and extragonadal) GCTs 
suggests that several genes on 12p may contribute to tumor development (see also Castedo et al., 
1988). The apparent clonal evolution of one of the 12p+ marker chromosomes, as described in 
Chapter 3.5, lends further support to this hypothesis. Very likely, the i(12p) chromosome 
represents a secondary chromosomal change (see Heim and Mitelman, 1992), since the formation 
of this anomaly appears to be preceded by an aneuploidization event (Chapter 3.2; Geurts van 
Kessel et al., 1989; De Jong et al., 1990). Still, this marker shows a high degree of tumor-
specificity, since its occurrence in malignancies other than germ cell tumors has been reported in a 
few isolated cases only (Van der Riet-Fox et al., 1979; Oosterhuis et al., 1989b; Rodriguez et al., 
1990; Sreekantaiah et al., 1992). In former cytogenetic studies (Delozier-Blanchet et al. 1987; 
Castedo et al. 1989b; Bosl et al. 1989) it has been suggested that the occurrence of i(12p) may be 
associated with tumor progression and that elevated copy numbers may lead to increased 
resistance to therapy. These suggestions are in agreement with our data (Chapter 3.5). De Jong 
and coworkers (1990) postulated that the development of chromosomal rearrangements like i(12p) 
may involve the deregulation of (onco)gene(s). The (exceptional) finding of amplification of a 
specified subregion on 12p in a metastasis of an i(12p)-negative seminoma (Chapter 3.7) indicates 
that this particular 12p-segment may harbor at least one of such genes, since genomic 
amplification occurring during solid tumor progression usually involves proto-oncogenes (Brison, 
1993). To substantiate and confirm these suggestions, additional experiments are needed such as 
mutation- and expression (i.e., mRNA or protein) analyses of candidate genes within the 
12pll.22-pl2.1 region. In this context, the parathyroid hormone-related hormone (PTHLH) gene 
(Mangin et al., 1989) may be an obvious candidate (see Chapter 3.7). 
Alternatively, the application of Micro-FISH techniques (Meltzer et al., 1992), starting from 
the isolation of the 12pll.22-pl2.1 region on the 12p+ marker chromosome described in Chapter 
3.7, may allow a more accurate characterization of this specific chromosome segment which is 
possibly involved in other TGCTs. In addition, regional targeting of 12p abnormalities in i(12p)-
negative TGCTs by multicolor FISH using a panel of differently labeled region-specific 12p-
probes (Chapter 2.3; Paulien et al., 1991; Takahashi et al., 1993; Montgomery et al., 1993) in 
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order to create a multicolor chromosomal "bar code" of 12p (see Lengauer et al., 1993; Popp et 
al., 1993) may yet be another way to identify relevant chromosome segments. Since the 
development of TGCTs seems to result from complex karyotypic changes including over- and 
underrepresentation of (whole) chromosomes (7, 8, 12 and 12, and 11, 13 and 18, respectively: 
De Jong et al., 1990), a comprehensive screening of total genomic tumor DNAs may yield 
additional information. For this purpose, comparative genomic hybridization analyses (CGH; see 
Chapters 2.1, 3.7, 4.4; Kallioniemi et al., 1992; Du Manoir et al., 1993) between carcinoma-in-
situ (CIS, as preinvasive precursor stage of TGCTs: Skakkebxk et al., 1987) and seminomas, 
between seminomas (as intermediate stage in the development towards nonseminomas: Damjanov 
et al., 1991, 1993) and nonseminomas (which are more aggressive than seminomas: De Jong et 
al., 1990) and between primary tumors and their metastases, should be particularly revealing (see 
also Chapter 2.1). Since these tumor types are developmentally related, such an approach should 
lead to the identification of a number of novel genomic regions containing genes that are 
important for TGCT initiation and/or progression. 
Consistent participation of two distinct chromosome 12q-derived amplicons in supernumerary 
marker chromosomes of well-differentiated liposarcomas 
Combined chromosome painting (Chapters 4.2 and 4.3) and comparative genomic 
hybridization (Chapter 4.4) analyses have, for the first time, revealed the occurrence of two 12q-
derived amplification units (i.e., 12ql4-ql5 and 12q21.3-q22) as the molecular-cytogenetic 
hallmark of human well-differentiated liposarcomas (WDLPS) (Karakousis et al., 1987; 
Sreekantaiah et al., 1992b). Also at the genomic level, some clarity has been achieved about a 
possible mechanistic relationship between WDLPS and myxoid liposarcoma (MLPS) development. 
These latter tumors usually display a t(12;16)(ql3.3)(pll.2) translocation which results in 
rearrangement of the CHOP gene (Aman et al., 1993). Since this gene does not reside within 
either one of the two WDLPS-associated 12q-amplicons, we suggest that different molecular 
mechanisms may be involved in these (histologically related) tumors. The genomic situation, 
however, is far from being clear. Region 12ql3-ql5 contains several cancer-relevant candidate 
genes of which two (GLI, A2MR) map proximal from the CHOP gene which renders their 
involvement unlikely. Two other genes, MDM2 (Oliner et al., 1992) and SAS (Meltzer et al., 
1991), are located within the 12ql4-ql5 region and were found to be co-amplified in 6 out of 6 
WDLPS studied (Chapter 4.3). The MDM2 gene is known to act as a negative regulator of the 
p53 tumor suppressor gene, and overexpression of the MDM2 gene via e.g. amplification may 
result in p53 inactivation in tumors in which the p53 gene itself appears to be normal (Oliner et 
al., 1992; Momand et al., 1992). In fact, the MDM2 gene (mouse-double-minute) has been found 
to be amplified in a variety of human sarcomas and in some other tumors (Oliner et al., 1992; 
Forus et al., 1993; Ladanyi et al., 1993; Reifenberger et al., 1993). The SAS gene (sarcoma-
amplifìed-sequence: Meltzer et al., 1991), located in the same segment, was found to be amplified 
in a high proportion of human malignant fibrohistiocytomas (Meltzer et al., 1991; Smith et al., 
1992) in a frequency similar to that reported for the MDM2 gene. In their samples of human 
sarcomas, Forus and coworkers found co-amplification of the two genes in more than 90% of the 
cases with amplicons (Forus et al., 1993). A similar phenomenon was observed in all of our 
WDLPS samples (Chapter 4.3). Since the two genes are separated by a distance of at least 500 
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kbp (Craig et al., 1992), it has been suggested that the selective target for these ampi ¡cons in 
human sarcomas may be an, as yet, unidentified gene localized in between SAS and MDM2. Initial 
CGH studies on bone- and soft tissue tumors other than WDLPS (e.g., parosteal osteosarcomas, 
hemangiopericytomas, fibrosarcomas, rhabdomyosarcomas) have revealed amplification of a 
12ql4-ql5 segment similar to that observed in WDLPS, whereas the 12q21.3-q22 region was not 
involved (unpublished observations). This may indicate that 12q21.3-q22 amplification is restricted 
to and thus may be specific for WDLPS while 12ql4-ql5 amplification represents a more general 
characteristic of soft tissue tumors. Obviously, the importance of these preliminary findings in the 
context of pathogenetic interrelationships and their significance in tumor development itself need 
to be substantiated further. 
In addition, our FISH and CGH findings on WDLPS (see Chapters 4.3-4.4) have raised a 
number of questions about the relevance of other chromosomal regions that appear to participate 
in the genetic constitution of giant ring and rod-shaped marker chromosomes. Do they represent 
non-coincidental features of WDLPS or, alternatively, mere random DNA amplifications resulting 
from genetic instability? The CGH data on one of our WDLPS cases show specific amplification 
of the two 12q-derived amplicons (see above) only (Chapter 4.4), indicating that involvement of 
sequences from other chromosomes may not be crucial. The identification of an additional 10pl4-
derived ampi icon in 4 out of 12 cases (unpublished results) may be relevant, but the significance 
of this finding is not yet clear. In most tumors non-recurrent amplicons have been observed, some 
of which map at the very end of chromosomes and, therefore, may contain telomeric sequences. It 
is obvious that additional CGH, FISH and other molecular-cytogenetic analyses on many more 
cases with well-documented pathological features are needed to shed more light on these different 
matters. 
Xpll.2 breakpoints in synovial sarcomas and papillary renal cell carcinomas 
FISH studies using region-specific yeast artificial chromosomes (YACs) have indicated that 
both the synovia] sarcoma (SS)-associated t(X;18)(pll.2;qll.2) (Turc-Carel et al., 1987) and 
papillary renal cell carcinoma (PRCC)-associated t(X;l)(pll.2;q21) (Meloni et al., 1993) 
breakpoints in Xpll.2 involve distinct genomic regions (Chapters 4.5-4.6). Moreover, the 
occurrence of two different SS-associated Xpll.2 breakpoints (OATL1- and OATL2-related; see 
Lafrenière et al., 1991) was found to be correlated with the histologic characteristics that 
distinguish these tumors (biphasic and monophasic, respectively) (Chapter 4.6; also Janz and de 
Leeuw, unpublished observations). So, the tumor-associated breakpoint-map in Xpll.2 as revealed 
by FISH reads as follows: Xpter - SS2 (OATL1) - PRCC - SSI (OATL2) - Xcen. The 
identification of YACs that span these Xpll.2 breakpoints offers good prospects for the detection 
and diagnostic characterization of these translocations in cytogenetically unspecified tumors by 
means of FISH. But, even more importantly, these YACs provide an ideal starting points from 
which the breakpoints can be isolated and the gene(s) involved can be characterized. Indeed, this 
approach has very recently resulted in the isolation of the SS-associated t(X;18)(pl 1.2;ql 1.2) 
breakpoint fragment from the OATL1 cluster region (De Leeuw et al., 1994), and preliminary 
molecular data on the 18qll.2 breakpoint region suggests that, in contrast to findings on the X 
chromosome, a single locus on chromosome 18 may be involved in the development of different 
histologic (sub)types of synovial sarcoma (De Leeuw et al., 1994). It may be expected that 
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translocation of this locus to the X chromosome is crucial in the genesis of synovial sarcomas and 
that juxtaposition to either one of the two breakpoint regions in Xpll.2 may define the tumor 
phenotype. Detailed characterization of the respective genomic areas should be instrumental for 
the molecular mechanisms that lead to the formation of (the different subtypes of) synovial 
sarcoma. At present, there is no sequence information on the Xpll.2 breakpoint region in 
papillary renal cell carcinomas. Interestingly, two other cytogenetic reports on renal papillary 
adenocarcinomas indicated the occurrence of structural abnormalities in Xpll, i.e., 
t(X;17)(pll;q25) (Tomlinson et al., 1991) and del(X)(pll) (Ohjimi et al., 1993), respectively. 
These results may suggest that the major gene(s) for these renal neoplasms is located in Xpll 
rather than in lql2. The availability of a YAC that spans the X;l breakpoint should, again, be 
instrumental for the elucidation of this problem. 
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CHAPTER 
6 

SUMMARY 
This thesis describes the molecular-cytogenetic analysis of human solid tumors through the 
employment of a broad scala of different fluorescence in situ hybridization (FISH) strategies. In 
Chapter 2 an overview is presented of the pro's and contra's of the use of single copy and/or 
more complex probes such as chromosome-specific (alphoid) repeats, phage or plasmid libraries, 
monochromosomal or radiation-reduced somatic cell hybrids, and flow sorted (marker) 
chromosomes for (multicolor) FISH or (reverse) "painting". In addition, the development and 
application of novel techniques such as comparative genomic in situ hybridization (CGH) and the 
combined use of chromosomal microdissection and FISH (micro-FISH) have been described. 
Unlike conventional cytogenetic methodologies, these new techniques allow the detection of 
specific DNA segments ranging in length from several kilobase pairs (kbp) up to whole 
chromosomes in both metaphase spreads and interphase nuclei (interphase cytogenetics). The 
specific aim of the studies presented in this thesis was the detection and identification of 
chromosome abnormalities in some selected tumors of urogenital (i.e., teratocarcinomas, renal cell 
carcinomas) and soft tissue (i.e., liposarcomas, synovial sarcomas) origins via FISH. 
The characterization of chromosome 12p abnormalities in human germ cell tumors 
(teratocarcinomas) is described in Chapter 3. The formation of a highly specific duplication of the 
short arm of chromosome 12, i(12p), was found to be preceded by an aneuploidization event and, 
thus, must represent a secondary step in the etiology of these tumors (Chapter 3.2). Furthermore, 
a specific "paint" for 12p was generated and used to establish the genuine isochromosome 
character of i(12p) and, in addition, to reveal the occurrence of this marker during the etiology of 
testicular germ cell tumors, TGCTs (Chapters 3.2 and 3.3). Moreover, other aberrations involving 
12p could now be identified by using this paint (Chapter 3.3). The application of bicolor double 
FISH using probes to visualize the entire length or the short arm of chromosome 12 in 
combination with a chromosome 12 centromeric probe allowed the identification and verification 
of i(12p) in GCTs of different anatomical sites (Chapter 3.4). Similarly, other (previously 
undetected) 12p abnormalities leading to a net overrepresentation of 12p sequences were 
consistently observed in so-called i(12p)-negat¡ve TGCTs (Chapter 3.5) and, to a lesser extent, in 
some i(12p)-positive TGCTs as well (Chapter 3.4). This consistent overrepresentation of 12p in 
i(12p)-negative TGCTs may, analogous to one or more copies of i(12p) in i(12p)-positive TGCTs, 
contribute to the process of TGCT development (Chapter 3.5). Molecular data demonstrating an 
uniparental origin of i(12p) and supernumerary 12p copies in i(12p)-positive and -negative TGCT-
derived cell lines are presented in Chapter 3.6. Moreover, we argue in this chapter that i(12p) 
most likely originates from a misdivision of the centromere rather than from a translocation or a 
non-sister chromatid exchange. Finally, Chapter 3.7 describes the identification and 
characterization of a subregion on the short arm of chromosome 12 which is amplified in a 
metastasis of an i(12p)-negative TGCT using region-specific probes in conjunction with FISH and 
CGH strategies. The amplification of this particular subregion (including the PTHLH gene) may 
point at genomic sequences relevant to (metastatic) progression of TGCTs. 
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Chapter 4 describes the (sub)chromosomal characterization of recurring alterations in some 
subtypes of soft tissue and renal tumors. The consistent participation of chromosome 12-derived 
sequences in supernumerary giant rod-shaped marker or ring chromosomes in well-differentiated 
liposarcomas (WDLPS) is demonstrated by FISH in Chapters 4.2 and 4.3. In addition, some other 
chromosomes were found to participate in the constitution of most of these bizarre markers. CGH 
analysis of WDLPS DNAs revealed two distinct genomic regions on the long arm of chromosome 
12, i.e., 12ql4-ql5 and 12q21.2-q22, that are consistently amplified in these tumors (Chapter 
4.4). Interestingly, co-amplification of two genes, SAS and MDM2, which both map in one of 
these regions (12ql4-ql5), was observed in the DNA of all the tumor samples examined (Chapter 
4.3). In contrast, DNA analysis did not reveal any alterations in the GADD153/CHOP gene, 
which is known to be rearranged in liposarcomas of the myxoid subtype. FISH analysis of 
synovial sarcomas, carrying a highly specific t(X;18)(pll.2;qll.2), revealed the occurrence of 
two distinct Xpll.2 breakpoint regions in different rumors (Chapter 4.5). Two yeast artificial 
chromosomes (YACs), containing distinct but related pseudogene clusters (OATL1 and OATL2) 
on Xpll.2, were found to span either one of the breakpoints. A correlation between the presence 
of these alternative breakpoints and the occurrence of major histologic characteristics of the 
tumors (biphasic versus monophasic) is hypothesized (Chapter 4.5). In conclusion, Chapter 4.6 
describes a detailed localization of the papillary renal cell carcinoma (PRCC)-associated 
t(X;l)(pll.2;q21) breakpoint in Xpll.2. Our data indicate that the OATL2-containing YAC, 
which was previously shown to overlap one of the Xpll.2 breakpoints in synovial sarcoma (see 
above), also spans the PRCC-associated t(X;l) junction region. However, it is clear that at the 
molecular level the Xpll.2 breakpoint in PRCC differs from that observed in synovial sarcoma 
(Chapter 4.6). 
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SAMENVATTING 
Dit proefschrift beschrijft de moleculair-cytogenetische analyse van humane solide tumoren 
via een breed scala van fluorescentie in si tu hybridisatie (FISH) strategieën Hoofdstuk 2 geeft een 
overzicht van de pro's en contra's van het gebruik van 'single copy' en/of complexere probes 
zoals chromosoom-specifieke (alphoide) gerepeteerde DNA sequenties, faag- of plasmide banken, 
somatische celhybriden met een enkel humaan chromosoom en daarvan afgeleide 
bestralingshybriden, en flow gesorteerde (marker) chromosomen voor (meerkleunge) FISH of 
'reverse painting' doeleinden Bovendien worden ontwikkeling en toepassing van de meest recente 
technieken, zoals de 'comparative genomic in situ hybridisation' (CGH) en de combinatie van 
chromosoom microdissectie en FISH (ook wel Micro-FISH genoemd), beschreven In tegenstelling 
tot conventionele cytogenetische methodes is het met FISH technieken mogelijk specifieke DNA 
segmenten met een lengte van enkele duizenden basenparen tot gehele chromosomen aan te tonen 
in zowel delende (metafase) als met-delende (interfase) cellen Het specifieke doel van de in dit 
proefschrift beschreven studies was het detecteren en identificeren van chromosoomafwijkingen in 
een aantal geselecteerde urogenitale (teratocarcinomen, niercel carcinomen) en weke delen 
(liposarcomen, synoviaal sarcomen) tumoren met behulp van FISH 
De karaktensatie van chromosoom 12 afwijkingen in humane kiemceltumoren 
(teratocarcinomen) wordt beschreven in Hoofdstuk 3 De vorming van een hoog specifieke 
verdubbeling van de korte (p) arm van chromosoom 12, isochromosoom 12p of i(12p), bleek 
vooraf gegaan te worden door aneuploidisatie en deze afwijking moet, dietengevolge, gezien 
worden als een secundaire stap in het ontstaansproces van deze tumoren (Hoofdstuk 3 2) 
Daarnaast werd een specifieke chromosoom 'paint' voor 12p gegenereerd en toegepast om het 
daadwerkelijke isochromosoom karakter van i(12p) vast te stellen Tevens kon het voorkomen van 
deze marker tijdens het ontstaansproces van kiemceltumoren worden geëvalueerd (Hoofdstuk 3 2 
en 3 3) en konden andere 12p afwijkingen worden geïdentificeerd (Hoofdstuk 3 3) De toepassing 
van tweekleuren FISH, voor het zichtbaar maken van het gehele chromosoom 12 of alleen de p-
arm in combinatie met het centromeer, leidde tot de identificatie van i(12p) in zowel gonadale als 
extragonadale kiemceltumoren (Hoofdstuk 3 4) In zogenaamde i(12p) negatieve kiemceltumoren 
werden op vergelijkbare wijze 12p afwijkingen waargenomen, welke steeds in een netto 
oververtegenwoordiging van 12p sequenties resulteerden (Hoofstuk 3 5) Zulke afwijkingen 
werden ook - zij het in mindere mate - in i(12p)-positieve kiemceltumoren van de testis 
waargenomen (Hoofdstuk 3 4) Deze consistente oververtegenwoordiging van 12p in i(12p)-
negatieve kiemceltumoren kan, analoog aan het voorkomen van een of meerdere copieen van 
i(12p) in i(12p)-positieve kiemceltumoren, bijdragen tot het proces van tumor ontwikkeling 
(Hoofdstuk 3 5) In Hoofdstuk 3 6 worden moleculaire gegevens gepresenteerd die aangeven dat 
de overtollige 12p armen aanwezig in i(12p)-positieve en -negatieve kiemceltumoren van een en 
hetzelfde ouderchromosoom afkomstig moeten zijn (Hoofdstuk 3 6) Bovendien wordt in dit 
hoofstuk geconcludeerd dat i(12p) hoogst waarschijnlijk ontstaat door een foutieve deling van het 
centromeer en niet door een translocatie of een met-zuster Chromatide uitwisseling Tenslotte 
wordt in Hoofstuk 3 7 de identificatie en karaktensatie van een subregio op de korte arm van 
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chromosoom 12 beschreven, welke in multipele copieën aanwezig is in cellen van een métastase 
van een ¡(12p)-negatieve kiemceltumor, zoals aangetoond met FISH en CGH. De vermeerdering 
van deze regio (welke het PTHLH gen omvat) wijst in de richting van genomische sequenties die 
van belang kunnen zijn voor progressie (metastasering) van kiemceltumoren. 
Hoofdstuk 4 beschrijft de (sub-) chromosomale karakterisatie van specifieke 
chromosoomveranderingen in enkele subtypes van weke delen- en niertumoren. De consistente 
aanwezigheid van DNA sequenties afkomstig van chromosoom 12 in staaf- en ringvormige marker 
chromosomen in goed-gedifferentieerde liposarcomen, welke konden worden aangetoond met 
behulp van FISH, is beschreven in Hoofdstuk 4.2 en 4.3. Verder werd gevonden dat een aantal 
andere chromosomen kunnen bijdragen aan de samenstelling van deze uitzonderlijke marker 
chromosomen. Analyse van verschillende tumor DNA's met behulp van de CGH techniek heeft 
geleid tot de identificatie van twee verschillende regio's op de lange arm van chromosome 12, 
12ql4-ql5 en 12q21.3-q22, welke in elk van de onderzochte tumoren in meerdere copieën 
aanwezig bleken te zijn (Hoofdstuk 4.4). Een interessant detail hierbij is dat in het DNA van alle 
onderzochte goed-gedifferentieerde liposarcomen amplificatie van twee naburig gelegen genen, 
SAS en MDM2, in een van de twee regio's (12ql4-ql5) werd waargenomen (Hoofdstuk 4.4). Dit 
in tegenstelling tot het GADD153/CHOP gen, waarvan bekend is dat het in liposarcomen van het 
myxoide type gerearrangeerd is: dit gen lijkt onaangedaan te blijven in goed-gedifferentieerde 
liposarcomen. 
FISH analyse van synoviale sarcomen, die gekenmerkt worden door een hoogspecifieke 
t(X;18)(pll.2;qll.2), leidde tot de identificatie van twee Xpll.2 breukpunt regio's in 
verschillende tumoren (Hoofdstuk 4.5). Bij twee 'yeast artificial chromosomes' (YAC's), waarvan 
bekend was dat ze verschillende, maar verwante, pseudogen clusters (respektievelijk OATL1 en 
OATL2) in Xpll.2 bevatten, werd gevonden dat ze elk over een van de twee breukpunten liggen. 
Een correlatie tussen de aanwezigheid van een van deze twee breukpunten en het voorkomen van 
de meest uitgesproken histologische kenmerken van de tumoren (namelijk monofasisch versus 
bifasisch) wordt als hypothese aangenomen (Hoofdstuk 4.5). Tenslotte wordt in Hoofdstuk 4.6 een 
gedetailleerde beschrijving gegeven van de localisata van het breukpunt in Xpll.2, zoals dat in 
papillaire niercel carcinomen met een t(X;l)(pll.2;q21) voorkomt. Onze gegevens geven aan dat 
de OATL2 bevattende YAC, waarvan eerder werd gevonden dat deze een van de Xpll.2 
breukpunten in synoviale sarcomen overlapt, ook over het Xpll.2 breukpunt in dit type niercel 
carcinomen is gelegen (Hoofdstuk 4.6). Uit verdere moleculaire analyse is overigens duidelijk 
geworden dat het Xpll.2 breukpunt in niercel carcinomen verschilt van dat in synoviale sarcomen 
(Hoofdstuk 4.6). 
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LEGENDS TO THE FIGURES ON COLOR PLATE I 
Figures 1-6 
Chromosomal paints using flow-sorted chromosomes 5 (1), flow-sorted chromosomes 6 (2), chromosome 6-
specific library pBS-6 (3), flow-sorted chromosomes 14 (4), chromosome 14-only hybrid WEGROTH-B3 (5), 
and chromosome 14-specific library pBS-14 (6). 
Figures 7-9 
Chromosome paints using flow-sorted del(ll)(q22-q23) chromosomes (7), der(22) t(ll;22)(q23;qll) 
chromosomes (8), and der(9)t(9;22)(q34;qll) chromosomes (9). In (7) the deletion is marked by arrows; in 
(8) positively staining # 1 1 and # 22 regions are indicated by arrows and arrowheads, respectively; in (9) 
positively staining U 9 and К 22 regions are indicated by arrows and arrowheads, respectively; in addition, 
asterisks in (9) mark cross-hybridizing copies of tt 19. 
Figures 11-14 Localization of human fragments present in the WgM hybrids on human chromosome 12 
using Alu element-mediated PCR (BK33) products as probes for chromosome painting. (11): WgM6B, (12): 
WgM8B, (13): WgM22C, and (14): WgM28.1. Signals arc shown in yellow; R-banded human chromosomes 
are shown in red. Images were made using con focal laser-scanning microscopy. 
Figure 19 Visualization of the Pallister-ICillian-derived i(12p) chromosome in hybrid cell line M28 (Zhang 
et al., 1989). Hybridization was carried out using biotin-labeled total human DNA. The i(12p) marker is 
present as the only human chromosome in multiple copies (arrows). 
Figures 20-23 
Results from C1SH experiments using biotin labeled DNA from two monochromosomal rodent-human 
somatic cell hybrids, specific for chromosome 12 (PK-89-12) and chromosome 12p (M28), as probes on 
metaphase spreads of TGCTs and TGCT-denved cell lines Chromosomal regions hybridized with either one 
of these probes were visualized with the fluorochrome FITC, resulting in a green/yellow fluorescent staining 
of these regions Counterstaining of the chromosomes was performed with PI (20, 21) or DAPI (22, 23), 
resulting in a red or blue staining, respectively (20) In situ hybridization of PK-89-12 DNA to a metaphase 
spread of a TGCT (a primary non-seminomatous TGCT), showing complete fluorescent staining of three 
copies of chromosome 12 (arrows) and four markers most likely representing iso-12p marker chromosomes 
(arrowheads) (21) In situ hybridization of PK 89-12 DNA to a preparation of a TGCT (a residual mature 
teratoma following chemotherapy) The metaphase spread displays three copies of chromosome 12 (arrows) 
and two markers one marker resembles an iso 12p chromosome (arrowhead) and the other marker is a 
translocation chromosome in which, probably, a 12p arm is involved (small arrow) (22) In situ 
hybridization of M28 DNA to a preparation of a TGCT-denved cell line (NT2/D1) The metaphase spread 
most likely displays three copies of chromosome 12, identifiable by their positively staining short arms 
(arrows) Furthermore, two iso 12p marker chromosomes are clearly recognizable (arrowheads) (23) In situ 
hybridization of M28 DNA to a metaphase spread of a TGCT-denved cell line (Scha 1) Three copies, most 
likely of chromosome 12, identifiable by their positively staining short arms (arrows), and two marker 
chromosomes - both translocation chromosomes - can easily be distinguished The small, metacentnc 
translocation chromosome (small arrow) contains only one positively staining arm The large translocation 
chromosome possesses a centrally located, positively staining, region (arrowhead) 
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LEGENDS TO THE FIGURES ON COLOR PLATE II 
Figures 25-27 Fluorescence in situ hybridization (FISH) patterns of chromosome 12 centromere-specific 
alphoid probe pa l2H8 (25), chromosome 12-specific library pBS-12 (26) and chromosome 12p-specific paint 
M28 (27) on normal human lymphocyte spreads (yellow-green signals). For constrast, DAPI counterstaining 
(blue) was performed. 
Figures 28-39 Results of bicolor double FISH using either pa l2H8 and pBS-12 (28, 31, 34, 37) or pa l2H8 
and M28 (29, 32, 35, 38) as probes on four different germ cell tumors, and their respective partial 
karyotypes: Ma-90 (28-30), KDK (31-33), Germa-1 (34-36), and Scha-1 (37-39) In FISH results, copies of 
chromosome 12 and of i(12p) are indicated by arrows and arrowheads respectively, whereas m(l-5) are the 
marker chromosomes as described in the text In the partial karyotypes, normal copies of chromosome 12 
and the different chromosome 12-denved markers are represented. 
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LEGENDS TO THE FIGURES ON COLOR PLATE III 
Figures 41 and 42 Results of multicolor FISH using the chromosome 12 centromere-specific alphoid repeat 
p a l 2 H 8 (red) and the 12p-specific "paint' M28 (green) as probes on metaphase spreads of i(12p)-negative 
TGCTs (41) Case 10 derived cell line luj showing three copies of a normal chromosome 12 (arrows) and 
three marker chromosomes (marl 3) containing 12p-positive material, (42) case 1 with, besides three copies 
of a normal chromosome 12 (arrows), two 12p positive chromosomes (marl-2) of which marl has been 
enlarged (insert) See Table 6 and text for full description of chromosome 12 abnormalities 
Figures 43-47 
Presentation of five different stages (1-5, corresponding to 43-47) of the cytogenetically defined add(12)(pl3) 
chromosome of case 5 (see Table 5), illustrating the presumed karyotypic evolution of this chromosome 
Chromosome 12-specific cenlromenc and ρ arm sequences are visible in red and green, respectively Arrows 
indicate the 12pll-»12pl3 orientation of the 12p-sequences in this chromosome The occurrence of the 
different karyotypic stages (1 5) in the tumor cell population was 6%, 10%, 42%, 35% and 1%, 
respectively, in the remaining 6% of the cells only an extra copy of a normal chromosome 12 was present 
(N=331) 
Figures 48 and 49 
Premature chromatid separation (PCS) of sister chromatids of a normal chromosome 12 in case 9, revealed 
by FISH using p a l 2 H 8 and chromosome 12 specific library pBS-12 as probes 
(48) Selected part of an informative metaphase spread (chromosome 12 in green, centromere in red), (49) 
Magnification of another PCS of chromosome 12 (red/orange), in which the 'kinelochonc bridge" (see text) 
is indicated by arrows (alphoid sequences in green) 
Figures 55-60. 
Results from fluorescence m situ hybridization (FISH) and comparative genomic hybridization (CGH) 
analyses (55) Chromosome 12-specific library pBS 12 (green) and 12 cenlromenc probe p a l 2 H 8 (red) 
hybridized onto a tumor-denved metaphase spread, revealing two copies of a normal chromosome 12 
(arrows), the add(17) chromosome (small arrow), and the add(12) chromosome (arrowhead) (see text) 
Chromosomes show blue counterstainmg The respective chromosomes are similarly indicated in Figs 56 
and 57 (56) Hybridization pattern of 12p specific paint M28 (green) and p a l 2 H 8 (red) In this figure only 
one normal chromosome 12 is present (57) Hybridization pattern of YAC 5 (mapped in 12pll 2-12 1) on 
metaphase chromosomes, visible in yellow Note that the add(17) chromosome shows three regions of 
hybridization (small arrow), whereas the add(12) chromosome displays multiple hybridization sites 
(arrowhead) For contrast, chromosomes are shown in red pseudocolor (also in Fig 58) (58) Interphase 
nuclei of the tumor hybridized with YAC 5 showing multiple hybridization signals Approximately, 25 35 
double spots (each representing one hybridization locus) can be observed per area (59) Representative result 
from comparative genomic m situ hybridization with differently labeled tumor (red) and reference tumor 
DNA (69,XXY, yellow) onto a normal human metaphase spread (46,XY), counterstainmg of chromosomes is 
in blue Strong red signals are visible on the short arm of both homologs of chromosome 12 (arrowheads), 
indicating the presence of amplified DNA sequences from this region within the original (umor DNA (60) 
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LEGENDS TO THE FIGURES ON COLOR PLATE IV 
Figures 78 and 79. 
Results of comparative genomic hybridization with differentially labeled tumor and normal human DNA on 
normal human metaphase spreads, after digital image acquisition and multi(pseudo)color representation (78) 
Hybridization of WDLPS DNA from case 1 (yellow pseudocolor) and total normal human DNA (red 
pseudocolor) on DAPI counterstained chromosomes (blue pseudocolor) The large 12ql4-q22 amphcon on 
both homologues of chromosome 12 is indicated by arrowheads Amplifications on other chromosomes are 
denoted by arrows (79A) A representative chromosome 12 after CGH with WDLPS DNA of case 6 (red 
pseudocolor) and normal human DNA (green pseudocolor) the amplified regions ql4-ql5 and q21 3-q22 are 
indicated by arrowheads above the chromosome (left to right), while the centromere and the ql3-region are 
represented by arrows below the chromosome (left to right) (79B) Representation of chromosome 12 
fluorescence intensity profiles belonging to the chromosome 12 displayed in В Tumor DNA and normal 
DNA fluorescence profiles are given by the red and the green line in the graphic, respectively The blue Ime 
shows the tumor-versus-normal DNA fluorescence ratio for this chromosome, which is aligned as DAPI-
banded image above the graphic Arrows and arrowheads correspond to the regions marked in В 
Figures 80-85. 
Metaphase (80-83) and interphase (84, 85) fluorescence in situ hybridization (FISH) analysis of synovial 
sarcomas ST-88-20756 (80, 81), ST-88-04017 (82, 83), 23-303/91 (84) and 28775/90 (85), using OATL1 
YAC/C2 (80, 82, 84 and 85 left panel) and OATL2 YACA7 (81, 83, 84 and 85 right panel) as probes in 
conjunction with the X centromere-specific repeat probe pBamXS The YAC signals are displayed in light 
blue and the X centromere signal in red The der(X) is marked by an arrow and der(18) by an arrowhead 
Also in 81 (top-left) and 82 (top-nght), interphase nuclei with the respective FISH signals can be observed 
Figures 88 and 89. 
FISH of OATL1 YAC02 (88) and OATL2 YAC#7 (89) on partial metaphase spreads of the renal tumor CL-
89-12117 In 88 a signal is apparent on dcr(l) only, in 89, a split signal is apparent on both der(X) and 
der(l) (arrows) 
84 85 
Example of CHG analysis on one of the two chromosomes 12 shown in Fig 59 The isolated chromosome 
has been stretched to perform accurate scanning of the red (tumor DNA) and yellow (reference DNA) 
fluorescence intensities over its whole length The measured intensity profiles for tumor and reference DNA 
are represented by the red and green lines in the graphic, respectively The blue line represents the CGH 
ratio profile, ι e , the red-to-yellow fluorescence ratio over the whole chromosome length, whereby values 
higher or lower than 1 indicate over- or underrepresentation of tumor DNA compared to reference DNA, 
respectively The overrepresentation of 12p sequences, especially the region 12pll 2-12 1 (with a peak value 
at 12pll 23), m the tumor DNA can easily be discerned 
Figures 66-68. 
Fluorescence in situ hybridization with WCP probe specific for chromosome 12 on extra ring chromosomes 
(large arrowheads) in partial metaphases of two WDLPS cases (66) Large ring from case 1 (stained with 
DAPI in the upper comer), the normal chromosome 1 is shown as a comparative scale (small arrowhead) 
(67) A smaller ring chromosome from case 1 (68) Three rings from case 3 Small arrowheads in 66 and 68 
show normal chromosome 12 
Figures 69-71. 
Fluorescence in situ hybridization with WCP probe specific for chromosome 12 on giant rod markers (large 
arrowheads) in partial metaphases from three WDLPS cases (69) Giant rod marker from case 4, small 
arrowheads point out normal chromosomes 12 (70) Rod marker mar2 from case 5 co-hybndized with 
spectrum green WCP probe specific for chromosome 12 and spectrum orange WCP probe specific to 
chromosome 4 (small arrowheads), marl is non clonally deleted (arrow) (71) Large rod marker from case 
6, one normal and two non clonal chromosome 12 derivatives are shown (small arrowheads) 
Figures 72-74. 
Fluorescence in situ hybridization with WCP probe specific for chromosome 1 on rod markers (large 
arrowheads) in partial metaphases of 2 WDLPS cases Small arrowheads point out normal chromosomes 1 
(72) Rod marker from case 4 (73) Rod marker from case 6, two non clonal unbalanced derivatives from 
chromosome 1 are shown in addition to the normal chromosome 1 (small arrowheads) (74) Hybridization 
with WCP probes specific for chromosome 4 on mar 1 and mar 2 (large arrowheads) in partial metaphase 
from case 5 small arrowheads show the two normal chromosomes 4 
Figure 75-76. 
Fluorescence m situ hybridization with WCP probe specific for chromosome 12 on interphase nuclei from 
case 1 (75) Arrowhead indicates a micronucleus entirely filled by chromosome 12 specific signal, arrows 
indicate chromosome 12-positive domains in neighbouring interphase nuclei (76) Nucleus with a 
chromosome 12 positive bleb (arrowhead) and two chromosome 12 positive domains (arrows) 
STELLINGEN 
1 I(12p)-negatieve kiemceltumoren van de testis lijken cytogenetisch en pathogenetisch sterk 
op hun i(12p)-positieve tegenhangers en moeten dus met als een aparte subgroep worden 
beschouwd (Castedo et al , Cancer Genet Cytogenet 35 171-178, 1988, dit proefschrift) 
2 De diagnostiek van kiemceltumoren van de testis via fluorescente in situ hybridisatie met 
een chromosoom 12 specifieke centromeerprobe is onbetrouwbaar (Mukherjee et al , 
Genes Chromos Cancer 3 300-307, 1991) 
3 De veronderstelling dat i(12p) vorming het resultaat zou zijn van een "non-sister" 
Chromatide uitwisseling is onjuist, omdat dit ïsochromosoom twee genetisch identieke 
chromosoomarmen bevat (Mukherjee et al , Genes Chromos Cancer 3 300-307, 1991, dit 
proefschrift) 
4 Amplificatie van twee aparte chromosoomregio's (12ql4-ql5 en 12q21 3-q22) is een 
karakteristieke genomische afwijking voor de subgroep van goed gedifferentieerde 
liposarcomen (Dit proefschrift) 
5 Het voorkomen van twee verschillende Xpll 2 breukpunt regio's in synoviaal sarcomen 
met t(X,18)(pll 2,qll 2) lijkt gerelateerd te zijn aan het histologisch fenotype van deze 
tumoren (Dit proefschrift) 
6 Het voorkomen van een subgroep van papillaire niercelcarcinomen met specifieke Xpll 2 
afwijkingen (translocaties, deleties) in uitsluitend mannelijke patiënten doet vermoeden dat 
de genetische informatie gelegen in het Xpll 2 locus tumor suppressor activiteit bezit (De 
Jong et al, Cancer Genet Cytogenet 21 165-169, 1986, Tomhnson et al , Cancer Genet 
Cytogenet 57 11-17, 1991, Meloni et al, Cancer Genet Cytogenet 65 1-6, 1993, Ohjimi 
et al , Cancer Genet Cytogenet 70 77-78, 1993) 
7 Vroegtijdige activatie van p34"k'', een serine-threonine kinase dat het ingaan van de mitose 
controleert, vormt mogelijk een algemeen mechanisme voor cellen die apoptose 
ondergaan (Shi et al , Science 263 1143-1145, 1994) 
8 Gezien het enthousiasme waarmee moleculaire wetenschappers zich tegenwoordig storten 
op humane (bot)resten van meer dan 75 jaar oud teneinde hun identiteit te achterhalen 
moet serieus worden gevreesd voor de eeuwige rust van vele dierbare gestorvenen 
(Hagelberg et al , Nature 352 427-428, 1991, Jeffreys et al , Forensic Scient Int 56 65-
76, 1992, Gill et al, Nature Genet 6 130-135, 1994) 
9 Het merendeel van de persoonlijke ongevallen tijdens vliegreizen wordt niet veroorzaakt 
door vliegtuigongelukken maar door ongelukken met zware bagage die door de reizigers 
zelf als handbagage boven de zitplaatsen wordt gedeponeerd 
10 Alle inspanningen op bodybuilding en fitness centra ten spijt is pure kracht geen maat van 
het lichaam maar een maat van de geest 
Ron Suijkerbuijk 
Nijmegen, 28 april 1994 



